1	Medium	medium	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	Chain	chain	NN	_	7	NMOD
4	Acyl	acyl	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	CoA	coa	NN	_	7	NMOD
7	Dehydrogenase	dehydrogenase	NN	_	8	NMOD
8	Deficiency	deficiency	NN	_	0	ROOT
9	in	in	IN	_	8	LOC
10	Gene	gene	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	Targeted	target	VBN	_	13	NMOD
13	Mice	mouse	NNS	_	9	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Medium	medium	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	chain	chain	NN	_	7	NMOD
4	acyl	acyl	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	CoA	coa	NN	_	7	NMOD
7	dehydrogenase	dehydrogenase	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	MCAD	mcad	NN	_	11	NMOD
10	)	)	-RRB-	_	11	P
11	deficiency	deficiency	NN	_	12	SBJ
12	is	be	VBZ	_	0	ROOT
13	the	the	DT	_	17	NMOD
14	most	most	RBS	_	15	AMOD
15	common	common	JJ	_	17	NMOD
16	inherited	inherit	VBN	_	17	NMOD
17	disorder	disorder	NN	_	12	PRD
18	of	of	IN	_	17	NMOD
19	mitochondrial	mitochondrial	JJ	_	24	NMOD
20	fatty	fatty	JJ	_	21	NMOD
21	acid	acid	NN	_	24	NMOD
22	β	β	NN	_	24	NMOD
23	-	-	HYPH	_	22	P
24	oxidation	oxidation	NN	_	18	PMOD
25	in	in	IN	_	12	LOC
26	humans	human	NNS	_	25	PMOD
27	.	.	.	_	12	P

1	To	to	TO	_	11	PRP
2	better	well	RBR	_	1	ADV
3	understand	understand	VB	_	1	IM
4	the	the	DT	_	5	NMOD
5	pathogenesis	pathogenesis	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	this	this	DT	_	8	NMOD
8	disease	disease	NN	_	6	PMOD
9	,	,	,	_	11	P
10	we	we	PRP	_	11	SBJ
11	developed	develop	VBD	_	0	ROOT
12	a	a	DT	_	14	NMOD
13	mouse	mouse	NN	_	14	NMOD
14	model	model	NN	_	11	OBJ
15	for	for	IN	_	14	NMOD
16	MCAD	mcad	NN	_	17	NMOD
17	deficiency	deficiency	NN	_	19	NMOD
18	(	(	-LRB-	_	19	P
19	MCAD	mcad	NN	_	15	PMOD
20	−	−	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	−	−	SYM	_	19	P
23	)	)	-RRB-	_	11	P
24	by	by	IN	_	11	MNR
25	gene	gene	NN	_	26	NMOD
26	targeting	targeting	NN	_	24	PMOD
27	in	in	IN	_	26	LOC
28	embryonic	embryonic	JJ	_	29	NMOD
29	stem	stem	NN	_	31	NMOD
30	(	(	-LRB-	_	31	P
31	ES	e	NN	_	33	NMOD
32	)	)	-RRB-	_	33	P
33	cells	cell	NNS	_	27	PMOD
34	.	.	.	_	11	P

1	The	the	DT	_	6	NMOD
2	MCAD	mcad	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	developed	develop	VBD	_	0	ROOT
8	an	an	DT	_	10	NMOD
9	organic	organic	JJ	_	10	NMOD
10	aciduria	aciduria	NN	_	7	OBJ
11	and	and	CC	_	10	COORD
12	fatty	fatty	JJ	_	13	NMOD
13	liver	liver	NN	_	11	CONJ
14	,	,	,	_	7	P
15	and	and	CC	_	7	COORD
16	showed	show	VBD	_	15	CONJ
17	profound	profound	JJ	_	19	NMOD
18	cold	cold	NN	_	19	NMOD
19	intolerance	intolerance	NN	_	16	OBJ
20	at	at	IN	_	16	ADV
21	4	0	CD	_	22	NMOD
22	°C	°c	NN	_	20	PMOD
23	with	with	IN	_	16	ADV
24	prior	prior	JJ	_	25	NMOD
25	fasting	fasting	NN	_	23	PMOD
26	.	.	.	_	7	P

1	The	the	DT	_	4	NMOD
2	sporadic	sporadic	JJ	_	4	NMOD
3	cardiac	cardiac	JJ	_	4	NMOD
4	lesions	lesion	NNS	_	12	SBJ
5	seen	see	VBN	_	4	NMOD
6	in	in	IN	_	5	ADV
7	MCAD	mcad	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	mice	mouse	NNS	_	6	PMOD
12	have	have	VBP	_	0	ROOT
13	not	not	RB	_	12	ADV
14	been	be	VBN	_	12	VC
15	reported	report	VBN	_	14	VC
16	in	in	IN	_	15	LOC
17	human	human	JJ	_	19	NMOD
18	MCAD	mcad	NN	_	19	NMOD
19	patients	patient	NNS	_	16	PMOD
20	.	.	.	_	12	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	significant	significant	JJ	_	5	NMOD
4	neonatal	neonatal	JJ	_	5	NMOD
5	mortality	mortality	NN	_	2	PRD
6	of	of	IN	_	5	NMOD
7	MCAD	mcad	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	pups	pup	NNS	_	6	PMOD
12	demonstrating	demonstrate	VBG	_	5	NMOD
13	similarities	similarity	NNS	_	12	OBJ
14	to	to	IN	_	13	NMOD
15	patterns	pattern	NNS	_	14	PMOD
16	of	of	IN	_	15	NMOD
17	clinical	clinical	JJ	_	18	NMOD
18	episodes	episode	NNS	_	16	PMOD
19	and	and	CC	_	18	COORD
20	mortality	mortality	NN	_	19	CONJ
21	in	in	IN	_	15	LOC
22	MCAD	mcad	NN	_	24	AMOD
23	-	-	HYPH	_	22	P
24	deficient	deficient	JJ	_	25	NMOD
25	patients	patient	NNS	_	21	PMOD
26	.	.	.	_	2	P

1	The	the	DT	_	5	NMOD
2	MCAD	mcad	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	deficient	deficient	JJ	_	5	NMOD
5	mouse	mouse	NN	_	6	SBJ
6	reproduced	reproduce	VBD	_	0	ROOT
7	important	important	JJ	_	8	NMOD
8	aspects	aspect	NNS	_	6	OBJ
9	of	of	IN	_	8	NMOD
10	human	human	JJ	_	12	NMOD
11	MCAD	mcad	NN	_	12	NMOD
12	deficiency	deficiency	NN	_	9	PMOD
13	and	and	CC	_	6	COORD
14	is	be	VBZ	_	13	CONJ
15	a	a	DT	_	17	NMOD
16	valuable	valuable	JJ	_	17	NMOD
17	model	model	NN	_	14	PRD
18	for	for	IN	_	17	NMOD
19	further	further	JJ	_	20	NMOD
20	analysis	analysis	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	roles	role	NNS	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	fatty	fatty	JJ	_	26	NMOD
26	acid	acid	NN	_	27	NMOD
27	oxidation	oxidation	NN	_	24	PMOD
28	and	and	CC	_	23	COORD
29	pathogenesis	pathogenesis	NN	_	28	CONJ
30	of	of	IN	_	29	NMOD
31	human	human	JJ	_	32	NMOD
32	diseases	disease	NNS	_	30	PMOD
33	involving	involve	VBG	_	32	NMOD
34	fatty	fatty	JJ	_	35	NMOD
35	acid	acid	NN	_	36	NMOD
36	oxidation	oxidation	NN	_	33	OBJ
37	.	.	.	_	6	P

1	Synopsis	synopsis	NN	_	0	ROOT

1	Medium	medium	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	chain	chain	NN	_	7	NMOD
4	acyl	acyl	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	CoA	coa	NN	_	7	NMOD
7	dehydrogenase	dehydrogenase	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	MCAD	mcad	NN	_	11	NMOD
10	)	)	-RRB-	_	11	P
11	deficiency	deficiency	NN	_	12	SBJ
12	is	be	VBZ	_	0	ROOT
13	one	one	CD	_	12	PRD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	19	NMOD
16	most	most	RBS	_	17	AMOD
17	common	common	JJ	_	19	NMOD
18	inherited	inherit	VBN	_	19	NMOD
19	disorders	disorder	NNS	_	14	PMOD
20	of	of	IN	_	19	NMOD
21	metabolism	metabolism	NN	_	20	PMOD
22	.	.	.	_	12	P

1	This	this	DT	_	2	NMOD
2	defect	defect	NN	_	7	SBJ
3	in	in	IN	_	2	NMOD
4	fatty	fatty	JJ	_	5	NMOD
5	acid	acid	NN	_	6	NMOD
6	oxidation	oxidation	NN	_	3	PMOD
7	can	can	MD	_	0	ROOT
8	lead	lead	VB	_	7	VC
9	to	to	IN	_	8	ADV
10	severe	severe	JJ	_	14	NMOD
11	and	and	CC	_	10	COORD
12	sometimes	sometimes	RB	_	13	TMP
13	fatal	fatal	JJ	_	11	CONJ
14	disease	disease	NN	_	9	PMOD
15	,	,	,	_	8	P
16	especially	especially	RB	_	17	PMOD
17	in	in	IN	_	8	LOC
18	young	young	JJ	_	19	NMOD
19	children	child	NNS	_	17	PMOD
20	because	because	IN	_	8	PRP
21	they	they	PRP	_	22	SBJ
22	are	be	VBP	_	20	SUB
23	unable	unable	JJ	_	22	PRD
24	to	to	TO	_	23	AMOD
25	tolerate	tolerate	VB	_	24	IM
26	a	a	DT	_	28	NMOD
27	fasting	fasting	NN	_	28	NMOD
28	episode	episode	NN	_	25	OBJ
29	.	.	.	_	7	P

1	Metabolic	metabolic	JJ	_	2	NMOD
2	complications	complication	NNS	_	3	SBJ
3	include	include	VBP	_	0	ROOT
4	very	very	RB	_	5	AMOD
5	low	low	JJ	_	8	NMOD
6	blood	blood	NN	_	7	NMOD
7	glucose	glucose	NN	_	8	NMOD
8	concentrations	concentration	NNS	_	3	OBJ
9	and	and	CC	_	8	COORD
10	generation	generation	NN	_	9	CONJ
11	of	of	IN	_	10	NMOD
12	toxic	toxic	JJ	_	15	NMOD
13	by	by	JJ	_	15	NMOD
14	-	-	HYPH	_	13	P
15	products	product	NNS	_	11	PMOD
16	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	disorder	disorder	NN	_	3	SBJ
3	can	can	MD	_	0	ROOT
4	result	result	VB	_	3	VC
5	in	in	IN	_	4	ADV
6	sudden	sudden	JJ	_	8	NMOD
7	infant	infant	NN	_	8	NMOD
8	death	death	NN	_	5	PMOD
9	.	.	.	_	3	P

1	Using	use	VBG	_	16	MNR
2	a	a	DT	_	3	NMOD
3	process	process	NN	_	1	OBJ
4	known	know	VBN	_	3	NMOD
5	as	as	IN	_	4	ADV
6	gene	gene	NN	_	7	NMOD
7	targeting	targeting	NN	_	5	PMOD
8	in	in	IN	_	1	LOC
9	mouse	mouse	NN	_	12	NMOD
10	embryonic	embryonic	JJ	_	12	NMOD
11	stem	stem	NN	_	12	NMOD
12	cells	cell	NNS	_	8	PMOD
13	,	,	,	_	16	P
14	the	the	DT	_	15	NMOD
15	authors	author	NNS	_	16	SBJ
16	have	have	VBP	_	0	ROOT
17	developed	develop	VBN	_	16	VC
18	a	a	DT	_	20	NMOD
19	mouse	mouse	NN	_	20	NMOD
20	model	model	NN	_	17	OBJ
21	with	with	IN	_	20	NMOD
22	the	the	DT	_	25	NMOD
23	same	same	JJ	_	25	NMOD
24	enzyme	enzyme	NN	_	25	NMOD
25	deficiency	deficiency	NN	_	21	PMOD
26	.	.	.	_	16	P

1	This	this	DT	_	3	NMOD
2	mouse	mouse	NN	_	3	NMOD
3	model	model	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	MCAD	mcad	NN	_	6	NMOD
6	deficiency	deficiency	NN	_	4	PMOD
7	develops	develop	VBZ	_	0	ROOT
8	many	many	JJ	_	7	OBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	13	NMOD
11	same	same	JJ	_	13	NMOD
12	disease	disease	NN	_	13	NMOD
13	characteristics	characteristic	NNS	_	9	PMOD
14	found	find	VBN	_	13	NMOD
15	in	in	IN	_	14	LOC
16	affected	affect	VBN	_	17	NMOD
17	children	child	NNS	_	15	PMOD
18	.	.	.	_	7	P

1	The	the	DT	_	6	NMOD
2	MCAD	mcad	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	deficient	deficient	JJ	_	6	NMOD
5	mouse	mouse	NN	_	6	NMOD
6	model	model	NN	_	7	SBJ
7	shows	show	VBZ	_	0	ROOT
8	a	a	DT	_	10	NMOD
9	high	high	JJ	_	10	NMOD
10	rate	rate	NN	_	7	OBJ
11	of	of	IN	_	10	NMOD
12	newborn	newborn	NN	_	13	NMOD
13	loss	loss	NN	_	11	PMOD
14	,	,	,	_	13	P
15	intolerance	intolerance	NN	_	13	CONJ
16	to	to	IN	_	15	NMOD
17	cold	cold	NN	_	16	PMOD
18	,	,	,	_	15	P
19	and	and	CC	_	15	COORD
20	the	the	DT	_	23	NMOD
21	characteristic	characteristic	JJ	_	23	NMOD
22	biochemical	biochemical	JJ	_	23	NMOD
23	changes	change	NNS	_	19	CONJ
24	in	in	IN	_	23	NMOD
25	the	the	DT	_	26	NMOD
26	blood	blood	NN	_	24	PMOD
27	,	,	,	_	26	P
28	tissues	tissue	NNS	_	26	CONJ
29	,	,	,	_	28	P
30	and	and	CC	_	28	COORD
31	urine	urine	NN	_	30	CONJ
32	that	that	WDT	_	33	SBJ
33	are	be	VBP	_	23	NMOD
34	very	very	RB	_	35	AMOD
35	similar	similar	JJ	_	33	PRD
36	to	to	IN	_	35	AMOD
37	those	those	DT	_	36	PMOD
38	found	find	VBN	_	37	NMOD
39	in	in	IN	_	38	ADV
40	the	the	DT	_	43	NMOD
41	human	human	JJ	_	43	NMOD
42	disease	disease	NN	_	43	NMOD
43	counterpart	counterpart	NN	_	39	PMOD
44	.	.	.	_	7	P

1	The	the	DT	_	6	NMOD
2	MCAD	mcad	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	deficient	deficient	JJ	_	6	NMOD
5	mouse	mouse	NN	_	6	NMOD
6	model	model	NN	_	7	SBJ
7	will	will	MD	_	0	ROOT
8	allow	allow	VB	_	7	VC
9	researchers	researcher	NNS	_	10	SBJ
10	to	to	TO	_	8	OPRD
11	better	well	RBR	_	10	ADV
12	understand	understand	VB	_	10	IM
13	disease	disease	NN	_	14	NMOD
14	mechanisms	mechanism	NNS	_	12	OBJ
15	so	so	IN	_	16	SUB
16	that	that	IN	_	12	PRP
17	new	new	JJ	_	19	NMOD
18	preventive	preventive	JJ	_	19	NMOD
19	measures	measure	NNS	_	22	SBJ
20	or	or	CC	_	19	COORD
21	therapies	therapy	NNS	_	20	CONJ
22	can	can	MD	_	16	SUB
23	be	be	VB	_	22	VC
24	developed	develop	VBN	_	23	VC
25	.	.	.	_	7	P

1	Introduction	introduction	NN	_	0	ROOT

1	Mitochondrial	mitochondrial	JJ	_	4	NMOD
2	β	β	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	oxidation	oxidation	NN	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	fatty	fatty	JJ	_	7	NMOD
7	acids	acid	NNS	_	5	PMOD
8	provides	provide	VBZ	_	0	ROOT
9	energy	energy	NN	_	8	OBJ
10	,	,	,	_	8	P
11	especially	especially	RB	_	12	PMOD
12	during	during	IN	_	8	TMP
13	fasting	fasting	NN	_	14	NMOD
14	conditions	condition	NNS	_	12	PMOD
15	.	.	.	_	8	P

1	Fatty	fatty	JJ	_	2	NMOD
2	acid	acid	NN	_	3	NMOD
3	oxidation	oxidation	NN	_	4	SBJ
4	occurs	occur	VBZ	_	0	ROOT
5	in	in	IN	_	4	LOC
6	mitochondria	mitochondrion	NNS	_	5	PMOD
7	and	and	CC	_	4	COORD
8	consists	consist	VBZ	_	7	CONJ
9	of	of	IN	_	8	ADV
10	a	a	DT	_	12	NMOD
11	repeating	repeat	VBG	_	12	NMOD
12	circuit	circuit	NN	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	four	four	CD	_	16	NMOD
15	sequential	sequential	JJ	_	16	NMOD
16	steps	step	NNS	_	13	PMOD
17	.	.	.	_	4	P

1	There	there	EX	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	four	four	CD	_	10	NMOD
4	straight	straight	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	chain	chain	NN	_	10	NMOD
7	acyl	acyl	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	CoA	coa	NN	_	10	NMOD
10	dehydrogenases	dehydrogenases	NNS	_	2	PRD
11	involved	involve	VBN	_	10	NMOD
12	in	in	IN	_	11	ADV
13	the	the	DT	_	15	NMOD
14	initial	initial	JJ	_	15	NMOD
15	step	step	NN	_	12	PMOD
16	.	.	.	_	2	P

1	Medium	medium	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	chain	chain	NN	_	7	NMOD
4	acyl	acyl	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	CoA	coa	NN	_	7	NMOD
7	dehydrogenase	dehydrogenase	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	MCAD	mcad	NN	_	27	SBJ
10	)	)	-RRB-	_	9	P
11	(	(	-LRB-	_	15	P
12	the	the	DT	_	14	NMOD
13	mouse	mouse	NN	_	14	NMOD
14	gene	gene	NN	_	15	SBJ
15	is	be	VBZ	_	9	PRN
16	Acadm	acadm	NN	_	15	PRD
17	,	,	,	_	15	P
18	whereas	whereas	IN	_	15	ADV
19	the	the	DT	_	20	NMOD
20	protein	protein	NN	_	21	SBJ
21	is	be	VBZ	_	18	SUB
22	MCAD	mcad	NN	_	21	PRD
23	)	)	-RRB-	_	15	P
24	,	,	,	_	27	P
25	specifically	specifically	RB	_	27	ADV
26	,	,	,	_	27	P
27	is	be	VBZ	_	0	ROOT
28	responsible	responsible	JJ	_	27	PRD
29	for	for	IN	_	28	AMOD
30	catalyzing	catalyze	VBG	_	29	PMOD
31	the	the	DT	_	32	NMOD
32	dehydrogenation	dehydrogenation	NN	_	30	OBJ
33	of	of	IN	_	32	NMOD
34	medium	medium	JJ	_	36	NMOD
35	-	-	HYPH	_	34	P
36	chain	chain	NN	_	37	NMOD
37	length	length	NN	_	45	NMOD
38	(	(	-LRB-	_	41	P
39	C6	c0	NN	_	41	NMOD
40	–	–	SYM	_	41	P
41	C12	c0	NN	_	37	PRN
42	)	)	-RRB-	_	41	P
43	fatty	fatty	JJ	_	44	NMOD
44	acid	acid	NN	_	45	NMOD
45	thioesters	thioesters	NNS	_	33	PMOD
46	[	[	-LRB-	_	47	P
47	1	0	CD	_	27	PRN
48	]	]	-RRB-	_	47	P
49	.	.	.	_	27	P

1	Acadm	acadm	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	transcribed	transcribe	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	the	the	DT	_	6	NMOD
6	nucleus	nucleus	NN	_	4	PMOD
7	,	,	,	_	3	P
8	translated	translate	VBN	_	3	CONJ
9	in	in	IN	_	8	LOC
10	the	the	DT	_	11	NMOD
11	cytosol	cytosol	NN	_	9	PMOD
12	,	,	,	_	8	P
13	and	and	CC	_	8	COORD
14	translocated	translocate	VBN	_	13	CONJ
15	into	into	IN	_	14	DIR
16	the	the	DT	_	18	NMOD
17	mitochondrial	mitochondrial	JJ	_	18	NMOD
18	matrix	matrix	NN	_	15	PMOD
19	[	[	-LRB-	_	20	P
20	2	0	CD	_	3	PRN
21	–	–	SYM	_	22	P
22	4	0	CD	_	20	NMOD
23	]	]	-RRB-	_	20	P
24	.	.	.	_	2	P

1	Once	once	IN	_	10	TMP
2	inside	inside	IN	_	1	SUB
3	the	the	DT	_	5	NMOD
4	mitochondrial	mitochondrial	JJ	_	5	NMOD
5	matrix	matrix	NN	_	2	PMOD
6	,	,	,	_	10	P
7	the	the	DT	_	9	NMOD
8	MCAD	mcad	NN	_	9	NMOD
9	monomers	monomer	NNS	_	10	SBJ
10	are	be	VBP	_	0	ROOT
11	assembled	assemble	VBN	_	10	VC
12	into	into	IN	_	11	ADV
13	homotetramers	homotetramers	NNS	_	12	PMOD
14	to	to	TO	_	11	PRP
15	gain	gain	VB	_	14	IM
16	enzymatic	enzymatic	JJ	_	17	NMOD
17	activity	activity	NN	_	15	OBJ
18	[	[	-LRB-	_	19	P
19	4	0	CD	_	11	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	10	P

1	MCAD	mcad	NN	_	2	NMOD
2	activity	activity	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	essential	essential	JJ	_	3	PRD
5	for	for	IN	_	4	AMOD
6	complete	complete	JJ	_	9	NMOD
7	fatty	fatty	JJ	_	8	NMOD
8	acid	acid	NN	_	9	NMOD
9	oxidation	oxidation	NN	_	5	PMOD
10	.	.	.	_	3	P

1	Inherited	inherit	VBN	_	3	NMOD
2	MCAD	mcad	NN	_	3	NMOD
3	deficiency	deficiency	NN	_	4	SBJ
4	exists	exist	VBZ	_	0	ROOT
5	in	in	IN	_	4	LOC
6	humans	human	NNS	_	5	PMOD
7	as	as	IN	_	4	ADV
8	an	an	DT	_	11	NMOD
9	autosomal	autosomal	JJ	_	11	NMOD
10	recessive	recessive	JJ	_	11	NMOD
11	disorder	disorder	NN	_	7	PMOD
12	.	.	.	_	4	P

1	MCAD	mcad	NN	_	2	NMOD
2	deficiency	deficiency	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	first	$#ORD#$	RB	_	3	TMP
5	described	describe	VBN	_	3	VC
6	in	in	IN	_	5	TMP
7	1982	0	CD	_	6	PMOD
8	—	—	SYM	_	9	P
9	1983	0	CD	_	7	NMOD
10	[	[	-LRB-	_	11	P
11	5	0	CD	_	5	PRN
12	–	–	SYM	_	13	P
13	7	0	CD	_	11	NMOD
14	]	]	-RRB-	_	11	P
15	and	and	CC	_	3	COORD
16	has	have	VBZ	_	15	CONJ
17	been	be	VBN	_	16	VC
18	described	describe	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	numerous	numerous	JJ	_	21	NMOD
21	patients	patient	NNS	_	19	PMOD
22	[	[	-LRB-	_	23	P
23	1	0	CD	_	18	PRN
24	,	,	,	_	23	P
25	8	0	CD	_	23	APPO
26	–	–	SYM	_	27	P
27	11	0	CD	_	25	NMOD
28	]	]	-RRB-	_	23	P
29	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	carrier	carrier	NN	_	3	NMOD
3	frequency	frequency	NN	_	8	SBJ
4	in	in	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	Caucasian	caucasian	JJ	_	7	NMOD
7	population	population	NN	_	4	PMOD
8	has	have	VBZ	_	0	ROOT
9	been	be	VBN	_	8	VC
10	estimated	estimate	VBN	_	9	VC
11	to	to	TO	_	10	OPRD
12	be	be	VB	_	11	IM
13	between	between	IN	_	14	QMOD
14	1	0	CD	_	12	PRD
15	in	in	IN	_	14	QMOD
16	50	0	CD	_	14	QMOD
17	to	to	IN	_	14	QMOD
18	80	0	CD	_	14	QMOD
19	with	with	IN	_	12	ADV
20	an	an	DT	_	21	NMOD
21	incidence	incidence	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	clinical	clinical	JJ	_	24	NMOD
24	disease	disease	NN	_	22	PMOD
25	expected	expect	VBN	_	24	NMOD
26	at	at	IN	_	25	ADV
27	around	around	IN	_	28	QMOD
28	1	0	CD	_	30	NMOD
29	in	in	IN	_	28	QMOD
30	15,000	0	CD	_	26	PMOD
31	[	[	-LRB-	_	36	P
32	1	0	CD	_	36	NMOD
33	,	,	,	_	36	P
34	9	0	CD	_	36	NMOD
35	,	,	,	_	36	P
36	12	0	CD	_	12	PRN
37	]	]	-RRB-	_	36	P
38	.	.	.	_	8	P

1	MCAD	mcad	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	deficient	deficient	JJ	_	4	NMOD
4	patients	patient	NNS	_	5	SBJ
5	exhibit	exhibit	VBP	_	0	ROOT
6	clinical	clinical	JJ	_	7	NMOD
7	episodes	episode	NNS	_	5	OBJ
8	often	often	RB	_	9	TMP
9	associated	associate	VBN	_	7	NMOD
10	with	with	IN	_	9	ADV
11	fasting	fasting	NN	_	10	PMOD
12	.	.	.	_	5	P

1	Patients	patient	NNS	_	2	SBJ
2	manifest	manifest	VBP	_	0	ROOT
3	disease	disease	NN	_	2	OBJ
4	usually	usually	RB	_	5	PMOD
5	during	during	IN	_	2	TMP
6	the	the	DT	_	9	NMOD
7	first	$#ORD#$	JJ	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	years	year	NNS	_	5	PMOD
10	of	of	IN	_	9	NMOD
11	life	life	NN	_	10	PMOD
12	.	.	.	_	2	P

1	Symptoms	symptom	NNS	_	2	SBJ
2	include	include	VBP	_	0	ROOT
3	hypoketotic	hypoketotic	JJ	_	4	NMOD
4	hypoglycemia	hypoglycemia	NN	_	2	OBJ
5	and	and	CC	_	4	COORD
6	Reye	reye	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	like	like	JJ	_	9	NMOD
9	episodes	episode	NNS	_	5	CONJ
10	[	[	-LRB-	_	11	P
11	1	0	CD	_	2	PRN
12	]	]	-RRB-	_	11	P
13	.	.	.	_	2	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	estimated	estimate	VBN	_	2	VC
4	that	that	IN	_	3	OBJ
5	approximately	approximately	RB	_	6	QMOD
6	59	0	CD	_	7	NMOD
7	%	%	NN	_	19	SBJ
8	of	of	IN	_	7	NMOD
9	patients	patient	NNS	_	8	PMOD
10	presenting	present	VBG	_	9	NMOD
11	clinically	clinically	RB	_	10	ADV
12	between	between	IN	_	10	TMP
13	15	0	CD	_	16	NMOD
14	to	to	IN	_	13	QMOD
15	26	0	CD	_	13	QMOD
16	mo	mo	NN	_	12	PMOD
17	of	of	IN	_	16	NMOD
18	age	age	NN	_	17	PMOD
19	die	die	VBP	_	4	SUB
20	during	during	IN	_	19	TMP
21	their	their	PRP$	_	24	NMOD
22	first	$#ORD#$	JJ	_	24	NMOD
23	clinical	clinical	JJ	_	24	NMOD
24	episode	episode	NN	_	20	PMOD
25	[	[	-LRB-	_	26	P
26	1	0	CD	_	3	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	pathogenesis	pathogenesis	NN	_	13	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	wide	wide	JJ	_	6	NMOD
6	range	range	NN	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	metabolic	metabolic	JJ	_	9	NMOD
9	disturbances	disturbance	NNS	_	7	PMOD
10	in	in	IN	_	9	NMOD
11	MCAD	mcad	NN	_	12	NMOD
12	deficiency	deficiency	NN	_	10	PMOD
13	is	be	VBZ	_	0	ROOT
14	poorly	poorly	RB	_	13	ADV
15	understood	understand	VBN	_	13	VC
16	and	and	CC	_	13	COORD
17	certain	certain	JJ	_	18	NMOD
18	aspects	aspect	NNS	_	22	SBJ
19	of	of	IN	_	18	NMOD
20	patient	patient	NN	_	21	NMOD
21	management	management	NN	_	19	PMOD
22	are	be	VBP	_	16	CONJ
23	controversial	controversial	JJ	_	22	PRD
24	.	.	.	_	13	P

1	An	an	DT	_	3	NMOD
2	animal	animal	NN	_	3	NMOD
3	model	model	NN	_	7	SBJ
4	for	for	IN	_	3	NMOD
5	MCAD	mcad	NN	_	6	NMOD
6	deficiency	deficiency	NN	_	4	PMOD
7	is	be	VBZ	_	0	ROOT
8	essential	essential	JJ	_	7	PRD
9	to	to	TO	_	7	PRP
10	better	well	RBR	_	9	ADV
11	understand	understand	VB	_	9	IM
12	the	the	DT	_	13	NMOD
13	pathogenesis	pathogenesis	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	MCAD	mcad	NN	_	16	NMOD
16	deficiency	deficiency	NN	_	14	PMOD
17	and	and	CC	_	9	COORD
18	to	to	TO	_	17	CONJ
19	develop	develop	VB	_	18	IM
20	better	good	JJR	_	22	NMOD
21	management	management	NN	_	22	NMOD
22	regimens	regimen	NNS	_	19	OBJ
23	for	for	IN	_	22	NMOD
24	human	human	JJ	_	25	NMOD
25	patients	patient	NNS	_	23	PMOD
26	.	.	.	_	7	P

1	To	to	TO	_	13	PRP
2	gain	gain	VB	_	1	IM
3	further	further	JJ	_	4	NMOD
4	insight	insight	NN	_	2	OBJ
5	into	into	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	mechanisms	mechanism	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	this	this	DT	_	10	NMOD
10	disease	disease	NN	_	8	PMOD
11	,	,	,	_	13	P
12	we	we	PRP	_	13	SBJ
13	developed	develop	VBD	_	0	ROOT
14	a	a	DT	_	16	NMOD
15	mouse	mouse	NN	_	16	NMOD
16	model	model	NN	_	13	OBJ
17	of	of	IN	_	16	NMOD
18	MCAD	mcad	NN	_	19	NMOD
19	deficiency	deficiency	NN	_	17	PMOD
20	by	by	IN	_	13	MNR
21	gene	gene	NN	_	22	NMOD
22	targeting	targeting	NN	_	20	PMOD
23	in	in	IN	_	22	LOC
24	embryonic	embryonic	JJ	_	25	NMOD
25	stem	stem	NN	_	27	NMOD
26	(	(	-LRB-	_	27	P
27	ES	e	NN	_	29	NMOD
28	)	)	-RRB-	_	29	P
29	cells	cell	NNS	_	23	PMOD
30	(	(	-LRB-	_	36	P
31	for	for	IN	_	36	PRP
32	reviews	review	NNS	_	31	PMOD
33	[	[	-LRB-	_	36	P
34	13	0	CD	_	36	NMOD
35	,	,	,	_	36	P
36	14	0	CD	_	13	PRN
37	]	]	-RRB-	_	36	P
38	)	)	-RRB-	_	36	P
39	.	.	.	_	13	P

1	The	the	DT	_	3	NMOD
2	mutant	mutant	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	had	have	VBD	_	0	ROOT
5	many	many	JJ	_	7	NMOD
6	relevant	relevant	JJ	_	7	NMOD
7	features	feature	NNS	_	4	OBJ
8	characteristic	characteristic	JJ	_	7	NMOD
9	of	of	IN	_	8	AMOD
10	the	the	DT	_	11	NMOD
11	disease	disease	NN	_	9	PMOD
12	found	find	VBN	_	7	NMOD
13	in	in	IN	_	12	LOC
14	human	human	JJ	_	18	NMOD
15	MCAD	mcad	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	deficient	deficient	JJ	_	18	NMOD
18	patients	patient	NNS	_	13	PMOD
19	,	,	,	_	7	P
20	along	along	IN	_	7	COORD
21	with	with	IN	_	20	DEP
22	some	some	DT	_	24	NMOD
23	unexpected	unexpected	JJ	_	24	NMOD
24	findings	finding	NNS	_	20	CONJ
25	.	.	.	_	4	P

1	Results	result	NNS	_	0	ROOT

1	Gene	gene	NN	_	2	NMOD
2	Targeting	targeting	NN	_	0	ROOT
3	and	and	CC	_	2	COORD
4	Generation	generation	NN	_	3	CONJ
5	of	of	IN	_	4	NMOD
6	MCAD	mcad	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	Deficient	deficient	JJ	_	9	NMOD
9	Mice	mouse	NNS	_	5	PMOD

1	MCAD	mcad	NN	_	3	NMOD
2	insertion	insertion	NN	_	3	NMOD
3	vector	vector	NN	_	6	NMOD
4	(	(	-LRB-	_	6	P
5	MCAD	mcad	NN	_	6	NMOD
6	IV2	iv0	NN	_	8	SBJ
7	)	)	-RRB-	_	8	P
8	was	be	VBD	_	0	ROOT
9	designed	design	VBN	_	8	VC
10	to	to	TO	_	9	PRP
11	undergo	undergo	VB	_	10	IM
12	gap	gap	NN	_	13	NMOD
13	repair	repair	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	20	NMOD
16	1.3	0	CD	_	18	NMOD
17	-	-	HYPH	_	16	P
18	kb	kb	NN	_	20	NMOD
19	deleted	delete	VBN	_	20	NMOD
20	region	region	NN	_	14	PMOD
21	upon	upon	IN	_	11	TMP
22	homologous	homologous	JJ	_	23	NMOD
23	recombination	recombination	NN	_	21	PMOD
24	in	in	IN	_	11	LOC
25	129P2	0p0	NN	_	32	NMOD
26	(	(	-LRB-	_	29	P
27	129P2	0p0	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	OlaHsd	olahsd	NN	_	32	PRN
30	)	)	-RRB-	_	29	P
31	ES	e	NN	_	32	NMOD
32	cells	cell	NNS	_	33	NMOD
33	E14	e0	NN	_	24	PMOD
34	–	–	HYPH	_	33	P
35	1	0	CD	_	33	NMOD
36	.	.	.	_	8	P

1	Correct	correct	JJ	_	2	NMOD
2	targeting	targeting	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	MCAD	mcad	NN	_	6	NMOD
6	locus	locus	NN	_	3	PMOD
7	resulted	result	VBD	_	0	ROOT
8	in	in	IN	_	7	ADV
9	a	a	DT	_	10	NMOD
10	duplication	duplication	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	exons	exon	NNS	_	13	NMOD
13	8	0	CD	_	11	PMOD
14	,	,	,	_	13	P
15	9	0	CD	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	10	0	CD	_	17	CONJ
19	and	and	CC	_	10	COORD
20	integration	integration	NN	_	19	CONJ
21	of	of	IN	_	20	NMOD
22	flanking	flank	VBG	_	23	NMOD
23	plasmid	plasmid	NN	_	21	PMOD
24	and	and	CC	_	23	COORD
25	Neo	neo	NN	_	26	NMOD
26	sequences	sequence	NNS	_	24	CONJ
27	(	(	-LRB-	_	28	P
28	Figure	figure	NN	_	7	PRN
29	1A	0a	CD	_	28	NMOD
30	)	)	-RRB-	_	28	P
31	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	insertion	insertion	NN	_	3	NMOD
3	vector	vector	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	designed	design	VBN	_	4	VC
6	to	to	TO	_	5	PRP
7	duplicate	duplicate	VB	_	6	IM
8	exon	exon	NN	_	9	NMOD
9	8	0	CD	_	7	OBJ
10	,	,	,	_	9	P
11	9	0	CD	_	9	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	10	0	CD	_	13	CONJ
15	at	at	IN	_	7	LOC
16	the	the	DT	_	18	NMOD
17	MCAD	mcad	NN	_	18	NMOD
18	locus	locus	NN	_	15	PMOD
19	.	.	.	_	4	P

1	Translation	translation	NN	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	7	NMOD
4	duplicated	duplicate	VBN	_	7	NMOD
5	exon	exon	NN	_	7	NMOD
6	8	0	CD	_	5	NMOD
7	region	region	NN	_	2	PMOD
8	results	result	VBZ	_	0	ROOT
9	in	in	IN	_	8	ADV
10	the	the	DT	_	11	NMOD
11	formation	formation	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	premature	premature	JJ	_	15	NMOD
14	stop	stop	NN	_	15	NMOD
15	codons	codon	NNS	_	12	PMOD
16	resulting	result	VBG	_	11	NMOD
17	in	in	IN	_	16	ADV
18	truncation	truncation	NN	_	17	PMOD
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	MCAD	mcad	NN	_	22	NMOD
22	monomer	monomer	NN	_	19	PMOD
23	.	.	.	_	8	P

1	Specifically	specifically	RB	_	8	ADV
2	,	,	,	_	8	P
3	the	the	DT	_	7	NMOD
4	first	$#ORD#$	JJ	_	7	NMOD
5	premature	premature	JJ	_	7	NMOD
6	stop	stop	NN	_	7	NMOD
7	codon	codon	NN	_	8	SBJ
8	arises	arise	VBZ	_	0	ROOT
9	after	after	IN	_	8	TMP
10	translation	translation	NN	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	only	only	RB	_	13	QMOD
13	seven	seven	CD	_	15	NMOD
14	amino	amino	NN	_	15	NMOD
15	acids	acid	NNS	_	11	PMOD
16	from	from	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	duplicated	duplicate	VBN	_	19	NMOD
19	exon	exon	NN	_	16	PMOD
20	8	0	CD	_	19	NMOD
21	.	.	.	_	8	P

1	The	the	DT	_	4	NMOD
2	resulting	result	VBG	_	4	NMOD
3	MCAD	mcad	NN	_	4	NMOD
4	monomer	monomer	NN	_	5	SBJ
5	is	be	VBZ	_	0	ROOT
6	missing	miss	VBG	_	5	VC
7	the	the	DT	_	14	NMOD
8	C	c	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	terminal	terminal	JJ	_	11	NMOD
11	domain	domain	NN	_	14	NMOD
12	α	α	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	helixes	helix	NNS	_	6	OBJ
15	that	that	WDT	_	16	SBJ
16	are	be	VBP	_	14	NMOD
17	responsible	responsible	JJ	_	16	PRD
18	for	for	IN	_	17	AMOD
19	making	make	VBG	_	18	PMOD
20	intersubunit	intersubunit	NN	_	21	NMOD
21	contacts	contact	NNS	_	19	OBJ
22	to	to	TO	_	19	PRP
23	generate	generate	VB	_	22	IM
24	the	the	DT	_	27	NMOD
25	functional	functional	JJ	_	27	NMOD
26	MCAD	mcad	NN	_	27	NMOD
27	homotetramer	homotetramer	NN	_	23	OBJ
28	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Strategy	strategy	NN	_	0	ROOT
2	for	for	IN	_	1	NMOD
3	Disruption	disruption	NN	_	2	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	Mouse	mouse	NN	_	8	NMOD
7	Acadm	acadm	NN	_	8	NMOD
8	Gene	gene	NN	_	4	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	9	NMOD
3	)	)	-RRB-	_	2	P
4	The	the	DT	_	9	NMOD
5	MCAD	mcad	NN	_	7	NMOD
6	IV2	iv0	NN	_	7	NMOD
7	insertion	insertion	NN	_	9	NMOD
8	targeting	targeting	NN	_	9	NMOD
9	vector	vector	NN	_	0	ROOT
10	with	with	IN	_	9	NMOD
11	a	a	DT	_	16	NMOD
12	deleted	delete	VBN	_	16	NMOD
13	1.3	0	CD	_	15	NMOD
14	-	-	HYPH	_	13	P
15	kb	kb	NN	_	16	NMOD
16	region	region	NN	_	10	PMOD
17	encompassing	encompass	VBG	_	16	NMOD
18	exon	exon	NN	_	17	OBJ
19	10	0	CD	_	18	NMOD
20	and	and	CC	_	18	COORD
21	flanking	flank	VBG	_	22	NMOD
22	sequences	sequence	NNS	_	20	CONJ
23	.	.	.	_	9	P

1	MCAD	mcad	NN	_	2	NMOD
2	IV2	iv0	NN	_	3	SBJ
3	undergoes	undergo	VBZ	_	0	ROOT
4	gap	gap	NN	_	5	NMOD
5	repair	repair	NN	_	3	OBJ
6	upon	upon	IN	_	3	TMP
7	homologous	homologous	JJ	_	8	NMOD
8	recombination	recombination	NN	_	6	PMOD
9	at	at	IN	_	3	LOC
10	the	the	DT	_	13	NMOD
11	endogenous	endogenous	JJ	_	13	NMOD
12	Acadm	acadm	NN	_	13	NMOD
13	locus	locus	NN	_	9	PMOD
14	resulting	result	VBG	_	3	ADV
15	in	in	IN	_	14	ADV
16	a	a	DT	_	17	NMOD
17	duplication	duplication	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	exons	exon	NNS	_	20	NMOD
20	8	0	CD	_	18	PMOD
21	,	,	,	_	20	P
22	9	0	CD	_	20	CONJ
23	,	,	,	_	22	P
24	and	and	CC	_	22	COORD
25	10	0	CD	_	24	CONJ
26	at	at	IN	_	17	LOC
27	the	the	DT	_	29	NMOD
28	disrupted	disrupt	VBN	_	29	NMOD
29	allele	allele	NN	_	26	PMOD
30	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Southern	southern	NNP	_	5	NMOD
5	blot	blot	NN	_	6	NMOD
6	analysis	analysis	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	EcoRI	ecori	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	digested	digest	VBN	_	12	NMOD
11	genomic	genomic	JJ	_	12	NMOD
12	DNA	dna	NN	_	7	PMOD
13	from	from	IN	_	12	NMOD
14	ES	e	NN	_	15	NMOD
15	cells	cell	NNS	_	13	PMOD
16	screened	screen	VBN	_	15	NMOD
17	by	by	IN	_	16	MNR
18	PCR	pcr	NN	_	17	PMOD
19	.	.	.	_	6	P

1	Probe	probe	NN	_	2	NMOD
2	A	a	NN	_	23	SBJ
3	,	,	,	_	2	P
4	a	a	DT	_	6	NMOD
5	DNA	dna	NN	_	6	NMOD
6	fragment	fragment	NN	_	2	APPO
7	consisting	consist	VBG	_	6	NMOD
8	of	of	IN	_	7	ADV
9	a	a	DT	_	10	NMOD
10	portion	portion	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	exon	exon	NN	_	11	PMOD
13	10	0	CD	_	12	NMOD
14	that	that	WDT	_	15	SBJ
15	is	be	VBZ	_	10	NMOD
16	not	not	RB	_	15	ADV
17	present	present	JJ	_	15	PRD
18	in	in	IN	_	15	LOC
19	the	the	DT	_	21	NMOD
20	targeting	targeting	NN	_	21	NMOD
21	vector	vector	NN	_	18	PMOD
22	,	,	,	_	23	P
23	hybridizes	hybridize	VBZ	_	0	ROOT
24	to	to	IN	_	23	ADV
25	an	an	DT	_	30	NMOD
26	endogenous	endogenous	JJ	_	30	NMOD
27	3.1	0	CD	_	29	NMOD
28	-	-	HYPH	_	27	P
29	kb	kb	NN	_	30	NMOD
30	fragment	fragment	NN	_	24	PMOD
31	and	and	CC	_	23	COORD
32	,	,	,	_	31	P
33	upon	upon	IN	_	31	GAP-TMP
34	homologous	homologous	JJ	_	35	NMOD
35	recombination	recombination	NN	_	33	PMOD
36	,	,	,	_	33	P
37	to	to	IN	_	33	ADV
38	a	a	DT	_	42	NMOD
39	13.2	0	CD	_	41	NMOD
40	-	-	HYPH	_	39	P
41	kb	kb	NN	_	42	NMOD
42	fragment	fragment	NN	_	37	PMOD
43	.	.	.	_	23	P

1	Lane	lane	NN	_	3	SBJ
2	1	0	CD	_	1	NMOD
3	represents	represent	VBZ	_	0	ROOT
4	a	a	DT	_	10	NMOD
5	wild	wild	JJ	_	7	NMOD
6	-	-	HYPH	_	5	P
7	type	type	NN	_	10	NMOD
8	ES	e	NN	_	10	NMOD
9	cell	cell	NN	_	10	NMOD
10	line	line	NN	_	3	OBJ
11	,	,	,	_	3	P
12	and	and	CC	_	3	COORD
13	Lane	lane	NN	_	14	NMOD
14	2	0	CD	_	17	SBJ
15	and	and	CC	_	14	COORD
16	3	0	CD	_	15	CONJ
17	represent	represent	VBP	_	12	CONJ
18	targeted	target	VBN	_	21	NMOD
19	ES	e	NN	_	21	NMOD
20	cell	cell	NN	_	21	NMOD
21	lines	line	NNS	_	17	OBJ
22	.	.	.	_	3	P

1	ES	e	NN	_	2	NMOD
2	cell	cell	NN	_	3	NMOD
3	clones	clone	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	screened	screen	VBN	_	4	VC
6	by	by	IN	_	5	MNR
7	PCR	pcr	NN	_	6	PMOD
8	(	(	-LRB-	_	11	P
9	data	datum	NNS	_	11	SBJ
10	not	not	RB	_	11	ADV
11	shown	show	VBN	_	5	PRN
12	)	)	-RRB-	_	11	P
13	and	and	CC	_	5	COORD
14	confirmed	confirm	VBN	_	13	CONJ
15	by	by	IN	_	14	MNR
16	Southern	southern	NNP	_	17	NMOD
17	blot	blot	NN	_	18	NMOD
18	analysis	analysis	NN	_	15	PMOD
19	.	.	.	_	4	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	used	use	VBD	_	0	ROOT
5	an	an	DT	_	8	NMOD
6	exon	exon	NN	_	8	NMOD
7	10	0	CD	_	6	NMOD
8	probe	probe	NN	_	4	OBJ
9	(	(	-LRB-	_	11	P
10	probe	probe	NN	_	11	NMOD
11	A	a	NN	_	8	PRN
12	)	)	-RRB-	_	11	P
13	,	,	,	_	8	P
14	not	not	RB	_	15	ADV
15	present	present	JJ	_	8	NMOD
16	in	in	IN	_	15	LOC
17	the	the	DT	_	19	NMOD
18	targeting	targeting	NN	_	19	NMOD
19	vector	vector	NN	_	16	PMOD
20	,	,	,	_	8	P
21	hybridized	hybridize	VBN	_	8	NMOD
22	to	to	IN	_	21	ADV
23	a	a	DT	_	27	NMOD
24	13.2	0	CD	_	26	NMOD
25	-	-	HYPH	_	24	P
26	kb	kb	NN	_	27	NMOD
27	band	band	NN	_	22	PMOD
28	in	in	IN	_	21	ADV
29	addition	addition	NN	_	28	PMOD
30	to	to	IN	_	29	NMOD
31	the	the	DT	_	36	NMOD
32	3.1	0	CD	_	34	NMOD
33	-	-	HYPH	_	32	P
34	kb	kb	NN	_	36	NMOD
35	endogenous	endogenous	JJ	_	36	NMOD
36	band	band	NN	_	30	PMOD
37	indicating	indicate	VBG	_	36	NMOD
38	targeted	target	VBN	_	39	NMOD
39	insertion	insertion	NN	_	37	OBJ
40	of	of	IN	_	39	NMOD
41	the	the	DT	_	42	NMOD
42	vector	vector	NN	_	40	PMOD
43	at	at	IN	_	39	NMOD
44	the	the	DT	_	46	NMOD
45	Acadm	acadm	NN	_	46	NMOD
46	locus	locus	NN	_	43	PMOD
47	(	(	-LRB-	_	48	P
48	Figure	figure	NN	_	4	PRN
49	1B	0b	CD	_	48	NMOD
50	)	)	-RRB-	_	48	P
51	.	.	.	_	4	P

1	Correctly	correctly	RB	_	2	AMOD
2	targeted	target	VBN	_	5	NMOD
3	ES	e	NN	_	4	NMOD
4	cell	cell	NN	_	5	NMOD
5	clones	clone	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	microinjected	microinjected	VBN	_	6	VC
8	into	into	IN	_	7	DIR
9	B6	b0	NN	_	15	NMOD
10	(	(	-LRB-	_	15	P
11	C57BL	c0bl	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	6NTac	0ntac	NN	_	15	NMOD
14	)	)	-RRB-	_	15	P
15	blastocysts	blastocyst	NNS	_	8	PMOD
16	to	to	TO	_	7	PRP
17	generate	generate	VB	_	16	IM
18	chimeric	chimeric	JJ	_	19	NMOD
19	mice	mouse	NNS	_	17	OBJ
20	.	.	.	_	6	P

1	Chimeric	chimeric	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	backcrossed	backcross	VBN	_	3	VC
5	to	to	IN	_	4	ADV
6	both	both	CC	_	7	COORD
7	129P2	0p0	NN	_	10	AMOD
8	and	and	CC	_	7	COORD
9	B6	b0	NN	_	8	CONJ
10	inbred	inbreed	VBN	_	11	NMOD
11	mice	mouse	NNS	_	5	PMOD
12	to	to	TO	_	4	PRP
13	produce	produce	VB	_	12	IM
14	MCAD	mcad	NN	_	24	NMOD
15	+	+	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	and	and	CC	_	14	COORD
19	eventually	eventually	RB	_	20	TMP
20	MCAD	mcad	NN	_	18	CONJ
21	−	−	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	−	−	SYM	_	20	P
24	mice	mouse	NNS	_	13	OBJ
25	on	on	IN	_	13	ADV
26	a	a	DT	_	31	NMOD
27	B6	b0	NN	_	31	NMOD
28	/	/	HYPH	_	27	P
29	129	0	CD	_	27	NMOD
30	mixed	mixed	JJ	_	31	NMOD
31	background	background	NN	_	25	PMOD
32	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	studies	study	NNS	_	5	SBJ
3	described	describe	VBN	_	2	NMOD
4	here	here	RB	_	3	ADV
5	were	be	VBD	_	0	ROOT
6	conducted	conduct	VBN	_	5	VC
7	exclusively	exclusively	RB	_	6	ADV
8	on	on	IN	_	6	ADV
9	the	the	DT	_	14	NMOD
10	B6	b0	NN	_	14	NMOD
11	/	/	HYPH	_	10	P
12	129	0	CD	_	10	NMOD
13	mixed	mixed	JJ	_	14	NMOD
14	background	background	NN	_	8	PMOD
15	compared	compare	VBN	_	14	NMOD
16	with	with	IN	_	15	PMOD
17	littermate	littermate	NN	_	18	NMOD
18	controls	control	NNS	_	16	PMOD
19	or	or	CC	_	18	COORD
20	B6	b0	NN	_	24	NMOD
21	/	/	HYPH	_	20	P
22	129	0	CD	_	20	NMOD
23	control	control	NN	_	24	NMOD
24	groups	group	NNS	_	19	CONJ
25	maintained	maintain	VBN	_	18	NMOD
26	by	by	IN	_	25	MNR
27	intercrosses	intercrosses	NNS	_	26	PMOD
28	as	as	IN	_	25	ADV
29	were	be	VBD	_	28	SUB
30	the	the	DT	_	31	NMOD
31	mutants	mutant	NNS	_	29	SBJ
32	.	.	.	_	5	P

1	Perpetuating	perpetuate	VBG	_	13	SBJ
2	this	this	DT	_	3	NMOD
3	mutation	mutation	NN	_	1	OBJ
4	as	as	IN	_	1	ADV
5	a	a	DT	_	8	NMOD
6	congenic	congenic	JJ	_	8	NMOD
7	mutant	mutant	NN	_	8	NMOD
8	line	line	NN	_	4	PMOD
9	on	on	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	129P2	0p0	NN	_	12	NMOD
12	background	background	NN	_	9	PMOD
13	proved	prove	VBD	_	0	ROOT
14	impractical	impractical	JJ	_	13	OPRD
15	.	.	.	_	13	P

1	The	the	DT	_	3	NMOD
2	129P2	0p0	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	poor	poor	JJ	_	6	NMOD
6	breeders	breeder	NNS	_	4	PRD
7	as	as	IN	_	4	ADV
8	wild	wild	JJ	_	10	NMOD
9	-	-	HYPH	_	8	P
10	types	type	NNS	_	7	PMOD
11	,	,	,	_	4	P
12	and	and	CC	_	4	COORD
13	when	when	WRB	_	14	TMP
14	introduced	introduce	VBN	_	19	TMP
15	,	,	,	_	19	P
16	the	the	DT	_	18	NMOD
17	Acadm	acadm	NN	_	18	NMOD
18	mutation	mutation	NN	_	19	SBJ
19	was	be	VBD	_	12	CONJ
20	nearly	nearly	RB	_	19	ADV
21	lost	lose	VBN	_	19	VC
22	on	on	IN	_	21	ADV
23	this	this	DT	_	24	NMOD
24	background	background	NN	_	22	PMOD
25	because	because	IN	_	21	PRP
26	of	of	IN	_	25	PMOD
27	the	the	DT	_	29	NMOD
28	high	high	JJ	_	29	NMOD
29	rate	rate	NN	_	25	PMOD
30	of	of	IN	_	29	NMOD
31	neonatal	neonatal	JJ	_	32	NMOD
32	death	death	NN	_	30	PMOD
33	.	.	.	_	4	P

1	Because	because	IN	_	12	PRP
2	of	of	IN	_	1	PMOD
3	the	the	DT	_	5	NMOD
4	molecular	molecular	JJ	_	5	NMOD
5	structure	structure	NN	_	1	PMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	targeted	target	VBN	_	9	NMOD
9	allele	allele	NN	_	6	PMOD
10	,	,	,	_	12	P
11	it	it	PRP	_	12	SBJ
12	proved	prove	VBD	_	0	ROOT
13	virtually	virtually	RB	_	14	AMOD
14	impossible	impossible	JJ	_	12	OPRD
15	to	to	TO	_	12	OPRD
16	distinguish	distinguish	VB	_	15	IM
17	all	all	DT	_	20	NMOD
18	three	three	CD	_	20	NMOD
19	potential	potential	JJ	_	20	NMOD
20	genotypes	genotype	NNS	_	16	OBJ
21	.	.	.	_	12	P

1	We	we	PRP	_	2	SBJ
2	could	could	MD	_	30	DEP
3	clearly	clearly	RB	_	2	ADV
4	detect	detect	VB	_	2	VC
5	the	the	DT	_	6	NMOD
6	presence	presence	NN	_	4	OBJ
7	or	or	CC	_	6	COORD
8	absence	absence	NN	_	7	CONJ
9	of	of	IN	_	6	NMOD
10	the	the	DT	_	12	NMOD
11	targeted	target	VBN	_	12	NMOD
12	allele	allele	NN	_	9	PMOD
13	,	,	,	_	30	P
14	however	however	RB	_	30	ADV
15	,	,	,	_	30	P
16	whether	whether	IN	_	30	SBJ
17	a	a	DT	_	19	NMOD
18	particular	particular	JJ	_	19	NMOD
19	mouse	mouse	NN	_	20	SBJ
20	was	be	VBD	_	16	SUB
21	MCAD	mcad	NN	_	20	PRD
22	−	−	SYM	_	21	P
23	/	/	HYPH	_	21	P
24	−	−	SYM	_	21	P
25	or	or	CC	_	21	COORD
26	MCAD	mcad	NN	_	25	CONJ
27	+	+	SYM	_	26	P
28	/	/	HYPH	_	26	P
29	−	−	SYM	_	26	P
30	could	could	MD	_	0	ROOT
31	not	not	RB	_	30	ADV
32	be	be	VB	_	30	VC
33	determined	determine	VBN	_	32	VC
34	by	by	IN	_	33	MNR
35	Southern	southern	NNP	_	36	NMOD
36	blot	blot	NN	_	34	PMOD
37	or	or	CC	_	36	COORD
38	PCR	pcr	NN	_	37	CONJ
39	of	of	IN	_	36	NMOD
40	genomic	genomic	JJ	_	41	NMOD
41	DNA	dna	NN	_	39	PMOD
42	.	.	.	_	30	P

1	Ultimately	ultimately	RB	_	7	ADV
2	MCAD	mcad	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	ascertained	ascertain	VBN	_	7	VC
9	by	by	IN	_	8	MNR
10	immunoblot	immunoblot	NN	_	11	NMOD
11	analysis	analysis	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	offspring	offspring	NN	_	12	PMOD
14	with	with	IN	_	11	NMOD
15	subsequent	subsequent	JJ	_	16	NMOD
16	perpetuation	perpetuation	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	MCAD	mcad	NN	_	27	NMOD
19	−	−	SYM	_	18	P
20	/	/	HYPH	_	18	P
21	−	−	SYM	_	18	P
22	and	and	CC	_	18	COORD
23	MCAD	mcad	NN	_	22	CONJ
24	+	+	SYM	_	23	P
25	/	/	HYPH	_	23	P
26	+	+	SYM	_	23	P
27	mice	mouse	NNS	_	17	PMOD
28	as	as	IN	_	16	NMOD
29	separate	separate	JJ	_	30	NMOD
30	groups	group	NNS	_	28	PMOD
31	.	.	.	_	7	P

1	RNA	rna	NN	_	2	NMOD
2	Analysis	analysis	NN	_	0	ROOT

1	RT	rt	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	PCR	pcr	NN	_	4	NMOD
4	amplification	amplification	NN	_	14	SBJ
5	from	from	IN	_	4	NMOD
6	exon	exon	NN	_	7	NMOD
7	7	0	CD	_	5	PMOD
8	to	to	IN	_	7	NMOD
9	11	0	CD	_	8	PMOD
10	from	from	IN	_	4	NMOD
11	total	total	JJ	_	13	NMOD
12	heart	heart	NN	_	13	NMOD
13	RNA	rna	NN	_	10	PMOD
14	amplified	amplify	VBD	_	0	ROOT
15	the	the	DT	_	24	NMOD
16	expected	expect	VBN	_	24	NMOD
17	600	0	CD	_	22	NMOD
18	-	-	HYPH	_	17	P
19	base	base	NN	_	20	NMOD
20	pair	pair	NN	_	22	NMOD
21	(	(	-LRB-	_	22	P
22	bp	bp	NN	_	24	NMOD
23	)	)	-RRB-	_	24	P
24	fragment	fragment	NN	_	14	OBJ
25	in	in	IN	_	24	LOC
26	MCAD	mcad	NN	_	35	NMOD
27	+	+	SYM	_	26	P
28	/	/	HYPH	_	26	P
29	+	+	SYM	_	26	P
30	and	and	CC	_	26	COORD
31	MCAD	mcad	NN	_	30	CONJ
32	+	+	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	−	−	SYM	_	31	P
35	mice	mouse	NNS	_	25	PMOD
36	,	,	,	_	24	P
37	and	and	CC	_	24	COORD
38	a	a	DT	_	42	NMOD
39	1.5	0	CD	_	41	NMOD
40	-	-	HYPH	_	39	P
41	kb	kb	NN	_	42	NMOD
42	fragment	fragment	NN	_	37	CONJ
43	in	in	IN	_	42	LOC
44	MCAD	mcad	NN	_	48	NMOD
45	−	−	SYM	_	44	P
46	/	/	HYPH	_	44	P
47	−	−	SYM	_	44	P
48	mice	mouse	NNS	_	43	PMOD
49	(	(	-LRB-	_	52	P
50	data	datum	NNS	_	52	SBJ
51	not	not	RB	_	52	ADV
52	shown	show	VBN	_	14	PRN
53	)	)	-RRB-	_	52	P
54	.	.	.	_	14	P

1	Sequence	sequence	NN	_	2	NMOD
2	analysis	analysis	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	8	NMOD
5	1.5	0	CD	_	7	NMOD
6	-	-	HYPH	_	5	P
7	kb	kb	NN	_	8	NMOD
8	fragment	fragment	NN	_	3	PMOD
9	revealed	reveal	VBD	_	0	ROOT
10	that	that	IN	_	9	OBJ
11	the	the	DT	_	13	NMOD
12	amplified	amplify	VBN	_	13	NMOD
13	fragment	fragment	NN	_	14	SBJ
14	consisted	consist	VBD	_	10	SUB
15	of	of	IN	_	14	ADV
16	exon	exon	NN	_	15	PMOD
17	7	0	CD	_	16	NMOD
18	to	to	IN	_	16	NMOD
19	exon	exon	NN	_	18	PMOD
20	10	0	CD	_	19	NMOD
21	with	with	IN	_	14	ADV
22	280	0	CD	_	23	NMOD
23	bp	bp	NN	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	pGEM	pgem	NN	_	27	NMOD
26	plasmid	plasmid	NN	_	27	NMOD
27	sequence	sequence	NN	_	24	PMOD
28	followed	follow	VBN	_	27	NMOD
29	by	by	IN	_	28	LGS
30	exons	exon	NNS	_	31	NMOD
31	8	0	CD	_	29	PMOD
32	–	–	SYM	_	33	P
33	11	0	CD	_	31	NMOD
34	.	.	.	_	9	P

1	Some	some	DT	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	plasmid	plasmid	NN	_	5	NMOD
5	sequences	sequence	NNS	_	2	PMOD
6	,	,	,	_	1	P
7	along	along	IN	_	1	COORD
8	with	with	IN	_	7	DEP
9	the	the	DT	_	11	NMOD
10	pPGKNEOpA	ppgkneopa	NN	_	11	NMOD
11	sequence	sequence	NN	_	7	CONJ
12	,	,	,	_	13	P
13	were	be	VBD	_	0	ROOT
14	deleted	delete	VBN	_	13	VC
15	from	from	IN	_	14	ADV
16	this	this	DT	_	18	NMOD
17	spliced	splice	VBN	_	18	NMOD
18	mRNA	mrna	NN	_	15	PMOD
19	.	.	.	_	13	P

1	Northern	northern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	revealed	reveal	VBD	_	0	ROOT
5	Acadm	acadm	NN	_	6	SBJ
6	was	be	VBD	_	4	OBJ
7	normally	normally	RB	_	6	ADV
8	expressed	express	VBN	_	6	VC
9	in	in	IN	_	8	LOC
10	all	all	DT	_	11	NMOD
11	tissues	tissue	NNS	_	9	PMOD
12	analyzed	analyze	VBN	_	11	NMOD
13	from	from	IN	_	11	NMOD
14	MCAD	mcad	NN	_	18	NMOD
15	+	+	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	+	+	SYM	_	14	P
18	mice	mouse	NNS	_	13	PMOD
19	with	with	IN	_	8	ADV
20	the	the	DT	_	23	NMOD
21	most	most	RBS	_	22	AMOD
22	robust	robust	JJ	_	23	NMOD
23	expression	expression	NN	_	24	SBJ
24	occurring	occur	VBG	_	19	PMOD
25	in	in	IN	_	24	LOC
26	brown	brown	JJ	_	27	NMOD
27	fat	fat	NN	_	25	PMOD
28	,	,	,	_	27	P
29	kidney	kidney	NN	_	27	CONJ
30	,	,	,	_	29	P
31	heart	heart	NN	_	29	CONJ
32	,	,	,	_	31	P
33	skeletal	skeletal	JJ	_	34	NMOD
34	muscle	muscle	NN	_	31	CONJ
35	,	,	,	_	34	P
36	and	and	CC	_	34	COORD
37	liver	liver	NN	_	36	CONJ
38	with	with	IN	_	8	ADV
39	minimal	minimal	JJ	_	40	NMOD
40	expression	expression	NN	_	38	PMOD
41	in	in	IN	_	40	LOC
42	the	the	DT	_	43	NMOD
43	brain	brain	NN	_	41	PMOD
44	,	,	,	_	43	P
45	white	white	JJ	_	46	NMOD
46	fat	fat	NN	_	43	CONJ
47	,	,	,	_	46	P
48	and	and	CC	_	46	COORD
49	testes	testis	NNS	_	48	CONJ
50	(	(	-LRB-	_	51	P
51	Figure	figure	NN	_	4	PRN
52	2	0	CD	_	51	NMOD
53	)	)	-RRB-	_	51	P
54	.	.	.	_	4	P

1	Interestingly	interestingly	RB	_	17	ADV
2	,	,	,	_	17	P
3	although	although	IN	_	17	ADV
4	RT	rt	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	PCR	pcr	NN	_	7	SBJ
7	amplified	amplify	VBD	_	3	SUB
8	an	an	DT	_	12	NMOD
9	incorrectly	incorrectly	RB	_	10	AMOD
10	spliced	splice	VBN	_	12	NMOD
11	Acadm	acadm	NN	_	12	NMOD
12	transcript	transcript	NN	_	7	OBJ
13	,	,	,	_	17	P
14	no	no	DT	_	16	NMOD
15	Acadm	acadm	NN	_	16	NMOD
16	transcripts	transcript	NNS	_	17	SBJ
17	were	be	VBD	_	0	ROOT
18	detected	detect	VBN	_	17	VC
19	by	by	IN	_	18	MNR
20	northern	northern	NNP	_	21	NMOD
21	blot	blot	NN	_	22	NMOD
22	analysis	analysis	NN	_	19	PMOD
23	from	from	IN	_	18	ADV
24	MCAD	mcad	NN	_	28	NMOD
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	mice	mouse	NNS	_	23	PMOD
29	.	.	.	_	17	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	4	SBJ
3	strongly	strongly	RB	_	4	ADV
4	suggest	suggest	VBP	_	0	ROOT
5	that	that	IN	_	4	OBJ
6	the	the	DT	_	8	NMOD
7	mutant	mutant	NN	_	8	NMOD
8	RNA	rna	NN	_	9	SBJ
9	is	be	VBZ	_	5	SUB
10	unstable	unstable	JJ	_	9	PRD
11	and	and	CC	_	9	COORD
12	degraded	degrade	VBN	_	11	CONJ
13	rapidly	rapidly	RB	_	12	TMP
14	or	or	CC	_	9	COORD
15	,	,	,	_	14	P
16	alternatively	alternatively	RB	_	18	ADV
17	,	,	,	_	18	P
18	undergoes	undergo	VBZ	_	14	CONJ
19	nonsense	nonsense	NN	_	20	AMOD
20	mediated	mediate	VBN	_	22	NMOD
21	RNA	rna	NN	_	22	NMOD
22	decay	decay	NN	_	18	OBJ
23	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Northern	northern	NNP	_	2	NMOD
2	Blot	blot	NN	_	3	NMOD
3	Analysis	analysis	NN	_	0	ROOT
4	from	from	IN	_	3	NMOD
5	MCAD	mcad	NN	_	24	NMOD
6	−	−	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	−	−	SYM	_	5	P
9	(	(	-LRB-	_	12	P
10	n	n	NN	_	12	SBJ
11	=	=	SYM	_	12	P
12	2	0	CD	_	5	PRN
13	)	)	-RRB-	_	12	P
14	and	and	CC	_	5	COORD
15	MCAD	mcad	NN	_	14	CONJ
16	+	+	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	+	+	SYM	_	15	P
19	(	(	-LRB-	_	22	P
20	n	n	NN	_	22	SBJ
21	=	=	SYM	_	22	P
22	2	0	CD	_	15	PRN
23	)	)	-RRB-	_	22	P
24	Mice	mouse	NNS	_	4	PMOD

1	Acadm	acadm	NN	_	2	NMOD
2	message	message	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	detected	detect	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	heart	heart	NN	_	5	PMOD
8	,	,	,	_	7	P
9	liver	liver	NN	_	7	CONJ
10	,	,	,	_	9	P
11	brown	brown	JJ	_	12	NMOD
12	fat	fat	NN	_	9	CONJ
13	,	,	,	_	12	P
14	brain	brain	NN	_	12	CONJ
15	,	,	,	_	14	P
16	kidney	kidney	NN	_	14	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	muscle	muscle	NN	_	18	CONJ
20	(	(	-LRB-	_	7	P
21	and	and	CC	_	7	COORD
22	white	white	JJ	_	23	NMOD
23	fat	fat	NN	_	21	CONJ
24	and	and	CC	_	23	COORD
25	testes	testis	NNS	_	24	CONJ
26	,	,	,	_	29	P
27	data	datum	NNS	_	29	SBJ
28	not	not	RB	_	29	ADV
29	shown	show	VBN	_	7	PRN
30	)	)	-RRB-	_	29	P
31	of	of	IN	_	7	NMOD
32	only	only	JJ	_	37	NMOD
33	MCAD	mcad	NN	_	37	NMOD
34	+	+	SYM	_	33	P
35	/	/	HYPH	_	33	P
36	+	+	SYM	_	33	P
37	mice	mouse	NNS	_	31	PMOD
38	.	.	.	_	3	P

1	Most	most	RBS	_	3	NMOD
2	robust	robust	JJ	_	3	NMOD
3	expression	expression	NN	_	4	SBJ
4	occurred	occur	VBD	_	0	ROOT
5	in	in	IN	_	4	LOC
6	brown	brown	JJ	_	7	NMOD
7	fat	fat	NN	_	5	PMOD
8	,	,	,	_	7	P
9	kidney	kidney	NN	_	7	CONJ
10	,	,	,	_	9	P
11	heart	heart	NN	_	9	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	skeletal	skeletal	JJ	_	15	NMOD
15	muscle	muscle	NN	_	13	CONJ
16	.	.	.	_	4	P

1	MCAD	mcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	had	have	VBD	_	0	ROOT
7	no	no	DT	_	9	NMOD
8	detectable	detectable	JJ	_	9	NMOD
9	message	message	NN	_	6	OBJ
10	in	in	IN	_	6	LOC
11	all	all	DT	_	12	NMOD
12	tissues	tissue	NNS	_	10	PMOD
13	examined	examine	VBN	_	12	NMOD
14	.	.	.	_	6	P

1	Liver	liver	NN	_	2	NMOD
2	Enzyme	enzyme	NN	_	3	NMOD
3	Analyses	analysis	NNS	_	0	ROOT

1	Immunoblot	immunoblot	NN	_	2	NMOD
2	analyses	analysis	NNS	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	liver	liver	NN	_	5	NMOD
5	homogenates	homogenate	NNS	_	3	PMOD
6	with	with	IN	_	2	NMOD
7	anti-MCAD	anti-mcad	JJ	_	8	NMOD
8	antisera	antiserum	NNS	_	6	PMOD
9	demonstrated	demonstrate	VBD	_	0	ROOT
10	that	that	IN	_	9	OBJ
11	the	the	DT	_	15	NMOD
12	42	0	CD	_	13	NMOD
13	kDa	kda	NN	_	15	NMOD
14	MCAD	mcad	NN	_	15	NMOD
15	monomer	monomer	NN	_	16	SBJ
16	was	be	VBD	_	10	SUB
17	present	present	JJ	_	16	PRD
18	in	in	IN	_	16	LOC
19	MCAD	mcad	NN	_	23	NMOD
20	+	+	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	+	+	SYM	_	19	P
23	mice	mouse	NNS	_	18	PMOD
24	,	,	,	_	18	P
25	but	but	CC	_	18	COORD
26	not	not	RB	_	25	ADV
27	in	in	IN	_	25	CONJ
28	MCAD	mcad	NN	_	32	NMOD
29	−	−	SYM	_	28	P
30	/	/	HYPH	_	28	P
31	−	−	SYM	_	28	P
32	mice	mouse	NNS	_	27	PMOD
33	(	(	-LRB-	_	34	P
34	Figure	figure	NN	_	9	PRN
35	3	0	CD	_	34	NMOD
36	)	)	-RRB-	_	34	P
37	.	.	.	_	9	P

1	As	as	IN	_	17	PRP
2	a	a	DT	_	4	NMOD
3	control	control	NN	_	4	NMOD
4	analysis	analysis	NN	_	1	PMOD
5	,	,	,	_	17	P
6	anti–short	anti–short	JJ	_	8	NMOD
7	-	-	HYPH	_	6	P
8	chain	chain	NN	_	12	NMOD
9	acyl	acyl	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	CoA	coa	NN	_	12	NMOD
12	dehydrogenase	dehydrogenase	NN	_	14	NMOD
13	(	(	-LRB-	_	14	P
14	SCAD	scad	NN	_	16	NMOD
15	)	)	-RRB-	_	14	P
16	antisera	antiserum	NNS	_	17	SBJ
17	revealed	reveal	VBD	_	0	ROOT
18	no	no	DT	_	19	NMOD
19	differences	difference	NNS	_	17	OBJ
20	in	in	IN	_	19	NMOD
21	levels	level	NNS	_	20	PMOD
22	of	of	IN	_	21	NMOD
23	expression	expression	NN	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	SCAD	scad	NN	_	26	NMOD
26	protein	protein	NN	_	24	PMOD
27	between	between	IN	_	19	NMOD
28	MCAD	mcad	NN	_	37	NMOD
29	+	+	SYM	_	28	P
30	/	/	HYPH	_	28	P
31	+	+	SYM	_	28	P
32	and	and	CC	_	28	COORD
33	MCAD	mcad	NN	_	32	CONJ
34	−	−	SYM	_	33	P
35	/	/	HYPH	_	33	P
36	−	−	SYM	_	33	P
37	mice	mouse	NNS	_	27	PMOD
38	(	(	-LRB-	_	39	P
39	Figure	figure	NN	_	17	PRN
40	3	0	CD	_	39	NMOD
41	)	)	-RRB-	_	39	P
42	.	.	.	_	17	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Immunoblots	immunoblots	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Liver	liver	NN	_	4	NMOD
4	Homogenates	homogenate	NNS	_	2	PMOD
5	from	from	IN	_	1	NMOD
6	MCAD	mcad	NN	_	15	NMOD
7	+	+	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	+	+	SYM	_	6	P
10	and	and	CC	_	6	COORD
11	MCAD	mcad	NN	_	10	CONJ
12	−	−	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	−	−	SYM	_	11	P
15	Mice	mouse	NNS	_	5	PMOD

1	These	these	DT	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	probed	probe	VBN	_	2	VC
4	with	with	IN	_	3	MNR
5	anti-MCAD	anti-mcad	JJ	_	6	NMOD
6	antibody	antibody	NN	_	4	PMOD
7	or	or	CC	_	6	COORD
8	anti-SCAD	anti-scad	JJ	_	9	NMOD
9	antibody	antibody	NN	_	7	CONJ
10	.	.	.	_	2	P

1	Homozygous	homozygous	JJ	_	6	NMOD
2	MCAD	mcad	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	had	have	VBD	_	0	ROOT
8	no	no	DT	_	11	NMOD
9	detectable	detectable	JJ	_	11	NMOD
10	MCAD	mcad	NN	_	11	NMOD
11	protein	protein	NN	_	7	OBJ
12	.	.	.	_	7	P

1	MCAD	mcad	NN	_	2	NMOD
2	protein	protein	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	only	only	RB	_	5	AMOD
5	detectable	detectable	JJ	_	3	PRD
6	under	under	IN	_	3	ADV
7	the	the	DT	_	16	NMOD
8	MCAD	mcad	NN	_	16	NMOD
9	protein	protein	NN	_	11	AMOD
10	–	–	HYPH	_	9	P
11	spiked	spike	VBN	_	16	NMOD
12	(	(	-LRB-	_	14	P
13	positive	positive	JJ	_	14	NMOD
14	control	control	NN	_	16	PRN
15	)	)	-RRB-	_	14	P
16	lane	lane	NN	_	6	PMOD
17	.	.	.	_	3	P

1	As	as	IN	_	12	ADV
2	a	a	DT	_	4	NMOD
3	control	control	NN	_	4	NMOD
4	analysis	analysis	NN	_	1	PMOD
5	,	,	,	_	12	P
6	liver	liver	NN	_	7	NMOD
7	homogenates	homogenate	NNS	_	12	SBJ
8	probed	probe	VBN	_	7	NMOD
9	with	with	IN	_	8	MNR
10	anti-SCAD	anti-scad	JJ	_	11	NMOD
11	antibody	antibody	NN	_	9	PMOD
12	revealed	reveal	VBD	_	0	ROOT
13	that	that	IN	_	12	OBJ
14	SCAD	scad	NN	_	15	NMOD
15	protein	protein	NN	_	16	SBJ
16	was	be	VBD	_	13	SUB
17	present	present	JJ	_	16	PRD
18	in	in	IN	_	16	LOC
19	both	both	CC	_	20	COORD
20	MCAD	mcad	NN	_	29	NMOD
21	+	+	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	+	+	SYM	_	20	P
24	and	and	CC	_	20	COORD
25	MCAD	mcad	NN	_	24	CONJ
26	−	−	SYM	_	25	P
27	/	/	HYPH	_	25	P
28	−	−	SYM	_	25	P
29	mice	mouse	NNS	_	18	PMOD
30	.	.	.	_	12	P

1	No	no	DT	_	6	NMOD
2	MCAD	mcad	NN	_	6	NMOD
3	positive	positive	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	control	control	NN	_	6	NMOD
6	protein	protein	NN	_	7	SBJ
7	is	be	VBZ	_	0	ROOT
8	detected	detect	VBN	_	7	VC
9	by	by	IN	_	8	MNR
10	anti-SCAD	anti-scad	JJ	_	11	NMOD
11	antibodies	antibody	NNS	_	9	PMOD
12	(	(	-LRB-	_	14	P
13	MCAD	mcad	NN	_	14	NMOD
14	lane	lane	NN	_	8	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	7	P

1	mw	mw	NN	_	0	ROOT
2	,	,	,	_	1	P
3	molecular	molecular	JJ	_	5	NMOD
4	weight	weight	NN	_	5	NMOD
5	standards	standard	NNS	_	1	APPO
6	.	.	.	_	1	P

1	Enzyme	enzyme	NN	_	2	NMOD
2	activity	activity	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	analyzed	analyze	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	mouse	mouse	NN	_	8	NMOD
7	liver	liver	NN	_	8	NMOD
8	homogenates	homogenate	NNS	_	5	PMOD
9	using	use	VBG	_	4	MNR
10	the	the	DT	_	18	NMOD
11	electron	electron	NN	_	13	NMOD
12	transport	transport	NN	_	13	NMOD
13	flavoprotein	flavoprotein	NN	_	15	NMOD
14	(	(	-LRB-	_	15	P
15	ETF	etf	NN	_	18	NMOD
16	)	)	-RRB-	_	18	P
17	reduction	reduction	NN	_	18	NMOD
18	assay	assay	NN	_	9	OBJ
19	with	with	IN	_	9	ADV
20	octanoyl	octanoyl	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	CoA	coa	NN	_	19	PMOD
23	(	(	-LRB-	_	24	P
24	C8	c0	NN	_	22	PRN
25	:	:	:	_	24	P
26	0	0	CD	_	24	NMOD
27	)	)	-RRB-	_	24	P
28	and	and	CC	_	22	COORD
29	palmitoyl	palmitoyl	NN	_	31	NMOD
30	-	-	HYPH	_	29	P
31	CoA	coa	NN	_	28	CONJ
32	(	(	-LRB-	_	33	P
33	C16	c0	NN	_	31	PRN
34	:	:	:	_	33	P
35	0	0	CD	_	33	NMOD
36	)	)	-RRB-	_	33	P
37	as	as	IN	_	22	NMOD
38	substrates	substrate	NNS	_	37	PMOD
39	.	.	.	_	3	P

1	MCAD	mcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	had	have	VBD	_	0	ROOT
7	a	a	DT	_	9	NMOD
8	significant	significant	JJ	_	9	NMOD
9	reduction	reduction	NN	_	6	OBJ
10	in	in	IN	_	9	NMOD
11	ability	ability	NN	_	10	PMOD
12	to	to	TO	_	11	NMOD
13	dehydrogenate	dehydrogenate	VB	_	12	IM
14	octanoyl	octanoyl	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	CoA	coa	NN	_	13	OBJ
17	and	and	CC	_	9	COORD
18	a	a	DT	_	20	NMOD
19	modest	modest	JJ	_	20	NMOD
20	reduction	reduction	NN	_	17	CONJ
21	in	in	IN	_	20	NMOD
22	activity	activity	NN	_	21	PMOD
23	toward	toward	IN	_	22	NMOD
24	palmitoyl	palmitoyl	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	CoA	coa	NN	_	23	PMOD
27	compared	compare	VBN	_	6	ADV
28	to	to	IN	_	27	PMOD
29	MCAD	mcad	NN	_	33	NMOD
30	+	+	SYM	_	29	P
31	/	/	HYPH	_	29	P
32	+	+	SYM	_	29	P
33	mice	mouse	NNS	_	28	PMOD
34	(	(	-LRB-	_	35	P
35	Table	table	NN	_	6	PRN
36	1	0	CD	_	35	NMOD
37	)	)	-RRB-	_	35	P
38	.	.	.	_	6	P

1	Specifically	specifically	RB	_	14	ADV
2	,	,	,	_	14	P
3	the	the	DT	_	4	NMOD
4	dehydrogenation	dehydrogenation	NN	_	14	SBJ
5	of	of	IN	_	4	NMOD
6	octanoyl	octanoyl	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	CoA	coa	NN	_	13	NMOD
9	and	and	CC	_	8	COORD
10	palmitoyl	palmitoyl	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	CoA	coa	NN	_	9	CONJ
13	substrates	substrate	NNS	_	5	PMOD
14	were	be	VBD	_	0	ROOT
15	reduced	reduce	VBN	_	14	VC
16	by	by	IN	_	15	EXT
17	75	0	CD	_	18	NMOD
18	%	%	NN	_	16	PMOD
19	and	and	CC	_	16	COORD
20	by	by	IN	_	19	CONJ
21	30	0	CD	_	22	NMOD
22	%	%	NN	_	20	PMOD
23	,	,	,	_	15	P
24	respectively	respectively	RB	_	15	ADV
25	,	,	,	_	15	P
26	in	in	IN	_	15	LOC
27	MCAD	mcad	NN	_	31	NMOD
28	−	−	SYM	_	27	P
29	/	/	HYPH	_	27	P
30	−	−	SYM	_	27	P
31	mice	mouse	NNS	_	26	PMOD
32	as	as	IN	_	15	ADV
33	compared	compare	VBN	_	32	SUB
34	to	to	IN	_	33	ADV
35	MCAD	mcad	NN	_	39	NMOD
36	+	+	SYM	_	35	P
37	/	/	HYPH	_	35	P
38	+	+	SYM	_	35	P
39	controls	control	NNS	_	34	PMOD
40	.	.	.	_	14	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Characteristics	characteristic	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	MCAD	mcad	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	Deficient	deficient	JJ	_	6	NMOD
6	Mice	mouse	NNS	_	2	PMOD

1	Values	value	NNS	_	3	SBJ
2	given	give	VBN	_	1	NMOD
3	are	be	VBP	_	0	ROOT
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SD	sd	NN	_	3	PRD
7	.	.	.	_	3	P

1	aMCAD	amcad	NN	_	0	ROOT
2	+	+	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	+	+	SYM	_	1	P
5	n	n	NN	_	7	SBJ
6	=	=	SYM	_	7	P
7	5	0	CD	_	1	DEP
8	and	and	CC	_	1	COORD
9	MCAD	mcad	NN	_	8	CONJ
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	n	n	NN	_	15	SBJ
14	=	=	SYM	_	15	P
15	5	0	CD	_	9	DEP
16	.	.	.	_	1	P

1	bMCAD	bmcad	NN	_	0	ROOT
2	+	+	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	+	+	SYM	_	1	P
5	n	n	NN	_	8	SBJ
6	=	=	SYM	_	8	P
7	8	0	CD	_	8	NMOD
8	litters	litter	NNS	_	1	DEP
9	and	and	CC	_	1	COORD
10	MCAD	mcad	NN	_	9	CONJ
11	−	−	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	−	−	SYM	_	10	P
14	n	n	NN	_	17	SBJ
15	=	=	SYM	_	17	P
16	10	0	CD	_	17	NMOD
17	litters	litter	NNS	_	10	DEP
18	.	.	.	_	1	P

1	cMCAD	cmcad	NN	_	0	ROOT
2	+	+	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	+	+	SYM	_	1	P
5	n	n	NN	_	7	SBJ
6	=	=	SYM	_	7	P
7	5	0	CD	_	1	DEP
8	and	and	CC	_	1	COORD
9	MCAD	mcad	NN	_	8	CONJ
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	n	n	NN	_	15	SBJ
14	=	=	SYM	_	15	P
15	6	0	CD	_	9	DEP
16	.	.	.	_	1	P

1	dMCAD	dmcad	NN	_	0	ROOT
2	+	+	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	+	+	SYM	_	1	P
5	n	n	NN	_	7	SBJ
6	=	=	SYM	_	7	P
7	4	0	CD	_	1	DEP
8	and	and	CC	_	1	COORD
9	MCAD	mcad	NN	_	8	CONJ
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	n	n	NN	_	15	SBJ
14	=	=	SYM	_	15	P
15	5	0	CD	_	9	DEP
16	.	.	.	_	1	P

1	eExpressed	eexpressed	VBN	_	0	ROOT
2	as	as	IN	_	1	MNR
3	a	a	DT	_	4	NMOD
4	ratio	ratio	NN	_	2	PMOD
5	relative	relative	JJ	_	4	NMOD
6	to	to	IN	_	5	AMOD
7	the	the	DT	_	9	NMOD
8	internal	internal	JJ	_	9	NMOD
9	standard	standard	NN	_	6	PMOD
10	.	.	.	_	1	P

1	Neonatal	neonatal	JJ	_	2	NMOD
2	Deaths	death	NNS	_	0	ROOT

1	Significant	significant	JJ	_	3	NMOD
2	neonatal	neonatal	JJ	_	3	NMOD
3	mortality	mortality	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	noted	note	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	MCAD	mcad	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	pups	pup	NNS	_	6	PMOD
12	.	.	.	_	4	P

1	Although	although	IN	_	29	ADV
2	equal	equal	JJ	_	3	NMOD
3	numbers	number	NNS	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	pups	pup	NNS	_	4	PMOD
6	were	be	VBD	_	1	SUB
7	born	bear	VBN	_	6	VC
8	from	from	IN	_	7	ADV
9	MCAD	mcad	NN	_	18	NMOD
10	+	+	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	+	+	SYM	_	9	P
13	and	and	CC	_	9	COORD
14	MCAD	mcad	NN	_	13	CONJ
15	−	−	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	mice	mouse	NNS	_	8	PMOD
19	,	,	,	_	29	P
20	only	only	RB	_	22	NMOD
21	41	0	CD	_	22	NMOD
22	%	%	NN	_	29	SBJ
23	of	of	IN	_	22	NMOD
24	MCAD	mcad	NN	_	28	NMOD
25	−	−	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	−	−	SYM	_	24	P
28	mice	mouse	NNS	_	23	PMOD
29	survived	survive	VBD	_	0	ROOT
30	to	to	IN	_	29	TMP
31	weaning	weaning	NN	_	30	PMOD
32	as	as	IN	_	29	ADV
33	compared	compare	VBN	_	32	SUB
34	to	to	IN	_	33	ADV
35	98	0	CD	_	36	NMOD
36	%	%	NN	_	34	PMOD
37	of	of	IN	_	36	NMOD
38	MCAD	mcad	NN	_	42	NMOD
39	+	+	SYM	_	38	P
40	/	/	HYPH	_	38	P
41	+	+	SYM	_	38	P
42	mice	mouse	NNS	_	37	PMOD
43	(	(	-LRB-	_	44	P
44	Table	table	NN	_	29	PRN
45	1	0	CD	_	44	NMOD
46	)	)	-RRB-	_	44	P
47	.	.	.	_	29	P

1	The	the	DT	_	2	NMOD
2	mechanism	mechanism	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	neonatal	neonatal	JJ	_	5	NMOD
5	loss	loss	NN	_	3	PMOD
6	remains	remain	VBZ	_	0	ROOT
7	undetermined	undetermined	JJ	_	6	PRD
8	.	.	.	_	6	P

1	The	the	DT	_	6	NMOD
2	MCAD	mcad	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	pups	pup	NNS	_	7	SBJ
7	are	be	VBP	_	0	ROOT
8	abandoned	abandon	VBN	_	7	VC
9	more	more	RBR	_	10	AMOD
10	frequently	frequently	RB	_	8	TMP
11	than	than	IN	_	10	AMOD
12	MCAD	mcad	NN	_	16	NMOD
13	+	+	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	+	+	SYM	_	12	P
16	pups	pup	NNS	_	11	PMOD
17	for	for	IN	_	8	PRP
18	unknown	unknown	JJ	_	19	NMOD
19	reasons	reason	NNS	_	17	PMOD
20	.	.	.	_	7	P

1	They	they	PRP	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	likely	likely	RB	_	2	ADV
4	more	more	RBR	_	5	AMOD
5	prone	prone	JJ	_	2	PRD
6	to	to	IN	_	5	AMOD
7	hypothermia	hypothermia	NN	_	6	PMOD
8	than	than	IN	_	5	AMOD
9	MCAD	mcad	NN	_	8	PMOD
10	+	+	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	+	+	SYM	_	9	P
13	.	.	.	_	2	P

1	Because	because	IN	_	31	PRP
2	of	of	IN	_	1	PMOD
3	the	the	DT	_	4	NMOD
4	difficulty	difficulty	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	distinguishing	distinguish	VBG	_	5	PMOD
7	the	the	DT	_	12	NMOD
8	MCAD	mcad	NN	_	12	NMOD
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mutants	mutant	NNS	_	6	OBJ
13	from	from	IN	_	6	ADV
14	the	the	DT	_	20	NMOD
15	MCAD	mcad	NN	_	20	NMOD
16	+	+	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	−	−	SYM	_	15	P
19	heterozygous	heterozygous	JJ	_	20	NMOD
20	pups	pup	NNS	_	13	PMOD
21	by	by	IN	_	6	MNR
22	molecular	molecular	JJ	_	23	NMOD
23	analysis	analysis	NN	_	21	PMOD
24	due	due	IN	_	4	NMOD
25	to	to	IN	_	24	PMOD
26	the	the	DT	_	28	NMOD
27	insertion	insertion	NN	_	28	NMOD
28	mutation	mutation	NN	_	24	PMOD
29	,	,	,	_	31	P
30	we	we	PRP	_	31	SBJ
31	could	could	MD	_	0	ROOT
32	only	only	RB	_	31	ADV
33	compare	compare	VB	_	31	VC
34	MCAD	mcad	NN	_	39	NMOD
35	+	+	SYM	_	34	P
36	/	/	HYPH	_	34	P
37	+	+	SYM	_	34	P
38	×	×	SYM	_	39	P
39	MCAD	mcad	NN	_	43	NMOD
40	+	+	SYM	_	39	P
41	/	/	HYPH	_	39	P
42	+	+	SYM	_	39	P
43	matings	mating	NNS	_	33	OBJ
44	with	with	IN	_	33	ADV
45	MCAD	mcad	NN	_	50	NMOD
46	−	−	SYM	_	45	P
47	/	/	HYPH	_	45	P
48	−	−	SYM	_	45	P
49	×	×	SYM	_	50	P
50	MCAD	mcad	NN	_	54	NMOD
51	−	−	SYM	_	50	P
52	/	/	HYPH	_	50	P
53	−	−	SYM	_	50	P
54	matings	mating	NNS	_	44	PMOD
55	.	.	.	_	31	P

1	Thus	thus	RB	_	4	ADV
2	,	,	,	_	4	P
3	we	we	PRP	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	unable	unable	JJ	_	4	PRD
6	to	to	TO	_	5	AMOD
7	evaluate	evaluate	VB	_	6	IM
8	the	the	DT	_	9	NMOD
9	pedigrees	pedigree	NNS	_	7	OBJ
10	from	from	IN	_	7	ADV
11	heterozygous	heterozygous	JJ	_	12	NMOD
12	matings	mating	NNS	_	10	PMOD
13	.	.	.	_	4	P

1	Fasting	fasting	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Cold	cold	NN	_	4	NMOD
4	Intolerance	intolerance	NN	_	2	CONJ

1	In	in	IN	_	17	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	examine	examine	VB	_	3	IM
5	the	the	DT	_	7	NMOD
6	stress	stress	NN	_	7	NMOD
7	effects	effect	NNS	_	4	OBJ
8	of	of	IN	_	7	NMOD
9	fasting	fasting	NN	_	8	PMOD
10	on	on	IN	_	7	NMOD
11	MCAD	mcad	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	deficient	deficient	JJ	_	14	NMOD
14	mice	mouse	NNS	_	10	PMOD
15	,	,	,	_	17	P
16	they	they	PRP	_	17	SBJ
17	were	be	VBD	_	0	ROOT
18	fasted	fast	VBN	_	17	VC
19	for	for	IN	_	18	TMP
20	24	0	CD	_	21	NMOD
21	h	h	NN	_	19	PMOD
22	prior	prior	JJ	_	23	PMOD
23	to	to	IN	_	18	TMP
24	analysis	analysis	NN	_	23	PMOD
25	.	.	.	_	17	P

1	MCAD	mcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	displayed	display	VBD	_	0	ROOT
7	lower	low	JJR	_	9	NMOD
8	serum	serum	NN	_	9	NMOD
9	glucose	glucose	NN	_	6	OBJ
10	and	and	CC	_	9	COORD
11	elevated	elevate	VBN	_	16	NMOD
12	serum	serum	NN	_	13	AMOD
13	free	free	JJ	_	15	NMOD
14	fatty	fatty	JJ	_	15	NMOD
15	acid	acid	NN	_	16	NMOD
16	levels	level	NNS	_	10	CONJ
17	although	although	IN	_	6	ADV
18	neither	neither	DT	_	19	NMOD
19	result	result	NN	_	20	SBJ
20	was	be	VBD	_	17	SUB
21	significant	significant	JJ	_	20	PRD
22	,	,	,	_	20	P
23	as	as	IN	_	20	ADV
24	compared	compare	VBN	_	23	SUB
25	to	to	IN	_	24	ADV
26	MCAD	mcad	NN	_	30	NMOD
27	+	+	SYM	_	26	P
28	/	/	HYPH	_	26	P
29	+	+	SYM	_	26	P
30	mice	mouse	NNS	_	25	PMOD
31	(	(	-LRB-	_	32	P
32	Table	table	NN	_	6	PRN
33	1	0	CD	_	32	NMOD
34	)	)	-RRB-	_	32	P
35	.	.	.	_	6	P

1	To	to	TO	_	10	PRP
2	determine	determine	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	effects	effect	NNS	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	cold	cold	NN	_	7	NMOD
7	stress	stress	NN	_	5	PMOD
8	,	,	,	_	10	P
9	mice	mouse	NNS	_	10	SBJ
10	were	be	VBD	_	0	ROOT
11	fasted	fast	VBN	_	10	VC
12	for	for	IN	_	11	TMP
13	18	0	CD	_	14	NMOD
14	h	h	NN	_	12	PMOD
15	and	and	CC	_	11	COORD
16	placed	place	VBN	_	15	CONJ
17	in	in	IN	_	16	LOC
18	4	0	CD	_	19	NMOD
19	°C	°c	NN	_	20	NMOD
20	environment	environment	NN	_	17	PMOD
21	for	for	IN	_	16	TMP
22	a	a	DT	_	26	NMOD
23	3	0	CD	_	25	NMOD
24	-	-	HYPH	_	23	P
25	h	h	NN	_	26	NMOD
26	period	period	NN	_	21	PMOD
27	.	.	.	_	10	P

1	The	the	DT	_	6	NMOD
2	MCAD	mcad	NN	_	6	NMOD
3	−	−	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	−	−	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	significantly	significantly	RB	_	7	ADV
9	compromised	compromise	VBN	_	7	VC
10	within	within	IN	_	9	TMP
11	this	this	DT	_	13	NMOD
12	short	short	JJ	_	13	NMOD
13	period	period	NN	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	cold	cold	NN	_	16	NMOD
16	stress	stress	NN	_	14	PMOD
17	,	,	,	_	7	P
18	some	some	DT	_	7	GAP-SBJ
19	severe	severe	JJ	_	18	OPRD
20	enough	enough	RB	_	19	AMOD
21	to	to	TO	_	19	AMOD
22	result	result	VB	_	21	IM
23	in	in	IN	_	22	ADV
24	fatalities	fatality	NNS	_	23	PMOD
25	.	.	.	_	7	P

1	After	after	IN	_	24	TMP
2	1	0	CD	_	3	NMOD
3	h	h	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	cold	cold	NN	_	7	NMOD
7	challenge	challenge	NN	_	4	PMOD
8	,	,	,	_	24	P
9	the	the	DT	_	12	NMOD
10	average	average	JJ	_	12	NMOD
11	rectal	rectal	JJ	_	12	NMOD
12	temperature	temperature	NN	_	24	SBJ
13	of	of	IN	_	12	NMOD
14	MCAD	mcad	NN	_	18	NMOD
15	−	−	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	mice	mouse	NNS	_	13	PMOD
19	(	(	-LRB-	_	22	P
20	n	n	NN	_	22	SBJ
21	=	=	SYM	_	22	P
22	5	0	CD	_	18	PRN
23	)	)	-RRB-	_	22	P
24	was	be	VBD	_	0	ROOT
25	23.4	0	CD	_	26	NMOD
26	°C	°c	NN	_	24	PRD
27	as	as	IN	_	24	ADV
28	compared	compare	VBN	_	27	SUB
29	with	with	IN	_	28	ADV
30	35	0	CD	_	31	NMOD
31	°C	°c	NN	_	29	PMOD
32	for	for	IN	_	31	NMOD
33	MCAD	mcad	NN	_	37	NMOD
34	+	+	SYM	_	33	P
35	/	/	HYPH	_	33	P
36	+	+	SYM	_	33	P
37	mice	mouse	NNS	_	32	PMOD
38	(	(	-LRB-	_	41	P
39	n	n	NN	_	41	SBJ
40	=	=	SYM	_	41	P
41	4	0	CD	_	37	PRN
42	)	)	-RRB-	_	41	P
43	.	.	.	_	24	P

1	Rectal	rectal	JJ	_	2	NMOD
2	temperatures	temperature	NNS	_	3	SBJ
3	declined	decline	VBD	_	0	ROOT
4	to	to	IN	_	3	ADV
5	unrecoverable	unrecoverable	JJ	_	6	NMOD
6	temperatures	temperature	NNS	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	16.7	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	19.2	0	CD	_	8	QMOD
11	°C	°c	NN	_	7	PMOD
12	in	in	IN	_	3	LOC
13	three	three	CD	_	21	NMOD
14	of	of	IN	_	13	QMOD
15	the	the	DT	_	13	QMOD
16	five	five	CD	_	13	QMOD
17	MCAD	mcad	NN	_	21	NMOD
18	−	−	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	mice	mouse	NNS	_	12	PMOD
22	.	.	.	_	3	P

1	By	by	IN	_	19	TMP
2	the	the	DT	_	3	NMOD
3	end	end	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	9	NMOD
6	1.5	0	CD	_	8	NMOD
7	-	-	HYPH	_	6	P
8	h	h	NN	_	9	NMOD
9	mark	mark	NN	_	4	PMOD
10	,	,	,	_	19	P
11	the	the	DT	_	18	NMOD
12	two	two	CD	_	18	NMOD
13	surviving	survive	VBG	_	18	NMOD
14	MCAD	mcad	NN	_	18	NMOD
15	−	−	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	−	−	SYM	_	14	P
18	mice	mouse	NNS	_	19	SBJ
19	averaged	average	VBD	_	0	ROOT
20	22.7	0	CD	_	21	NMOD
21	°C	°c	NN	_	19	OBJ
22	.	.	.	_	19	P

1	In	in	IN	_	11	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	11	P
4	all	all	DT	_	10	NMOD
5	four	four	CD	_	10	NMOD
6	MCAD	mcad	NN	_	10	NMOD
7	+	+	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	+	+	SYM	_	6	P
10	mice	mouse	NNS	_	11	SBJ
11	survived	survive	VBD	_	0	ROOT
12	the	the	DT	_	17	NMOD
13	3	0	CD	_	15	NMOD
14	-	-	HYPH	_	13	P
15	h	h	NN	_	17	NMOD
16	cold	cold	NN	_	17	NMOD
17	stress	stress	NN	_	11	OBJ
18	,	,	,	_	11	P
19	ending	end	VBG	_	11	ADV
20	with	with	IN	_	19	ADV
21	an	an	DT	_	24	NMOD
22	average	average	JJ	_	24	NMOD
23	rectal	rectal	JJ	_	24	NMOD
24	temperature	temperature	NN	_	20	PMOD
25	of	of	IN	_	24	NMOD
26	33.6	0	CD	_	27	NMOD
27	°C	°c	NN	_	25	PMOD
28	.	.	.	_	11	P

1	Organic	organic	JJ	_	2	NMOD
2	Acid	acid	NN	_	0	ROOT
3	and	and	CC	_	2	COORD
4	Acylcarnitine	acylcarnitine	NN	_	5	NMOD
5	Analysis	analysis	NN	_	3	CONJ

1	Urine	urine	NN	_	3	NMOD
2	organic	organic	JJ	_	3	NMOD
3	acid	acid	NN	_	4	NMOD
4	analysis	analysis	NN	_	5	SBJ
5	revealed	reveal	VBD	_	0	ROOT
6	that	that	IN	_	5	OBJ
7	MCAD	mcad	NN	_	11	NMOD
8	−	−	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	−	−	SYM	_	7	P
11	mice	mouse	NNS	_	12	SBJ
12	developed	develop	VBD	_	6	SUB
13	an	an	DT	_	16	NMOD
14	organic	organic	JJ	_	15	NMOD
15	acid	acid	NN	_	16	NMOD
16	profile	profile	NN	_	12	OBJ
17	similar	similar	JJ	_	16	NMOD
18	to	to	IN	_	17	AMOD
19	MCAD	mcad	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	deficient	deficient	JJ	_	23	NMOD
22	human	human	JJ	_	23	NMOD
23	patients	patient	NNS	_	18	PMOD
24	.	.	.	_	5	P

1	Specifically	specifically	RB	_	14	ADV
2	,	,	,	_	14	P
3	when	when	WRB	_	4	TMP
4	fasted	fast	VBN	_	14	TMP
5	for	for	IN	_	4	TMP
6	18	0	CD	_	7	NMOD
7	h	h	NN	_	5	PMOD
8	,	,	,	_	14	P
9	MCAD	mcad	NN	_	13	NMOD
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	mice	mouse	NNS	_	14	SBJ
14	developed	develop	VBD	_	0	ROOT
15	significantly	significantly	RB	_	16	AMOD
16	elevated	elevate	VBN	_	17	NMOD
17	concentrations	concentration	NNS	_	14	OBJ
18	of	of	IN	_	17	NMOD
19	adipic	adipic	JJ	_	25	NMOD
20	,	,	,	_	19	P
21	suberic	suberic	JJ	_	19	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	sebacic	sebacic	JJ	_	23	CONJ
25	acids	acid	NNS	_	18	PMOD
26	and	and	CC	_	25	COORD
27	hexanoylglycine	hexanoylglycine	NN	_	26	CONJ
28	as	as	IN	_	14	ADV
29	compared	compare	VBN	_	28	SUB
30	to	to	IN	_	29	ADV
31	MCAD	mcad	NN	_	35	NMOD
32	+	+	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	+	+	SYM	_	31	P
35	controls	control	NNS	_	30	PMOD
36	,	,	,	_	35	P
37	which	which	WDT	_	38	SBJ
38	showed	show	VBD	_	35	NMOD
39	trace	trace	NN	_	38	OBJ
40	to	to	IN	_	39	NMOD
41	no	no	DT	_	43	NMOD
42	detectable	detectable	JJ	_	43	NMOD
43	amounts	amount	NNS	_	40	PMOD
44	of	of	IN	_	39	NMOD
45	the	the	DT	_	48	NMOD
46	same	same	JJ	_	48	NMOD
47	organic	organic	JJ	_	48	NMOD
48	acids	acid	NNS	_	44	PMOD
49	(	(	-LRB-	_	50	P
50	Table	table	NN	_	14	PRN
51	1	0	CD	_	50	NMOD
52	)	)	-RRB-	_	50	P
53	.	.	.	_	14	P

1	Adipic	adipic	JJ	_	2	NMOD
2	acid	acid	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	not	not	RB	_	3	ADV
5	specific	specific	JJ	_	3	PRD
6	to	to	IN	_	5	AMOD
7	MCAD	mcad	NN	_	8	NMOD
8	deficiency	deficiency	NN	_	6	PMOD
9	.	.	.	_	3	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	evaluated	evaluate	VBD	_	0	ROOT
4	β	β	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	hydroxybutyric	hydroxybutyric	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	acetoacetic	acetoacetic	JJ	_	7	CONJ
9	concentrations	concentration	NNS	_	3	OBJ
10	and	and	CC	_	3	COORD
11	found	find	VBD	_	10	CONJ
12	no	no	DT	_	14	NMOD
13	significant	significant	JJ	_	14	NMOD
14	differences	difference	NNS	_	11	OBJ
15	between	between	IN	_	14	NMOD
16	MCAD	mcad	NN	_	17	NMOD
17	genotypes	genotype	NNS	_	15	PMOD
18	(	(	-LRB-	_	21	P
19	data	datum	NNS	_	21	SBJ
20	not	not	RB	_	21	ADV
21	shown	show	VBN	_	3	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	3	P

1	Comparison	comparison	NN	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	MCAD	mcad	NN	_	12	NMOD
4	+	+	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	+	+	SYM	_	3	P
7	and	and	CC	_	3	COORD
8	MCAD	mcad	NN	_	7	CONJ
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mice	mouse	NNS	_	2	PMOD
13	revealed	reveal	VBD	_	0	ROOT
14	no	no	DT	_	16	NMOD
15	significant	significant	JJ	_	16	NMOD
16	differences	difference	NNS	_	13	OBJ
17	in	in	IN	_	16	NMOD
18	total	total	JJ	_	21	NMOD
19	serum	serum	NN	_	21	NMOD
20	carnitine	carnitine	NN	_	21	NMOD
21	concentrations	concentration	NNS	_	17	PMOD
22	between	between	IN	_	16	NMOD
23	MCAD	mcad	NN	_	32	NMOD
24	+	+	SYM	_	23	P
25	/	/	HYPH	_	23	P
26	+	+	SYM	_	23	P
27	and	and	CC	_	23	COORD
28	MCAD	mcad	NN	_	27	CONJ
29	−	−	SYM	_	28	P
30	/	/	HYPH	_	28	P
31	−	−	SYM	_	28	P
32	mice	mouse	NNS	_	22	PMOD
33	,	,	,	_	13	P
34	but	but	CC	_	13	COORD
35	MCAD	mcad	NN	_	39	NMOD
36	−	−	SYM	_	35	P
37	/	/	HYPH	_	35	P
38	−	−	SYM	_	35	P
39	mice	mouse	NNS	_	40	SBJ
40	had	have	VBD	_	34	CONJ
41	a	a	DT	_	48	NMOD
42	5	0	CD	_	47	QMOD
43	-	-	HYPH	_	42	P
44	to	to	IN	_	42	QMOD
45	6	0	CD	_	42	QMOD
46	-	-	HYPH	_	42	P
47	fold	fold	JJ	_	48	NMOD
48	elevation	elevation	NN	_	40	OBJ
49	of	of	IN	_	48	NMOD
50	serum	serum	NN	_	51	NMOD
51	decenoylcarnitine	decenoylcarnitine	NN	_	49	PMOD
52	evident	evident	JJ	_	48	OPRD
53	in	in	IN	_	48	LOC
54	the	the	DT	_	56	NMOD
55	acylcarnitine	acylcarnitine	NN	_	56	NMOD
56	profile	profile	NN	_	53	PMOD
57	(	(	-LRB-	_	58	P
58	Figure	figure	NN	_	40	PRN
59	4A	0a	CD	_	58	NMOD
60	)	)	-RRB-	_	58	P
61	.	.	.	_	13	P

1	Bile	bile	NN	_	2	NMOD
2	acylcarnitine	acylcarnitine	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	revealed	reveal	VBD	_	0	ROOT
5	a	a	DT	_	8	NMOD
6	similar	similar	JJ	_	8	NMOD
7	acylcarnitine	acylcarnitine	NN	_	8	NMOD
8	pattern	pattern	NN	_	4	OBJ
9	as	as	IN	_	8	NMOD
10	in	in	IN	_	9	PMOD
11	serum	serum	NN	_	10	PMOD
12	(	(	-LRB-	_	13	P
13	Figure	figure	NN	_	4	PRN
14	4B	0b	CD	_	13	NMOD
15	)	)	-RRB-	_	13	P
16	.	.	.	_	4	P

1	However	however	RB	_	13	ADV
2	,	,	,	_	13	P
3	the	the	DT	_	5	NMOD
4	acylcarnitine	acylcarnitine	NN	_	5	NMOD
5	profiles	profile	NNS	_	13	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	12	NMOD
8	MCAD	mcad	NN	_	12	NMOD
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mice	mouse	NNS	_	6	PMOD
13	are	be	VBP	_	0	ROOT
14	different	different	JJ	_	13	PRD
15	from	from	IN	_	14	AMOD
16	those	those	DT	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	human	human	JJ	_	22	NMOD
19	MCAD	mcad	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	deficient	deficient	JJ	_	22	NMOD
22	patients	patient	NNS	_	17	PMOD
23	(	(	-LRB-	_	24	P
24	Figure	figure	NN	_	13	PRN
25	4C	0c	CD	_	24	NMOD
26	)	)	-RRB-	_	24	P
27	.	.	.	_	13	P

1	Human	human	JJ	_	2	NMOD
2	patients	patient	NNS	_	3	SBJ
3	present	present	VBP	_	29	DEP
4	with	with	IN	_	3	ADV
5	elevated	elevate	VBN	_	6	NMOD
6	levels	level	NNS	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	C6	c0	NN	_	16	NMOD
9	,	,	,	_	8	P
10	C8	c0	NN	_	8	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	C10	c0	NN	_	12	CONJ
14	:	:	:	_	13	P
15	1	0	CD	_	13	NMOD
16	acylcarnitines	acylcarnitines	NNS	_	7	PMOD
17	,	,	,	_	3	P
18	as	as	IN	_	3	ADV
19	did	do	VBD	_	18	SUB
20	the	the	DT	_	22	NMOD
21	mutant	mutant	NN	_	22	NMOD
22	mice	mouse	NNS	_	19	SBJ
23	;	;	:	_	29	P
24	however	however	RB	_	29	ADV
25	,	,	,	_	29	P
26	the	the	DT	_	28	NMOD
27	predominant	predominant	JJ	_	28	NMOD
28	peak	peak	NN	_	29	SBJ
29	was	be	VBD	_	0	ROOT
30	C8	c0	NN	_	31	NMOD
31	acylcarnitine	acylcarnitine	NN	_	29	PRD
32	in	in	IN	_	29	LOC
33	humans	human	NNS	_	32	PMOD
34	,	,	,	_	29	P
35	whereas	whereas	IN	_	29	ADV
36	in	in	IN	_	40	LOC
37	the	the	DT	_	38	NMOD
38	mouse	mouse	NN	_	36	PMOD
39	it	it	PRP	_	40	SBJ
40	was	be	VBD	_	35	SUB
41	C10	c0	NN	_	44	NMOD
42	:	:	:	_	41	P
43	1	0	CD	_	41	NMOD
44	acylcarnitine	acylcarnitine	NN	_	40	PRD
45	.	.	.	_	29	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Acylcarnitine	acylcarnitine	NN	_	2	NMOD
2	Analyses	analysis	NNS	_	0	ROOT

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Serum	serum	NN	_	5	NMOD
5	acylcarnitine	acylcarnitine	NN	_	6	NMOD
6	analysis	analysis	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	MCAD	mcad	NN	_	22	NMOD
9	+	+	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	+	+	SYM	_	8	P
12	(	(	-LRB-	_	15	P
13	n	n	NN	_	15	SBJ
14	=	=	SYM	_	15	P
15	4	0	CD	_	8	PRN
16	)	)	-RRB-	_	15	P
17	and	and	CC	_	8	COORD
18	MCAD	mcad	NN	_	17	CONJ
19	−	−	SYM	_	18	P
20	/	/	HYPH	_	18	P
21	−	−	SYM	_	18	P
22	mice	mouse	NNS	_	7	PMOD
23	(	(	-LRB-	_	26	P
24	n	n	NN	_	26	SBJ
25	=	=	SYM	_	26	P
26	4	0	CD	_	22	PRN
27	)	)	-RRB-	_	26	P

1	There	there	EX	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	significant	significant	JJ	_	4	NMOD
4	elevations	elevation	NNS	_	2	PRD
5	in	in	IN	_	2	LOC
6	acylcarnitine	acylcarnitine	NN	_	7	NMOD
7	species	specie	NNS	_	5	PMOD
8	as	as	IN	_	2	ADV
9	indicated	indicate	VBN	_	8	SUB
10	in	in	IN	_	9	LOC
11	MCAD	mcad	NN	_	15	NMOD
12	−	−	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	−	−	SYM	_	11	P
15	mice	mouse	NNS	_	10	PMOD
16	.	.	.	_	2	P

1	Values	value	NNS	_	3	SBJ
2	shown	show	VBN	_	1	NMOD
3	are	be	VBP	_	0	ROOT
4	mean	mean	NN	_	5	NMOD
5	values	value	NNS	_	10	NMOD
6	±	±	SYM	_	10	P
7	standard	standard	JJ	_	8	NMOD
8	deviation	deviation	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	SD	sd	NN	_	3	PRD
11	)	)	-RRB-	_	3	P
12	.	.	.	_	3	P

1	Asterisk	asterisk	NN	_	2	SBJ
2	indicates	indicate	VBZ	_	0	ROOT
3	p	p	NN	_	2	OBJ
4	<	<	SYM	_	5	P
5	0.002	0	CD	_	3	NMOD
6	and	and	CC	_	2	COORD
7	‡	‡	SYM	_	8	SBJ
8	indicates	indicate	VBZ	_	6	CONJ
9	p	p	NN	_	8	OBJ
10	<	<	SYM	_	11	P
11	0.01	0	CD	_	9	NMOD
12	.	.	.	_	2	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	5	DEP
3	)	)	-RRB-	_	2	P
4	There	there	EX	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	significant	significant	JJ	_	7	NMOD
7	elevations	elevation	NNS	_	5	PRD
8	in	in	IN	_	7	NMOD
9	bile	bile	NN	_	10	NMOD
10	acylcarnitines	acylcarnitines	NNS	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	same	same	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	shown	show	VBN	_	14	NMOD
16	in	in	IN	_	15	ADV
17	(	(	-LRB-	_	16	P
18	A	a	NN	_	16	PMOD
19	)	)	-RRB-	_	15	P
20	as	as	IN	_	15	ADV
21	indicated	indicate	VBN	_	20	SUB
22	.	.	.	_	5	P

1	Values	value	NNS	_	3	SBJ
2	shown	show	VBN	_	1	NMOD
3	are	be	VBP	_	0	ROOT
4	mean	mean	NN	_	5	NMOD
5	values	value	NNS	_	7	NMOD
6	±	±	SYM	_	7	P
7	SD	sd	NN	_	3	PRD
8	.	.	.	_	3	P

1	Asterisk	asterisk	NN	_	2	SBJ
2	indicates	indicate	VBZ	_	0	ROOT
3	p	p	NN	_	2	OBJ
4	<	<	SYM	_	5	P
5	0.001	0	CD	_	3	NMOD
6	.	.	.	_	2	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Bile	bile	NN	_	5	NMOD
5	acylcarnitine	acylcarnitine	NN	_	6	NMOD
6	profile	profile	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	an	an	DT	_	13	NMOD
9	MCAD	mcad	NN	_	13	NMOD
10	−	−	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	−	−	SYM	_	9	P
13	mouse	mouse	NN	_	7	PMOD
14	compared	compare	VBN	_	6	NMOD
15	to	to	IN	_	14	PMOD
16	a	a	DT	_	18	NMOD
17	human	human	JJ	_	18	NMOD
18	patient	patient	NN	_	15	PMOD
19	with	with	IN	_	18	NMOD
20	MCAD	mcad	NN	_	21	NMOD
21	deficiency	deficiency	NN	_	19	PMOD
22	.	.	.	_	6	P

1	Internal	internal	JJ	_	2	NMOD
2	standards	standard	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	indicated	indicate	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	an	an	DT	_	7	NMOD
7	asterisk	asterisk	NN	_	5	PMOD
8	.	.	.	_	3	P

1	Histopathology	histopathology	NN	_	0	ROOT

1	Complete	complete	JJ	_	3	NMOD
2	histopathologic	histopathologic	JJ	_	3	NMOD
3	examination	examination	NN	_	22	SBJ
4	of	of	IN	_	3	NMOD
5	one	one	CD	_	6	NMOD
6	group	group	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	mutant	mutant	NN	_	15	NMOD
9	and	and	CC	_	8	COORD
10	MCAD	mcad	NN	_	9	CONJ
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	+	+	SYM	_	10	P
14	control	control	NN	_	15	NMOD
15	mice	mouse	NNS	_	7	PMOD
16	after	after	IN	_	3	TMP
17	a	a	DT	_	21	NMOD
18	24	0	CD	_	20	NMOD
19	-	-	HYPH	_	18	P
20	h	h	NN	_	21	NMOD
21	fast	fast	NN	_	16	PMOD
22	demonstrated	demonstrate	VBD	_	0	ROOT
23	diffuse	diffuse	JJ	_	28	NMOD
24	microvesicular	microvesicular	JJ	_	28	NMOD
25	and	and	CC	_	24	COORD
26	macrovesicular	macrovesicular	JJ	_	25	CONJ
27	hepatic	hepatic	JJ	_	28	NMOD
28	steatosis	steatosis	NN	_	22	OBJ
29	in	in	IN	_	22	LOC
30	6	0	CD	_	34	NMOD
31	–	–	SYM	_	30	P
32	8	0	CD	_	30	QMOD
33	-	-	HYPH	_	30	P
34	wk	wk	NN	_	36	AMOD
35	-	-	HYPH	_	34	P
36	old	old	JJ	_	41	NMOD
37	MCAD	mcad	NN	_	41	NMOD
38	−	−	SYM	_	37	P
39	/	/	HYPH	_	37	P
40	−	−	SYM	_	37	P
41	mice	mouse	NNS	_	29	PMOD
42	whereas	whereas	IN	_	22	ADV
43	MCAD	mcad	NN	_	47	NMOD
44	+	+	SYM	_	43	P
45	/	/	HYPH	_	43	P
46	+	+	SYM	_	43	P
47	mice	mouse	NNS	_	48	SBJ
48	had	have	VBD	_	42	SUB
49	no	no	DT	_	51	NMOD
50	histologic	histologic	JJ	_	51	NMOD
51	changes	change	NNS	_	48	OBJ
52	(	(	-LRB-	_	54	P
53	Figure	figure	NN	_	54	NMOD
54	5A	0a	CD	_	22	PRN
55	and	and	CC	_	54	COORD
56	5B	0b	CD	_	55	CONJ
57	)	)	-RRB-	_	54	P
58	.	.	.	_	22	P

1	In	in	IN	_	27	ADV
2	another	another	DT	_	3	NMOD
3	group	group	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	4	0	CD	_	7	NMOD
6	-	-	HYPH	_	5	P
7	wk	wk	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	old	old	JJ	_	19	NMOD
10	MCAD	mcad	NN	_	19	NMOD
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	+	+	SYM	_	10	P
14	and	and	CC	_	10	COORD
15	MCAD	mcad	NN	_	14	CONJ
16	−	−	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	−	−	SYM	_	15	P
19	mice	mouse	NNS	_	4	PMOD
20	fasted	fast	VBN	_	19	NMOD
21	for	for	IN	_	20	TMP
22	24	0	CD	_	24	NMOD
23	-	-	HYPH	_	22	P
24	h	h	NN	_	21	PMOD
25	,	,	,	_	27	P
26	there	there	EX	_	27	SBJ
27	were	be	VBD	_	0	ROOT
28	minimal	minimal	JJ	_	31	NMOD
29	to	to	IN	_	27	PRD
30	no	no	DT	_	29	PMOD
31	abnormalities	abnormality	NNS	_	30	NMOD
32	in	in	IN	_	27	LOC
33	all	all	DT	_	34	NMOD
34	organs	organ	NNS	_	32	PMOD
35	evaluated	evaluate	VBN	_	34	NMOD
36	.	.	.	_	27	P

1	Only	only	RB	_	8	NMOD
2	the	the	DT	_	8	NMOD
3	older	old	JJR	_	8	NMOD
4	MCAD	mcad	NN	_	8	NMOD
5	−	−	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	−	−	SYM	_	4	P
8	mice	mouse	NNS	_	12	SBJ
9	,	,	,	_	12	P
10	therefore	therefore	RB	_	12	ADV
11	,	,	,	_	12	P
12	demonstrated	demonstrate	VBD	_	0	ROOT
13	hepatic	hepatic	JJ	_	14	NMOD
14	steatosis	steatosis	NN	_	12	OBJ
15	.	.	.	_	12	P

1	In	in	IN	_	5	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	5	P
4	we	we	PRP	_	5	SBJ
5	found	find	VBD	_	0	ROOT
6	sporadic	sporadic	JJ	_	8	NMOD
7	cardiac	cardiac	JJ	_	8	NMOD
8	lesions	lesion	NNS	_	5	OBJ
9	in	in	IN	_	5	LOC
10	multiple	multiple	JJ	_	15	NMOD
11	MCAD	mcad	NN	_	15	NMOD
12	−	−	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	−	−	SYM	_	11	P
15	mice	mouse	NNS	_	9	PMOD
16	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	Histopathology	histopathology	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	MCAD	mcad	NN	_	12	NMOD
4	+	+	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	+	+	SYM	_	3	P
7	and	and	CC	_	3	COORD
8	MCAD	mcad	NN	_	7	CONJ
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	Mice	mouse	NNS	_	2	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	9	DEP
3	)	)	-RRB-	_	2	P
4	MCAD	mcad	NN	_	8	NMOD
5	+	+	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	+	+	SYM	_	4	P
8	mice	mouse	NNS	_	9	SBJ
9	had	have	VBD	_	0	ROOT
10	no	no	DT	_	11	NMOD
11	evidence	evidence	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	hepatic	hepatic	JJ	_	14	NMOD
14	steatosis	steatosis	NN	_	12	PMOD
15	following	follow	VBG	_	9	TMP
16	a	a	DT	_	20	NMOD
17	24	0	CD	_	19	NMOD
18	-	-	HYPH	_	17	P
19	h	h	NN	_	20	NMOD
20	fast	fast	NN	_	15	PMOD
21	.	.	.	_	9	P

1	Liver	liver	NN	_	2	NMOD
2	section	section	NN	_	0	ROOT
3	with	with	IN	_	2	NMOD
4	Oil	oil	NN	_	7	NMOD
5	-	-	HYPH	_	4	P
6	Red	red	JJ	_	7	NMOD
7	O	o	NN	_	8	NMOD
8	stain	stain	NN	_	3	PMOD
9	.	.	.	_	2	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Hepatosteatosis	hepatosteatosis	NN	_	0	ROOT
5	in	in	IN	_	4	LOC
6	MCAD	mcad	NN	_	9	NMOD
7	−	−	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	−	−	NN	_	10	NMOD
10	mouse	mouse	NN	_	5	PMOD
11	following	follow	VBG	_	4	TMP
12	a	a	DT	_	16	NMOD
13	24	0	CD	_	15	NMOD
14	-	-	HYPH	_	13	P
15	h	h	NN	_	16	NMOD
16	fast	fast	NN	_	11	PMOD
17	.	.	.	_	4	P

1	Oil	oil	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	Red	red	JJ	_	4	NMOD
4	O	o	NN	_	5	AMOD
5	stained	stain	VBN	_	7	NMOD
6	liver	liver	NN	_	7	NMOD
7	sections	section	NNS	_	8	SBJ
8	revealed	reveal	VBD	_	0	ROOT
9	severe	severe	JJ	_	16	NMOD
10	and	and	CC	_	9	COORD
11	diffuse	diffuse	JJ	_	10	CONJ
12	microvesicular	microvesicular	JJ	_	16	NMOD
13	and	and	CC	_	12	COORD
14	macrovesicular	macrovesicular	JJ	_	13	CONJ
15	hepatic	hepatic	JJ	_	16	NMOD
16	steatosis	steatosis	NN	_	8	OBJ
17	in	in	IN	_	8	LOC
18	MCAD	mcad	NN	_	22	NMOD
19	−	−	SYM	_	18	P
20	/	/	HYPH	_	18	P
21	−	−	SYM	_	18	P
22	mice	mouse	NNS	_	17	PMOD
23	.	.	.	_	8	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	7	NMOD
3	and	and	CC	_	2	COORD
4	D	d	LS	_	3	CONJ
5	)	)	-RRB-	_	2	P
6	Diffuse	diffuse	JJ	_	7	NMOD
7	cardiomyopathy	cardiomyopathy	NN	_	0	ROOT
8	with	with	IN	_	7	NMOD
9	chronic	chronic	JJ	_	13	NMOD
10	active	active	JJ	_	13	NMOD
11	multifocal	multifocal	JJ	_	13	NMOD
12	myocyte	myocyte	NN	_	13	NMOD
13	degeneration	degeneration	NN	_	8	PMOD
14	and	and	CC	_	13	COORD
15	necrosis	necrosis	NN	_	14	CONJ
16	in	in	IN	_	7	LOC
17	MCAD	mcad	NN	_	21	NMOD
18	−	−	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	mice	mouse	NNS	_	16	PMOD
22	.	.	.	_	7	P

1	In	in	IN	_	11	ADV
2	one	one	CD	_	3	NMOD
3	example	example	NN	_	1	PMOD
4	,	,	,	_	11	P
5	an	an	DT	_	10	NMOD
6	MCAD	mcad	NN	_	10	NMOD
7	−	−	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	−	−	SYM	_	6	P
10	mouse	mouse	NN	_	11	SBJ
11	had	have	VBD	_	0	ROOT
12	diffuse	diffuse	JJ	_	13	NMOD
13	cardiomyopathy	cardiomyopathy	NN	_	11	OBJ
14	with	with	IN	_	13	NMOD
15	chronic	chronic	JJ	_	19	NMOD
16	active	active	JJ	_	19	NMOD
17	multifocal	multifocal	JJ	_	19	NMOD
18	myocyte	myocyte	NN	_	19	NMOD
19	degeneration	degeneration	NN	_	14	PMOD
20	and	and	CC	_	19	COORD
21	necrosis	necrosis	NN	_	20	CONJ
22	(	(	-LRB-	_	24	P
23	Figure	figure	NN	_	24	NMOD
24	5C	0c	CD	_	11	PRN
25	and	and	CC	_	24	COORD
26	5D	0d	CD	_	25	CONJ
27	)	)	-RRB-	_	24	P
28	.	.	.	_	11	P

1	Changes	change	NNS	_	5	SBJ
2	in	in	IN	_	1	LOC
3	degenerating	degenerate	VBG	_	4	NMOD
4	myocytes	myocytes	NNS	_	2	PMOD
5	included	include	VBD	_	0	ROOT
6	swelling	swell	VBG	_	5	OPRD
7	,	,	,	_	6	P
8	pale	pale	JJ	_	9	NMOD
9	staining	staining	NN	_	6	CONJ
10	,	,	,	_	9	P
11	and	and	CC	_	9	COORD
12	,	,	,	_	11	P
13	in	in	IN	_	19	LOC
14	portions	portion	NNS	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	sarcoplasm	sarcoplasm	NN	_	15	PMOD
18	,	,	,	_	19	P
19	replacement	replacement	NN	_	11	CONJ
20	of	of	IN	_	19	NMOD
21	myofibrils	myofibril	NNS	_	20	PMOD
22	with	with	IN	_	19	NMOD
23	finely	finely	RB	_	24	AMOD
24	granular	granular	JJ	_	26	NMOD
25	eosinophilic	eosinophilic	JJ	_	26	NMOD
26	material	material	NN	_	22	PMOD
27	.	.	.	_	5	P

1	Nuclei	nucleus	NNS	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	affected	affect	VBN	_	4	NMOD
4	myocytes	myocytes	NNS	_	2	PMOD
5	were	be	VBD	_	0	ROOT
6	large	large	JJ	_	5	PRD
7	,	,	,	_	6	P
8	pale	pale	JJ	_	6	CONJ
9	,	,	,	_	8	P
10	and	and	CC	_	8	COORD
11	vesicular	vesicular	JJ	_	10	CONJ
12	and	and	CC	_	5	COORD
13	had	have	VBD	_	12	CONJ
14	prominent	prominent	JJ	_	15	NMOD
15	nucleoli	nucleolus	NNS	_	13	OBJ
16	.	.	.	_	5	P

1	In	in	IN	_	9	LOC
2	the	the	DT	_	6	NMOD
3	most	most	RBS	_	4	AMOD
4	severely	severely	RB	_	5	AMOD
5	affected	affect	VBN	_	6	NMOD
6	areas	area	NNS	_	1	PMOD
7	,	,	,	_	9	P
8	there	there	EX	_	9	SBJ
9	was	be	VBD	_	0	ROOT
10	loss	loss	NN	_	9	PRD
11	of	of	IN	_	10	NMOD
12	myocytes	myocytes	NNS	_	11	PMOD
13	accompanied	accompany	VBN	_	10	NMOD
14	by	by	IN	_	13	LGS
15	fibrosis	fibrosis	NN	_	14	PMOD
16	.	.	.	_	9	P

1	In	in	IN	_	14	LOC
2	the	the	DT	_	3	NMOD
3	wall	wall	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	aorta	aorta	NN	_	4	PMOD
7	at	at	IN	_	6	LOC
8	the	the	DT	_	9	NMOD
9	base	base	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	heart	heart	NN	_	10	PMOD
13	there	there	EX	_	14	SBJ
14	was	be	VBD	_	0	ROOT
15	multifocal	multifocal	JJ	_	16	NMOD
16	degeneration	degeneration	NN	_	14	PRD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	elastic	elastic	JJ	_	20	NMOD
20	tissue	tissue	NN	_	17	PMOD
21	,	,	,	_	16	P
22	accompanied	accompany	VBN	_	16	NMOD
23	by	by	IN	_	22	LGS
24	multifocal	multifocal	JJ	_	25	NMOD
25	collections	collection	NNS	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	globular	globular	JJ	_	32	NMOD
28	translucent	translucent	JJ	_	32	NMOD
29	yellow	yellow	JJ	_	31	AMOD
30	-	-	HYPH	_	29	P
31	brown	brown	JJ	_	32	NMOD
32	pigment	pigment	NN	_	26	PMOD
33	interpreted	interpret	VBN	_	25	NMOD
34	to	to	TO	_	33	OPRD
35	be	be	VB	_	34	IM
36	ceroid	ceroid	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	lipofuscin	lipofuscin	NN	_	35	PRD
39	.	.	.	_	14	P

1	Similar	similar	JJ	_	2	NMOD
2	deposits	deposit	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	scattered	scatter	VBN	_	3	VC
5	within	within	IN	_	4	LOC
6	adjacent	adjacent	JJ	_	8	NMOD
7	adipose	adipose	NN	_	8	NMOD
8	tissue	tissue	NN	_	5	PMOD
9	.	.	.	_	3	P

1	Discussion	discussion	NN	_	0	ROOT

1	Successfully	successfully	RB	_	2	ADV
2	targeting	target	VBG	_	4	SBJ
3	Acadm	acadm	NN	_	2	OBJ
4	produced	produce	VBD	_	0	ROOT
5	a	a	DT	_	7	NMOD
6	mouse	mouse	NN	_	7	NMOD
7	model	model	NN	_	4	OBJ
8	for	for	IN	_	7	NMOD
9	MCAD	mcad	NN	_	10	NMOD
10	deficiency	deficiency	NN	_	8	PMOD
11	with	with	IN	_	7	NMOD
12	features	feature	NNS	_	11	PMOD
13	that	that	WDT	_	14	SBJ
14	mimic	mimic	VBP	_	12	NMOD
15	the	the	DT	_	22	NMOD
16	clinical	clinical	JJ	_	22	NMOD
17	,	,	,	_	16	P
18	biochemical	biochemical	JJ	_	16	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	pathologic	pathologic	JJ	_	20	CONJ
22	phenotype	phenotype	NN	_	14	OBJ
23	found	find	VBN	_	22	NMOD
24	in	in	IN	_	23	LOC
25	human	human	JJ	_	26	NMOD
26	patients	patient	NNS	_	24	PMOD
27	.	.	.	_	4	P

1	MCAD	mcad	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	deficient	deficient	JJ	_	4	NMOD
4	patients	patient	NNS	_	5	SBJ
5	have	have	VBP	_	0	ROOT
6	abnormal	abnormal	JJ	_	10	NMOD
7	plasma	plasma	NN	_	10	NMOD
8	and	and	CC	_	7	COORD
9	urine	urine	NN	_	8	CONJ
10	metabolites	metabolite	NNS	_	5	OBJ
11	associated	associate	VBN	_	10	NMOD
12	with	with	IN	_	11	ADV
13	the	the	DT	_	19	NMOD
14	medium	medium	JJ	_	15	NMOD
15	chain	chain	NN	_	17	NMOD
16	–	–	HYPH	_	15	P
17	length	length	NN	_	19	NMOD
18	enzyme	enzyme	NN	_	19	NMOD
19	specificity	specificity	NN	_	12	PMOD
20	.	.	.	_	5	P

1	MCAD	mcad	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	deficient	deficient	JJ	_	4	NMOD
4	patients	patient	NNS	_	9	SBJ
5	[	[	-LRB-	_	6	P
6	15	0	CD	_	4	PRN
7	]	]	-RRB-	_	6	P
8	often	often	RB	_	9	TMP
9	display	display	VBP	_	0	ROOT
10	a	a	DT	_	14	NMOD
11	characteristic	characteristic	JJ	_	14	NMOD
12	urinary	urinary	JJ	_	14	NMOD
13	hexanoylglycine	hexanoylglycine	NN	_	14	NMOD
14	peak	peak	NN	_	9	OBJ
15	,	,	,	_	9	P
16	as	as	IN	_	9	ADV
17	was	be	VBD	_	16	SUB
18	seen	see	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	MCAD	mcad	NN	_	24	NMOD
21	−	−	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	−	−	SYM	_	20	P
24	mice	mouse	NNS	_	19	PMOD
25	.	.	.	_	9	P

1	Acylcarnitine	acylcarnitine	NN	_	2	NMOD
2	analysis	analysis	NN	_	3	SBJ
3	indicated	indicate	VBD	_	0	ROOT
4	,	,	,	_	3	P
5	however	however	RB	_	3	ADV
6	,	,	,	_	3	P
7	mouse	mouse	NN	_	8	NMOD
8	MCAD	mcad	NN	_	9	SBJ
9	is	be	VBZ	_	3	OBJ
10	more	more	RBR	_	11	AMOD
11	active	active	JJ	_	9	PRD
12	toward	toward	IN	_	11	AMOD
13	longer	long	JJR	_	15	NMOD
14	chain	chain	NN	_	15	NMOD
15	substrates	substrate	NNS	_	12	PMOD
16	than	than	IN	_	11	AMOD
17	the	the	DT	_	20	NMOD
18	human	human	JJ	_	20	NMOD
19	MCAD	mcad	NN	_	20	NMOD
20	enzyme	enzyme	NN	_	16	PMOD
21	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	finding	finding	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	similar	similar	JJ	_	3	PRD
5	to	to	IN	_	4	AMOD
6	that	that	DT	_	5	PMOD
7	seen	see	VBN	_	6	NMOD
8	with	with	IN	_	7	ADV
9	very	very	RB	_	10	AMOD
10	long	long	JJ	_	12	NMOD
11	-	-	HYPH	_	10	P
12	chain	chain	NN	_	16	NMOD
13	acyl	acyl	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	CoA	coa	NN	_	16	NMOD
16	dehydrogenase	dehydrogenase	NN	_	18	NMOD
17	(	(	-LRB-	_	18	P
18	VLCAD	vlcad	NN	_	8	PMOD
19	)	)	-RRB-	_	18	P
20	where	where	WRB	_	23	ADV
21	mouse	mouse	NN	_	22	NMOD
22	VLCAD	vlcad	NN	_	23	SBJ
23	is	be	VBZ	_	18	NMOD
24	most	most	RBS	_	25	AMOD
25	active	active	JJ	_	23	PRD
26	toward	toward	IN	_	25	AMOD
27	C16	c0	NN	_	30	NMOD
28	acyl	acyl	NN	_	30	NMOD
29	-	-	HYPH	_	28	P
30	substrates	substrate	NNS	_	26	PMOD
31	as	as	IN	_	23	ADV
32	compared	compare	VBN	_	31	SUB
33	to	to	IN	_	32	ADV
34	human	human	JJ	_	35	NMOD
35	VLCAD	vlcad	NN	_	33	PMOD
36	with	with	IN	_	35	NMOD
37	the	the	DT	_	40	NMOD
38	most	most	RBS	_	40	NMOD
39	enzymatic	enzymatic	JJ	_	40	NMOD
40	activity	activity	NN	_	36	PMOD
41	toward	toward	IN	_	40	NMOD
42	C14	c0	NN	_	45	NMOD
43	acyl	acyl	NN	_	45	NMOD
44	-	-	HYPH	_	43	P
45	substrates	substrate	NNS	_	41	PMOD
46	[	[	-LRB-	_	47	P
47	16	0	CD	_	3	PRN
48	]	]	-RRB-	_	47	P
49	.	.	.	_	3	P

1	ETF	etf	NN	_	3	NMOD
2	reduction	reduction	NN	_	3	NMOD
3	assays	assay	NNS	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	liver	liver	NN	_	6	NMOD
6	homogenates	homogenate	NNS	_	4	PMOD
7	were	be	VBD	_	0	ROOT
8	performed	perform	VBN	_	7	VC
9	to	to	TO	_	8	PRP
10	characterize	characterize	VB	_	9	IM
11	the	the	DT	_	16	NMOD
12	MCAD	mcad	NN	_	16	NMOD
13	−	−	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	−	−	SYM	_	12	P
16	mice	mouse	NNS	_	10	OBJ
17	at	at	IN	_	10	ADV
18	the	the	DT	_	20	NMOD
19	enzymatic	enzymatic	JJ	_	20	NMOD
20	level	level	NN	_	17	PMOD
21	.	.	.	_	7	P

1	MCAD	mcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	had	have	VBD	_	0	ROOT
7	a	a	DT	_	10	NMOD
8	significantly	significantly	RB	_	9	AMOD
9	reduced	reduce	VBN	_	10	NMOD
10	ability	ability	NN	_	6	OBJ
11	to	to	TO	_	10	NMOD
12	dehydrogenate	dehydrogenate	VB	_	11	IM
13	C8	c0	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	CoA	coa	NN	_	12	OBJ
16	,	,	,	_	6	P
17	as	as	IN	_	6	ADV
18	is	be	VBZ	_	17	SUB
19	the	the	DT	_	20	NMOD
20	case	case	NN	_	18	PRD
21	in	in	IN	_	18	LOC
22	human	human	JJ	_	23	NMOD
23	patients	patient	NNS	_	21	PMOD
24	where	where	WRB	_	28	LOC
25	MCAD	mcad	NN	_	26	NMOD
26	activity	activity	NN	_	27	SBJ
27	is	be	VBZ	_	23	NMOD
28	reduced	reduce	VBN	_	27	VC
29	to	to	IN	_	28	EXT
30	near	near	IN	_	31	QMOD
31	zero	zero	CD	_	29	PMOD
32	with	with	IN	_	28	ADV
33	C8	c0	NN	_	35	NMOD
34	-	-	HYPH	_	33	P
35	CoA	coa	NN	_	32	PMOD
36	.	.	.	_	6	P

1	This	this	DT	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	less	less	RBR	_	4	AMOD
4	so	so	RB	_	2	PRD
5	with	with	IN	_	2	ADV
6	palmitoyl	palmitoyl	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	CoA	coa	NN	_	5	PMOD
9	(	(	-LRB-	_	10	P
10	C16	c0	NN	_	2	PRN
11	:	:	:	_	10	P
12	0	0	CD	_	10	NMOD
13	)	)	-RRB-	_	10	P
14	.	.	.	_	2	P

1	Because	because	IN	_	25	PRP
2	there	there	EX	_	3	SBJ
3	was	be	VBD	_	1	SUB
4	clearly	clearly	RB	_	3	ADV
5	no	no	DT	_	7	NMOD
6	MCAD	mcad	NN	_	7	NMOD
7	antigen	antigen	NN	_	3	PRD
8	detected	detect	VBN	_	7	NMOD
9	in	in	IN	_	8	LOC
10	MCAD	mcad	NN	_	14	NMOD
11	−	−	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	−	−	SYM	_	10	P
14	mice	mouse	NNS	_	9	PMOD
15	,	,	,	_	25	P
16	the	the	DT	_	19	NMOD
17	residual	residual	JJ	_	19	NMOD
18	dehydrogenase	dehydrogenase	NN	_	19	NMOD
19	activity	activity	NN	_	25	SBJ
20	measured	measure	VBN	_	19	NMOD
21	with	with	IN	_	20	ADV
22	these	these	DT	_	24	NMOD
23	two	two	CD	_	24	NMOD
24	substrates	substrate	NNS	_	21	PMOD
25	must	must	MD	_	0	ROOT
26	represent	represent	VB	_	25	VC
27	the	the	DT	_	28	NMOD
28	activity	activity	NN	_	26	OBJ
29	of	of	IN	_	28	NMOD
30	other	other	JJ	_	38	NMOD
31	chain	chain	NN	_	32	NMOD
32	length	length	NN	_	34	AMOD
33	–	–	HYPH	_	32	P
34	specific	specific	JJ	_	38	NMOD
35	acyl	acyl	NN	_	37	NMOD
36	-	-	HYPH	_	35	P
37	CoA	coa	NN	_	38	NMOD
38	dehydrogenases	dehydrogenases	NNS	_	29	PMOD
39	.	.	.	_	25	P

1	A	a	DT	_	3	NMOD
2	high	high	JJ	_	3	NMOD
3	degree	degree	NN	_	13	SBJ
4	of	of	IN	_	3	NMOD
5	neonatal	neonatal	JJ	_	6	NMOD
6	mortality	mortality	NN	_	4	PMOD
7	in	in	IN	_	3	LOC
8	MCAD	mcad	NN	_	12	NMOD
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mice	mouse	NNS	_	7	PMOD
13	was	be	VBD	_	0	ROOT
14	a	a	DT	_	16	NMOD
15	striking	striking	JJ	_	16	NMOD
16	observation	observation	NN	_	13	PRD
17	and	and	CC	_	13	COORD
18	appears	appear	VBZ	_	17	CONJ
19	to	to	TO	_	18	OPRD
20	be	be	VB	_	19	IM
21	analogous	analogous	JJ	_	20	PRD
22	to	to	IN	_	21	AMOD
23	the	the	DT	_	24	NMOD
24	patterns	pattern	NNS	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	clinical	clinical	JJ	_	27	NMOD
27	episodes	episode	NNS	_	25	PMOD
28	and	and	CC	_	27	COORD
29	mortality	mortality	NN	_	28	CONJ
30	in	in	IN	_	24	LOC
31	MCAD	mcad	NN	_	33	AMOD
32	-	-	HYPH	_	31	P
33	deficient	deficient	JJ	_	34	NMOD
34	patients	patient	NNS	_	30	PMOD
35	.	.	.	_	13	P

1	MCAD	mcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	exhibited	exhibit	VBD	_	0	ROOT
7	significant	significant	JJ	_	9	NMOD
8	neonatal	neonatal	JJ	_	9	NMOD
9	mortality	mortality	NN	_	6	OBJ
10	with	with	IN	_	6	ADV
11	approximately	approximately	RB	_	12	QMOD
12	60	0	CD	_	13	NMOD
13	%	%	NN	_	21	SBJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	20	NMOD
16	MCAD	mcad	NN	_	20	NMOD
17	−	−	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	−	−	SYM	_	16	P
20	pups	pup	NNS	_	14	PMOD
21	dying	die	VBG	_	10	PMOD
22	prior	prior	JJ	_	23	PMOD
23	to	to	IN	_	21	TMP
24	weaning	weaning	NN	_	23	PMOD
25	at	at	IN	_	21	TMP
26	3	0	CD	_	27	NMOD
27	wk	wk	NN	_	25	PMOD
28	of	of	IN	_	27	NMOD
29	age	age	NN	_	28	PMOD
30	.	.	.	_	6	P

1	Human	human	JJ	_	2	NMOD
2	patients	patient	NNS	_	3	SBJ
3	present	present	VBP	_	0	ROOT
4	with	with	IN	_	3	ADV
5	hypoglycemia	hypoglycemia	NN	_	4	PMOD
6	,	,	,	_	5	P
7	hypoketonemia	hypoketonemia	NN	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	nonketotic	nonketotic	JJ	_	12	NMOD
11	organic	organic	JJ	_	12	NMOD
12	aciduria	aciduria	NN	_	9	CONJ
13	precipitated	precipitate	VBN	_	12	NMOD
14	by	by	IN	_	13	LGS
15	fasting	fasting	NN	_	14	PMOD
16	,	,	,	_	3	P
17	most	most	RBS	_	18	AMOD
18	frequently	frequently	RB	_	19	TMP
19	during	during	IN	_	3	TMP
20	the	the	DT	_	23	NMOD
21	first	$#ORD#$	JJ	_	23	NMOD
22	24	0	CD	_	23	NMOD
23	mo	mo	NN	_	19	PMOD
24	in	in	IN	_	23	NMOD
25	life	life	NN	_	24	PMOD
26	[	[	-LRB-	_	27	P
27	1	0	CD	_	3	PRN
28	]	]	-RRB-	_	27	P
29	.	.	.	_	3	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	likely	likely	JJ	_	2	PRD
4	that	that	IN	_	2	OBJ
5	neonatal	neonatal	JJ	_	10	NMOD
6	MCAD	mcad	NN	_	10	NMOD
7	−	−	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	−	−	SYM	_	6	P
10	pups	pup	NNS	_	11	SBJ
11	are	be	VBP	_	4	SUB
12	manifesting	manifest	VBG	_	11	VC
13	sensitivity	sensitivity	NN	_	12	OBJ
14	to	to	IN	_	13	NMOD
15	fasting	fasting	NN	_	14	PMOD
16	with	with	IN	_	12	MNR
17	decompensation	decompensation	NN	_	16	PMOD
18	in	in	IN	_	17	TMP
19	a	a	DT	_	21	NMOD
20	short	short	JJ	_	21	NMOD
21	period	period	NN	_	18	PMOD
22	of	of	IN	_	21	NMOD
23	time	time	NN	_	22	PMOD
24	if	if	IN	_	12	ADV
25	maternal	maternal	JJ	_	26	NMOD
26	milk	milk	NN	_	27	SBJ
27	is	be	VBZ	_	24	SUB
28	not	not	RB	_	27	ADV
29	ingested	ingest	VBN	_	27	VC
30	.	.	.	_	2	P

1	In	in	IN	_	6	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	6	P
4	no	no	DT	_	5	NMOD
5	mortality	mortality	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	noted	note	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	adult	adult	JJ	_	14	NMOD
10	MCAD	mcad	NN	_	14	NMOD
11	−	−	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	−	−	SYM	_	10	P
14	mice	mouse	NNS	_	8	PMOD
15	unless	unless	IN	_	7	ADV
16	challenged	challenge	VBN	_	15	SUB
17	with	with	IN	_	16	MNR
18	cold	cold	NN	_	19	NMOD
19	stress	stress	NN	_	17	PMOD
20	and	and	CC	_	19	COORD
21	fasting	fasting	NN	_	20	CONJ
22	.	.	.	_	6	P

1	Under	under	IN	_	13	ADV
2	cold	cold	NN	_	3	NMOD
3	challenge	challenge	NN	_	4	NMOD
4	conditions	condition	NNS	_	1	PMOD
5	,	,	,	_	13	P
6	however	however	RB	_	13	ADV
7	,	,	,	_	13	P
8	MCAD	mcad	NN	_	12	NMOD
9	−	−	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	−	−	SYM	_	8	P
12	mice	mouse	NNS	_	13	SBJ
13	were	be	VBD	_	0	ROOT
14	unable	unable	JJ	_	13	PRD
15	to	to	TO	_	14	AMOD
16	maintain	maintain	VB	_	15	IM
17	body	body	NN	_	18	NMOD
18	temperature	temperature	NN	_	16	OBJ
19	.	.	.	_	13	P

1	Brown	brown	JJ	_	2	NMOD
2	fat	fat	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	predominantly	predominantly	RB	_	5	AMOD
5	responsible	responsible	JJ	_	3	PRD
6	for	for	IN	_	5	AMOD
7	thermogenesis	thermogenesis	NN	_	6	PMOD
8	and	and	CC	_	3	COORD
9	normally	normally	RB	_	10	ADV
10	expresses	express	VBZ	_	8	CONJ
11	high	high	JJ	_	12	NMOD
12	levels	level	NNS	_	10	OBJ
13	of	of	IN	_	12	NMOD
14	Acadm	acadm	NN	_	15	NMOD
15	mRNA	mrna	NN	_	13	PMOD
16	.	.	.	_	3	P

1	The	the	DT	_	6	NMOD
2	microvesicular	microvesicular	JJ	_	6	NMOD
3	and	and	CC	_	2	COORD
4	macrovesicular	macrovesicular	JJ	_	3	CONJ
5	hepatic	hepatic	JJ	_	6	NMOD
6	steatosis	steatosis	NN	_	15	SBJ
7	seen	see	VBN	_	6	NMOD
8	in	in	IN	_	7	LOC
9	fasted	fast	VBN	_	14	NMOD
10	MCAD	mcad	NN	_	14	NMOD
11	−	−	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	−	−	SYM	_	10	P
14	mice	mouse	NNS	_	8	PMOD
15	is	be	VBZ	_	0	ROOT
16	consistent	consistent	JJ	_	15	PRD
17	with	with	IN	_	16	AMOD
18	the	the	DT	_	21	NMOD
19	primary	primary	JJ	_	21	NMOD
20	pathological	pathological	JJ	_	21	NMOD
21	finding	finding	NN	_	17	PMOD
22	seen	see	VBN	_	21	NMOD
23	in	in	IN	_	22	LOC
24	human	human	JJ	_	26	NMOD
25	MCAD	mcad	NN	_	26	NMOD
26	patients	patient	NNS	_	23	PMOD
27	with	with	IN	_	26	NMOD
28	fasting	fasting	NN	_	29	NMOD
29	stress	stress	NN	_	27	PMOD
30	.	.	.	_	15	P

1	Sporadic	sporadic	JJ	_	3	NMOD
2	cardiac	cardiac	JJ	_	3	NMOD
3	lesions	lesion	NNS	_	13	SBJ
4	in	in	IN	_	3	LOC
5	MCAD	mcad	NN	_	9	NMOD
6	−	−	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	−	−	SYM	_	5	P
9	mice	mouse	NNS	_	4	PMOD
10	,	,	,	_	13	P
11	however	however	RB	_	13	ADV
12	,	,	,	_	13	P
13	were	be	VBD	_	0	ROOT
14	an	an	DT	_	18	NMOD
15	interesting	interesting	JJ	_	18	NMOD
16	and	and	CC	_	15	COORD
17	unexpected	unexpected	JJ	_	16	CONJ
18	finding	finding	NN	_	13	PRD
19	.	.	.	_	13	P

1	The	the	DT	_	3	NMOD
2	diffuse	diffuse	JJ	_	3	NMOD
3	cardiomyopathy	cardiomyopathy	NN	_	17	SBJ
4	with	with	IN	_	3	NMOD
5	multifocal	multifocal	JJ	_	7	NMOD
6	myocyte	myocyte	NN	_	7	NMOD
7	degeneration	degeneration	NN	_	4	PMOD
8	and	and	CC	_	7	COORD
9	necrosis	necrosis	NN	_	8	CONJ
10	observed	observe	VBN	_	3	NMOD
11	in	in	IN	_	10	LOC
12	MCAD	mcad	NN	_	16	NMOD
13	−	−	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	−	−	SYM	_	12	P
16	mice	mouse	NNS	_	11	PMOD
17	has	have	VBZ	_	32	DEP
18	not	not	RB	_	17	ADV
19	been	be	VBN	_	17	VC
20	reported	report	VBN	_	19	VC
21	in	in	IN	_	20	LOC
22	human	human	JJ	_	24	NMOD
23	MCAD	mcad	NN	_	24	NMOD
24	patients	patient	NNS	_	21	PMOD
25	,	,	,	_	32	P
26	however	however	RB	_	32	ADV
27	,	,	,	_	32	P
28	cardiac	cardiac	JJ	_	29	NMOD
29	arrhythmias	arrhythmia	NNS	_	32	SBJ
30	and	and	CC	_	29	COORD
31	dysfunction	dysfunction	NN	_	30	CONJ
32	have	have	VBP	_	0	ROOT
33	been	be	VBN	_	32	VC
34	reported	report	VBN	_	33	VC
35	in	in	IN	_	34	LOC
36	MCAD	mcad	NN	_	38	AMOD
37	-	-	HYPH	_	36	P
38	deficient	deficient	JJ	_	39	NMOD
39	patients	patient	NNS	_	35	PMOD
40	[	[	-LRB-	_	43	P
41	17	0	CD	_	43	NMOD
42	,	,	,	_	43	P
43	18	0	CD	_	34	PRN
44	]	]	-RRB-	_	43	P
45	.	.	.	_	32	P

1	Interestingly	interestingly	RB	_	4	ADV
2	,	,	,	_	4	P
3	cardiomyopathy	cardiomyopathy	NN	_	4	SBJ
4	has	have	VBZ	_	0	ROOT
5	been	be	VBN	_	4	VC
6	observed	observe	VBN	_	5	VC
7	in	in	IN	_	6	ADV
8	VLCAD	vlcad	NN	_	9	NMOD
9	deficiency	deficiency	NN	_	7	PMOD
10	[	[	-LRB-	_	11	P
11	19	0	CD	_	9	PRN
12	]	]	-RRB-	_	11	P
13	and	and	CC	_	9	COORD
14	other	other	JJ	_	15	NMOD
15	disorders	disorder	NNS	_	13	CONJ
16	of	of	IN	_	15	NMOD
17	long	long	JJ	_	18	NMOD
18	chain	chain	NN	_	19	NMOD
19	fat	fat	NN	_	20	NMOD
20	metabolism	metabolism	NN	_	16	PMOD
21	such	such	JJ	_	22	PMOD
22	as	as	IN	_	15	NMOD
23	severe	severe	JJ	_	30	NMOD
24	CPT	cpt	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	1	0	CD	_	30	NMOD
27	and	and	CC	_	26	COORD
28	-	-	HYPH	_	29	P
29	2	0	CD	_	27	CONJ
30	deficiencies	deficiency	NNS	_	22	PMOD
31	[	[	-LRB-	_	32	P
32	1	0	CD	_	6	PRN
33	]	]	-RRB-	_	32	P
34	.	.	.	_	4	P

1	Thus	thus	RB	_	3	ADV
2	it	it	PRP	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	tempting	tempting	JJ	_	3	PRD
5	to	to	TO	_	3	OPRD
6	relate	relate	VB	_	5	IM
7	the	the	DT	_	9	NMOD
8	cardiac	cardiac	JJ	_	9	NMOD
9	problems	problem	NNS	_	6	OBJ
10	in	in	IN	_	9	LOC
11	the	the	DT	_	12	NMOD
12	mouse	mouse	NN	_	10	PMOD
13	to	to	IN	_	6	ADV
14	the	the	DT	_	17	NMOD
15	apparent	apparent	JJ	_	17	NMOD
16	broader	broad	JJR	_	17	NMOD
17	range	range	NN	_	13	PMOD
18	of	of	IN	_	17	NMOD
19	substrate	substrate	NN	_	20	NMOD
20	utilization	utilization	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	mouse	mouse	NN	_	23	NMOD
23	MCAD	mcad	NN	_	21	PMOD
24	.	.	.	_	3	P

1	The	the	DT	_	6	NMOD
2	inconsistent	inconsistent	JJ	_	6	NMOD
3	liver	liver	NN	_	6	NMOD
4	and	and	CC	_	3	COORD
5	cardiac	cardiac	JJ	_	4	CONJ
6	lesions	lesion	NNS	_	10	SBJ
7	in	in	IN	_	6	LOC
8	these	these	DT	_	9	NMOD
9	mice	mouse	NNS	_	7	PMOD
10	is	be	VBZ	_	0	ROOT
11	analogous	analogous	JJ	_	10	PRD
12	with	with	IN	_	11	AMOD
13	the	the	DT	_	20	NMOD
14	significant	significant	JJ	_	20	NMOD
15	inter	inter	AFX	_	20	NMOD
16	-	-	HYPH	_	15	P
17	and	and	CC	_	15	COORD
18	intrafamilial	intrafamilial	JJ	_	17	CONJ
19	phenotypic	phenotypic	JJ	_	20	NMOD
20	heterogeneity	heterogeneity	NN	_	12	PMOD
21	seen	see	VBN	_	20	NMOD
22	in	in	IN	_	21	ADV
23	MCAD	mcad	NN	_	24	NMOD
24	deficiency	deficiency	NN	_	22	PMOD
25	in	in	IN	_	21	LOC
26	humans	human	NNS	_	25	PMOD
27	[	[	-LRB-	_	30	P
28	1	0	CD	_	30	NMOD
29	,	,	,	_	30	P
30	20	0	CD	_	10	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	10	P

1	In	in	IN	_	27	ADV
2	comparisons	comparison	NNS	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	our	our	PRP$	_	5	NMOD
5	experiences	experience	NNS	_	3	PMOD
6	with	with	IN	_	5	NMOD
7	the	the	DT	_	10	NMOD
8	other	other	JJ	_	10	NMOD
9	mouse	mouse	NN	_	10	NMOD
10	models	model	NNS	_	6	PMOD
11	for	for	IN	_	10	NMOD
12	acyl	acyl	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	CoA	coa	NN	_	15	NMOD
15	dehydrogenase	dehydrogenase	NN	_	16	NMOD
16	deficiencies	deficiency	NNS	_	11	PMOD
17	,	,	,	_	27	P
18	the	the	DT	_	20	NMOD
19	overall	overall	JJ	_	20	NMOD
20	phenotype	phenotype	NN	_	27	SBJ
21	of	of	IN	_	20	NMOD
22	MCAD	mcad	NN	_	26	NMOD
23	−	−	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	−	−	SYM	_	22	P
26	mice	mouse	NNS	_	21	PMOD
27	is	be	VBZ	_	0	ROOT
28	less	less	RBR	_	29	AMOD
29	severe	severe	JJ	_	27	PRD
30	than	than	IN	_	29	AMOD
31	that	that	DT	_	30	PMOD
32	found	find	VBN	_	31	NMOD
33	in	in	IN	_	32	LOC
34	LCAD	lcad	NN	_	38	NMOD
35	−	−	SYM	_	34	P
36	/	/	HYPH	_	34	P
37	−	−	SYM	_	34	P
38	mice	mouse	NNS	_	33	PMOD
39	,	,	,	_	29	P
40	yet	yet	CC	_	29	COORD
41	more	more	RBR	_	42	AMOD
42	pronounced	pronounced	JJ	_	40	CONJ
43	than	than	IN	_	42	AMOD
44	the	the	DT	_	55	NMOD
45	VLCAD	vlcad	NN	_	55	NMOD
46	−	−	SYM	_	45	P
47	/	/	HYPH	_	45	P
48	−	−	SYM	_	45	P
49	or	or	CC	_	45	COORD
50	SCAD	scad	NN	_	49	CONJ
51	−	−	SYM	_	50	P
52	/	/	HYPH	_	50	P
53	−	−	SYM	_	50	P
54	mouse	mouse	NN	_	55	NMOD
55	models	model	NNS	_	43	PMOD
56	[	[	-LRB-	_	61	P
57	16	0	CD	_	61	NMOD
58	,	,	,	_	61	P
59	21	0	CD	_	61	NMOD
60	,	,	,	_	61	P
61	22	0	CD	_	27	PRN
62	]	]	-RRB-	_	61	P
63	.	.	.	_	27	P

1	All	all	DT	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	these	these	DT	_	4	NMOD
4	mutants	mutant	NNS	_	2	PMOD
5	are	be	VBP	_	0	ROOT
6	cold	cold	NN	_	7	AMOD
7	intolerant	intolerant	JJ	_	5	PRD
8	and	and	CC	_	5	COORD
9	display	display	VBP	_	8	CONJ
10	varying	vary	VBG	_	11	NMOD
11	degrees	degree	NNS	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	fatty	fatty	JJ	_	14	NMOD
14	changes	change	NNS	_	12	PMOD
15	in	in	IN	_	9	LOC
16	liver	liver	NN	_	15	PMOD
17	,	,	,	_	16	P
18	heart	heart	NN	_	16	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	kidney	kidney	NN	_	20	CONJ
22	.	.	.	_	5	P

1	LCAD	lcad	NN	_	5	NMOD
2	−	−	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	−	−	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	show	show	VBP	_	0	ROOT
7	more	more	JJR	_	9	NMOD
8	spontaneous	spontaneous	JJ	_	9	NMOD
9	deaths	death	NNS	_	6	OBJ
10	and	and	CC	_	9	COORD
11	gestational	gestational	JJ	_	12	NMOD
12	losses	loss	NNS	_	10	CONJ
13	than	than	IN	_	9	NMOD
14	the	the	DT	_	16	NMOD
15	other	other	JJ	_	16	NMOD
16	deficiencies	deficiency	NNS	_	13	PMOD
17	[	[	-LRB-	_	18	P
18	21	0	CD	_	6	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	6	P

1	The	the	DT	_	4	NMOD
2	significant	significant	JJ	_	4	NMOD
3	neonatal	neonatal	JJ	_	4	NMOD
4	mortality	mortality	NN	_	11	SBJ
5	in	in	IN	_	4	LOC
6	MCAD	mcad	NN	_	10	NMOD
7	−	−	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	−	−	SYM	_	6	P
10	mice	mouse	NNS	_	5	PMOD
11	is	be	VBZ	_	0	ROOT
12	distinctive	distinctive	JJ	_	11	PRD
13	from	from	IN	_	12	AMOD
14	these	these	DT	_	17	NMOD
15	other	other	JJ	_	17	NMOD
16	mouse	mouse	NN	_	17	NMOD
17	models	model	NNS	_	13	PMOD
18	suggesting	suggest	VBG	_	11	ADV
19	a	a	DT	_	21	NMOD
20	greater	great	JJR	_	21	NMOD
21	degree	degree	NN	_	18	OBJ
22	of	of	IN	_	21	NMOD
23	sensitivity	sensitivity	NN	_	22	PMOD
24	to	to	IN	_	23	NMOD
25	fasting	fasting	NN	_	26	NMOD
26	intolerance	intolerance	NN	_	24	PMOD
27	.	.	.	_	11	P

1	The	the	DT	_	2	NMOD
2	phenotypes	phenotype	NNS	_	16	SBJ
3	of	of	IN	_	2	NMOD
4	both	both	CC	_	15	COORD
5	the	the	DT	_	15	NMOD
6	VLCAD	vlcad	NN	_	15	NMOD
7	−	−	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	−	−	SYM	_	6	P
10	and	and	CC	_	6	COORD
11	SCAD	scad	NN	_	10	CONJ
12	−	−	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	−	−	SYM	_	11	P
15	mice	mouse	NNS	_	3	PMOD
16	are	be	VBP	_	0	ROOT
17	relatively	relatively	RB	_	18	AMOD
18	mild	mild	JJ	_	16	PRD
19	if	if	IN	_	16	ADV
20	the	the	DT	_	21	NMOD
21	animals	animal	NNS	_	22	SBJ
22	are	be	VBP	_	19	SUB
23	not	not	RB	_	22	ADV
24	cold	cold	JJ	_	25	DEP
25	stressed	stress	VBN	_	22	VC
26	[	[	-LRB-	_	29	P
27	16	0	CD	_	29	NMOD
28	,	,	,	_	29	P
29	22	0	CD	_	16	PRN
30	]	]	-RRB-	_	29	P
31	.	.	.	_	16	P

1	The	the	DT	_	5	NMOD
2	MCAD	mcad	JJ	_	4	AMOD
3	-	-	HYPH	_	2	P
4	deficient	deficient	JJ	_	5	NMOD
5	mouse	mouse	NN	_	6	SBJ
6	offers	offer	VBZ	_	0	ROOT
7	new	new	JJ	_	8	NMOD
8	insights	insight	NNS	_	6	OBJ
9	into	into	IN	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	pathogenesis	pathogenesis	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	mitochondrial	mitochondrial	JJ	_	17	NMOD
14	β	β	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	oxidation	oxidation	NN	_	17	NMOD
17	deficiencies	deficiency	NNS	_	12	PMOD
18	and	and	CC	_	6	COORD
19	will	will	MD	_	18	CONJ
20	provide	provide	VB	_	19	VC
21	a	a	DT	_	23	NMOD
22	robust	robust	JJ	_	23	NMOD
23	tool	tool	NN	_	20	OBJ
24	to	to	TO	_	23	NMOD
25	better	well	RBR	_	24	ADV
26	understand	understand	VB	_	24	IM
27	the	the	DT	_	28	NMOD
28	role	role	NN	_	26	OBJ
29	of	of	IN	_	28	NMOD
30	fatty	fatty	JJ	_	31	NMOD
31	acids	acid	NNS	_	29	PMOD
32	in	in	IN	_	28	NMOD
33	other	other	JJ	_	35	NMOD
34	relevant	relevant	JJ	_	35	NMOD
35	diseases	disease	NNS	_	32	PMOD
36	.	.	.	_	6	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Methods	method	NNS	_	2	CONJ

1	Construction	construction	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	MCAD	mcad	NN	_	5	NMOD
4	targeting	targeting	NN	_	5	NMOD
5	vector	vector	NN	_	2	PMOD
6	.	.	.	_	1	P

1	A	a	DT	_	5	NMOD
2	neomycin	neomycin	NN	_	3	NMOD
3	resistance	resistance	NN	_	5	NMOD
4	gene	gene	NN	_	5	NMOD
5	cassette	cassette	NN	_	9	SBJ
6	[	[	-LRB-	_	7	P
7	23	0	CD	_	5	PRN
8	]	]	-RRB-	_	7	P
9	was	be	VBD	_	0	ROOT
10	subcloned	subcloned	VBN	_	9	VC
11	into	into	IN	_	10	DIR
12	the	the	DT	_	14	NMOD
13	SalI	sali	NN	_	14	NMOD
14	site	site	NN	_	11	PMOD
15	of	of	IN	_	14	NMOD
16	pGEM11Zf	pgem0zf	NN	_	15	PMOD
17	(	(	-LRB-	_	18	P
18	+	+	SYM	_	16	PRN
19	)	)	-RRB-	_	18	P
20	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	plasmid	plasmid	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	digested	digest	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	EcoRI	ecori	NN	_	5	PMOD
7	and	and	CC	_	3	COORD
8	the	the	DT	_	9	NMOD
9	overhangs	overhang	NNS	_	10	SBJ
10	were	be	VBD	_	7	CONJ
11	filled	fill	VBN	_	10	VC
12	with	with	IN	_	11	MNR
13	Klenow	klenow	NN	_	14	NMOD
14	enzyme	enzyme	NN	_	12	PMOD
15	.	.	.	_	3	P

1	Subsequent	subsequent	JJ	_	2	NMOD
2	ligation	ligation	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	blunt	blunt	NN	_	6	NMOD
6	ends	end	NNS	_	3	PMOD
7	recircularized	recircularized	VBD	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	vector	vector	NN	_	7	OBJ
10	and	and	CC	_	7	COORD
11	destroyed	destroy	VBD	_	10	CONJ
12	the	the	DT	_	14	NMOD
13	EcoRI	ecori	NN	_	14	NMOD
14	site	site	NN	_	11	OBJ
15	within	within	IN	_	14	LOC
16	the	the	DT	_	17	NMOD
17	polylinker	polylinker	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	24	NMOD
20	pGEMl1Zf	pgeml0zf	NN	_	24	NMOD
21	(	(	-LRB-	_	22	P
22	+	+	SYM	_	24	PRN
23	)	)	-RRB-	_	22	P
24	plasmid	plasmid	NN	_	18	PMOD
25	.	.	.	_	7	P

1	Next	next	RB	_	39	TMP
2	,	,	,	_	39	P
3	an	an	DT	_	9	NMOD
4	8	0	CD	_	6	NMOD
5	-	-	HYPH	_	4	P
6	kb	kb	NN	_	9	NMOD
7	Acadm	acadm	NN	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	fragment	fragment	NN	_	39	SBJ
10	spanning	span	VBG	_	9	NMOD
11	exons	exon	NNS	_	12	NMOD
12	8	0	CD	_	10	OBJ
13	,	,	,	_	12	P
14	9	0	CD	_	12	CONJ
15	,	,	,	_	14	P
16	and	and	CC	_	14	COORD
17	10	0	CD	_	16	CONJ
18	and	and	CC	_	10	COORD
19	flanking	flank	VBG	_	18	CONJ
20	intron	intron	NN	_	21	NMOD
21	sequences	sequence	NNS	_	19	OBJ
22	,	,	,	_	9	P
23	originally	originally	RB	_	24	ADV
24	obtained	obtain	VBN	_	9	NMOD
25	from	from	IN	_	24	ADV
26	a	a	DT	_	32	NMOD
27	Lambda	lambda	NNP	_	28	NMOD
28	FIXII	fixii	NN	_	32	NMOD
29	129Sv	0sv	NN	_	32	NMOD
30	mouse	mouse	NN	_	32	NMOD
31	genomic	genomic	JJ	_	32	NMOD
32	library	library	NN	_	25	PMOD
33	[	[	-LRB-	_	36	P
34	24	0	CD	_	36	NMOD
35	,	,	,	_	36	P
36	25	0	CD	_	32	PRN
37	]	]	-RRB-	_	36	P
38	,	,	,	_	39	P
39	was	be	VBD	_	0	ROOT
40	directionally	directionally	RB	_	39	ADV
41	cloned	clone	VBN	_	39	VC
42	into	into	IN	_	41	DIR
43	the	the	DT	_	47	NMOD
44	NotI	noti	NN	_	47	NMOD
45	and	and	CC	_	44	COORD
46	XhoI	xhoi	NN	_	45	CONJ
47	sites	site	NNS	_	42	PMOD
48	of	of	IN	_	47	NMOD
49	pGEM11Zf	pgem0zf	NN	_	48	PMOD
50	(	(	-LRB-	_	51	P
51	+	+	SYM	_	49	PRN
52	)	)	-RRB-	_	51	P
53	.	.	.	_	39	P

1	The	the	DT	_	2	NMOD
2	vector	vector	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	digested	digest	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	BamHI	bamhi	NN	_	5	PMOD
7	and	and	CC	_	6	COORD
8	EcoRI	ecori	NN	_	7	CONJ
9	to	to	TO	_	4	PRP
10	remove	remove	VB	_	9	IM
11	a	a	DT	_	19	NMOD
12	1.3	0	CD	_	14	NMOD
13	-	-	HYPH	_	12	P
14	kb	kb	NN	_	19	NMOD
15	BamHI	bamhi	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	EcoRI	ecori	NN	_	19	NMOD
18	genomic	genomic	JJ	_	19	NMOD
19	fragment	fragment	NN	_	10	OBJ
20	containing	contain	VBG	_	19	NMOD
21	exon	exon	NN	_	20	OBJ
22	10	0	CD	_	21	NMOD
23	and	and	CC	_	20	COORD
24	flanking	flank	VBG	_	23	CONJ
25	intron	intron	NN	_	26	NMOD
26	sequences	sequence	NNS	_	24	OBJ
27	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	digested	digest	VBN	_	3	NMOD
3	vector	vector	NN	_	16	SBJ
4	,	,	,	_	3	P
5	without	without	IN	_	3	NMOD
6	the	the	DT	_	14	NMOD
7	1.3	0	CD	_	9	NMOD
8	-	-	HYPH	_	7	P
9	kb	kb	NN	_	14	NMOD
10	BamHI	bamhi	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	EcoRI	ecori	NN	_	14	NMOD
13	genomic	genomic	JJ	_	14	NMOD
14	fragment	fragment	NN	_	5	PMOD
15	,	,	,	_	16	P
16	was	be	VBD	_	0	ROOT
17	purified	purify	VBN	_	16	VC
18	by	by	IN	_	17	MNR
19	gel	gel	NN	_	20	NMOD
20	purification	purification	NN	_	18	PMOD
21	and	and	CC	_	17	COORD
22	recircularized	recircularized	VBN	_	21	CONJ
23	by	by	IN	_	22	MNR
24	ligation	ligation	NN	_	23	PMOD
25	using	use	VBG	_	22	MNR
26	three	three	CD	_	27	NMOD
27	oligonucleotides	oligonucleotides	NNS	_	32	NMOD
28	:	:	:	_	32	P
29	5	0	CD	_	32	NMOD
30	′	′	SYM	_	29	P
31	-	-	HYPH	_	29	P
32	AATTGTCGACA	aattgtcgaca	NN	_	25	OBJ
33	-	-	HYPH	_	32	P
34	3	0	CD	_	32	NMOD
35	′	′	SYM	_	32	P
36	;	;	:	_	32	P
37	5	0	CD	_	39	NMOD
38	′	′	SYM	_	37	P
39	GATCGTCGACA	gatcgtcgaca	NN	_	32	CONJ
40	-	-	HYPH	_	39	P
41	3	0	CD	_	39	NMOD
42	′	′	SYM	_	39	P
43	;	;	:	_	39	P
44	and	and	CC	_	39	COORD
45	5	0	CD	_	48	NMOD
46	′	′	SYM	_	45	P
47	-	-	HYPH	_	45	P
48	TCGATGTCGAC	tcgatgtcgac	NN	_	44	CONJ
49	-	-	HYPH	_	48	P
50	3	0	CD	_	48	NMOD
51	′	′	SYM	_	48	P
52	.	.	.	_	16	P

1	The	the	DT	_	3	NMOD
2	recircularized	recircularized	VBN	_	3	NMOD
3	vector	vector	NN	_	20	SBJ
4	,	,	,	_	3	P
5	resulting	result	VBG	_	3	NMOD
6	from	from	IN	_	5	ADV
7	the	the	DT	_	8	NMOD
8	ligation	ligation	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	long	long	JJ	_	12	NMOD
12	arm	arm	NN	_	9	PMOD
13	to	to	IN	_	8	NMOD
14	the	the	DT	_	16	NMOD
15	short	short	JJ	_	16	NMOD
16	arm	arm	NN	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	homology	homology	NN	_	17	PMOD
19	,	,	,	_	20	P
20	contained	contain	VBD	_	0	ROOT
21	a	a	DT	_	24	NMOD
22	unique	unique	JJ	_	24	NMOD
23	SalI	sali	NN	_	24	NMOD
24	site	site	NN	_	20	OBJ
25	where	where	WRB	_	34	LOC
26	the	the	DT	_	32	NMOD
27	1.3	0	CD	_	29	NMOD
28	-	-	HYPH	_	27	P
29	kb	kb	NN	_	32	NMOD
30	exon	exon	NN	_	32	NMOD
31	10	0	CD	_	30	NMOD
32	region	region	NN	_	33	SBJ
33	was	be	VBD	_	24	NMOD
34	deleted	delete	VBN	_	33	VC
35	.	.	.	_	20	P

1	Generation	generation	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	MCAD	mcad	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	deficient	deficient	JJ	_	6	NMOD
6	mice	mouse	NNS	_	2	PMOD
7	.	.	.	_	1	P

1	The	the	DT	_	4	NMOD
2	Acadm	acadm	NN	_	4	NMOD
3	insertion	insertion	NN	_	4	NMOD
4	vector	vector	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	linearized	linearize	VBN	_	5	VC
7	by	by	IN	_	6	MNR
8	SalI	sali	NN	_	9	NMOD
9	digestion	digestion	NN	_	7	PMOD
10	,	,	,	_	9	P
11	the	the	DT	_	12	NMOD
12	site	site	NN	_	9	APPO
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	20	NMOD
15	1.3	0	CD	_	17	NMOD
16	-	-	HYPH	_	15	P
17	kb	kb	NN	_	20	NMOD
18	genomic	genomic	JJ	_	19	NMOD
19	fragment	fragment	NN	_	20	NMOD
20	deletion	deletion	NN	_	13	PMOD
21	,	,	,	_	5	P
22	and	and	CC	_	5	COORD
23	electroporated	electroporated	VBN	_	22	CONJ
24	into	into	IN	_	23	DIR
25	E14	e0	NN	_	29	NMOD
26	–	–	HYPH	_	25	P
27	1	0	CD	_	25	NMOD
28	ES	e	NN	_	29	NMOD
29	cells	cell	NNS	_	24	PMOD
30	(	(	-LRB-	_	33	P
31	a	a	DT	_	33	NMOD
32	kind	kind	JJ	_	33	NMOD
33	gift	gift	NN	_	29	PRN
34	from	from	IN	_	33	NMOD
35	R.	r.	NNP	_	36	NMOD
36	Kuhn	kuhn	NNP	_	34	PMOD
37	)	)	-RRB-	_	33	P
38	,	,	,	_	29	P
39	derived	derive	VBN	_	29	NMOD
40	from	from	IN	_	39	ADV
41	129P2	0p0	NN	_	42	NMOD
42	mice	mouse	NNS	_	40	PMOD
43	.	.	.	_	5	P

1	Correctly	correctly	RB	_	2	AMOD
2	targeted	target	VBN	_	5	NMOD
3	Acadm	acadm	NN	_	5	NMOD
4	insertion	insertion	NN	_	5	NMOD
5	vector	vector	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	designed	design	VBN	_	6	VC
8	to	to	TO	_	7	PRP
9	undergo	undergo	VB	_	8	IM
10	gap	gap	NN	_	11	NMOD
11	repair	repair	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	17	NMOD
14	1.3	0	CD	_	16	NMOD
15	-	-	HYPH	_	14	P
16	kb	kb	NN	_	17	NMOD
17	deletion	deletion	NN	_	12	PMOD
18	upon	upon	IN	_	9	TMP
19	double	double	JJ	_	20	AMOD
20	stranded	strand	VBN	_	22	NMOD
21	–	–	HYPH	_	20	P
22	break	break	NN	_	23	NMOD
23	repair	repair	NN	_	18	PMOD
24	[	[	-LRB-	_	25	P
25	26	0	CD	_	23	PRN
26	]	]	-RRB-	_	25	P
27	during	during	IN	_	23	TMP
28	homologous	homologous	JJ	_	29	NMOD
29	recombination	recombination	NN	_	27	PMOD
30	.	.	.	_	6	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	conducted	conduct	VBN	_	4	VC
6	to	to	TO	_	5	PRP
7	confirm	confirm	VB	_	6	IM
8	homologous	homologous	JJ	_	9	NMOD
9	recombination	recombination	NN	_	7	OBJ
10	.	.	.	_	4	P

1	Genomic	genomic	JJ	_	2	NMOD
2	DNA	dna	NN	_	8	SBJ
3	from	from	IN	_	2	NMOD
4	G418	g0	NN	_	5	AMOD
5	resistant	resistant	JJ	_	7	NMOD
6	ES	e	NN	_	7	NMOD
7	colonies	colony	NNS	_	3	PMOD
8	was	be	VBD	_	0	ROOT
9	digested	digest	VBN	_	8	VC
10	with	with	IN	_	9	MNR
11	EcoRI	ecori	NN	_	10	PMOD
12	,	,	,	_	9	P
13	electrophoresed	electrophoresed	VBN	_	9	CONJ
14	,	,	,	_	13	P
15	blotted	blot	VBN	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	probed	probe	VBN	_	17	CONJ
19	with	with	IN	_	18	MNR
20	an	an	DT	_	24	NMOD
21	850	0	CD	_	23	NMOD
22	-	-	HYPH	_	21	P
23	bp	bp	NN	_	24	NMOD
24	probe	probe	NN	_	19	PMOD
25	(	(	-LRB-	_	27	P
26	probe	probe	NN	_	27	NMOD
27	A	a	NN	_	24	PRN
28	)	)	-RRB-	_	27	P
29	generated	generate	VBN	_	24	NMOD
30	by	by	IN	_	29	MNR
31	PCR	pcr	NN	_	30	PMOD
32	from	from	IN	_	29	ADV
33	Acadm	acadm	NN	_	34	NMOD
34	exon	exon	NN	_	32	PMOD
35	10	0	CD	_	34	NMOD
36	to	to	IN	_	32	PMOD
37	intron	intron	NN	_	36	PMOD
38	10	0	CD	_	37	NMOD
39	.	.	.	_	8	P

1	This	this	DT	_	3	NMOD
2	DNA	dna	NN	_	3	NMOD
3	fragment	fragment	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	not	not	RB	_	4	ADV
6	present	present	JJ	_	4	PRD
7	within	within	IN	_	4	LOC
8	Acadm	acadm	NN	_	10	NMOD
9	insertion	insertion	NN	_	10	NMOD
10	vector	vector	NN	_	7	PMOD
11	and	and	CC	_	4	COORD
12	was	be	VBD	_	11	CONJ
13	expected	expect	VBN	_	12	VC
14	to	to	TO	_	13	OPRD
15	hybridize	hybridize	VB	_	14	IM
16	to	to	IN	_	15	ADV
17	a	a	DT	_	23	NMOD
18	13.2	0	CD	_	20	NMOD
19	-	-	HYPH	_	18	P
20	kb	kb	NN	_	23	NMOD
21	genomic	genomic	JJ	_	23	NMOD
22	DNA	dna	NN	_	23	NMOD
23	fragment	fragment	NN	_	16	PMOD
24	upon	upon	IN	_	15	TMP
25	homologous	homologous	JJ	_	26	NMOD
26	recombination	recombination	NN	_	24	PMOD
27	.	.	.	_	4	P

1	Correctly	correctly	RB	_	2	AMOD
2	targeted	target	VBN	_	5	NMOD
3	ES	e	NN	_	4	NMOD
4	cell	cell	NN	_	5	NMOD
5	clones	clone	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	microinjected	microinjected	VBN	_	6	VC
8	into	into	IN	_	7	DIR
9	B6	b0	NN	_	10	NMOD
10	blastocysts	blastocyst	NNS	_	8	PMOD
11	to	to	TO	_	7	PRP
12	generate	generate	VB	_	11	IM
13	chimeric	chimeric	JJ	_	14	NMOD
14	mice	mouse	NNS	_	12	OBJ
15	.	.	.	_	6	P

1	Chimeric	chimeric	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	subsequently	subsequently	RB	_	3	TMP
5	backcrossed	backcross	VBN	_	3	VC
6	to	to	IN	_	5	ADV
7	B6	b0	NN	_	10	NMOD
8	and	and	CC	_	7	COORD
9	129P2	0p0	NN	_	8	CONJ
10	mice	mouse	NNS	_	6	PMOD
11	to	to	TO	_	5	PRP
12	produce	produce	VB	_	11	IM
13	gene	gene	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	targeted	target	VBN	_	16	NMOD
16	mice	mouse	NNS	_	17	NMOD
17	AcadmtmUab1	acadmtmuab0	NN	_	12	OBJ
18	/	/	HYPH	_	17	P
19	+	+	SYM	_	17	P
20	(	(	-LRB-	_	21	P
21	MCAD	mcad	NN	_	17	PRN
22	+	+	SYM	_	21	P
23	/	/	HYPH	_	21	P
24	−	−	SYM	_	21	P
25	)	)	-RRB-	_	21	P
26	and	and	CC	_	17	COORD
27	eventually	eventually	RB	_	40	NMOD
28	AcadmtmUab1	acadmtmuab0	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	tm1Uab	tm0uab	NN	_	40	NMOD
31	MCAD	mcad	NN	_	40	NMOD
32	−	−	SYM	_	40	P
33	/	/	HYPH	_	31	P
34	−	−	SYM	_	40	P
35	(	(	-LRB-	_	36	P
36	B6	b0	NN	_	40	PRN
37	;	;	:	_	36	P
38	129	0	CD	_	36	NMOD
39	)	)	-RRB-	_	36	P
40	mice	mouse	NNS	_	26	CONJ
41	.	.	.	_	3	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	negative	negative	JJ	_	2	PRD
4	for	for	IN	_	3	AMOD
5	mouse	mouse	NN	_	6	NMOD
6	pathogens	pathogen	NNS	_	4	PMOD
7	based	base	VBN	_	2	ADV
8	on	on	IN	_	7	PMOD
9	serological	serological	JJ	_	10	NMOD
10	assays	assay	NNS	_	8	PMOD
11	for	for	IN	_	10	NMOD
12	ten	ten	CD	_	14	NMOD
13	different	different	JJ	_	14	NMOD
14	viruses	virus	NNS	_	11	PMOD
15	,	,	,	_	10	P
16	aerobic	aerobic	JJ	_	18	NMOD
17	bacterial	bacterial	JJ	_	18	NMOD
18	cultures	culture	NNS	_	10	CONJ
19	of	of	IN	_	18	NMOD
20	nasopharynx	nasopharynx	NN	_	19	PMOD
21	and	and	CC	_	20	COORD
22	cecum	cecum	NN	_	21	CONJ
23	,	,	,	_	18	P
24	examinations	examination	NNS	_	18	CONJ
25	for	for	IN	_	24	NMOD
26	endo	endo	AFX	_	25	PMOD
27	-	-	HYPH	_	26	P
28	and	and	CC	_	26	COORD
29	ectoparasites	ectoparasite	NNS	_	28	CONJ
30	,	,	,	_	24	P
31	and	and	CC	_	24	COORD
32	histopathology	histopathology	NN	_	31	CONJ
33	of	of	IN	_	32	NMOD
34	all	all	DT	_	36	NMOD
35	major	major	JJ	_	36	NMOD
36	organs	organ	NNS	_	33	PMOD
37	.	.	.	_	2	P

1	RNA	rna	NN	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT
3	.	.	.	_	2	P

1	Total	total	JJ	_	2	NMOD
2	RNA	rna	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	isolated	isolate	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	heart	heart	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	30	0	CD	_	10	NMOD
10	day	day	NN	_	11	AMOD
11	old	old	JJ	_	27	NMOD
12	MCAD	mcad	NN	_	27	NMOD
13	+	+	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	+	+	SYM	_	12	P
16	,	,	,	_	12	P
17	MCAD	mcad	NN	_	12	CONJ
18	+	+	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	,	,	,	_	17	P
22	and	and	CC	_	17	COORD
23	MCAD	mcad	NN	_	22	CONJ
24	−	−	SYM	_	23	P
25	/	/	HYPH	_	23	P
26	−	−	SYM	_	23	P
27	mice	mouse	NNS	_	8	PMOD
28	by	by	IN	_	4	MNR
29	standard	standard	JJ	_	30	NMOD
30	techniques	technique	NNS	_	28	PMOD
31	using	use	VBG	_	4	MNR
32	guanidinium	guanidinium	NN	_	34	NMOD
33	thiocyanate	thiocyanate	NN	_	34	NMOD
34	method	method	NN	_	31	OBJ
35	[	[	-LRB-	_	36	P
36	27	0	CD	_	4	PRN
37	]	]	-RRB-	_	36	P
38	.	.	.	_	3	P

1	Reverse	reverse	JJ	_	2	NMOD
2	transcription	transcription	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	random	random	JJ	_	7	NMOD
7	oligonucleotides	oligonucleotides	NNS	_	5	OBJ
8	as	as	IN	_	4	ADV
9	recommended	recommend	VBN	_	8	SUB
10	by	by	IN	_	9	LGS
11	the	the	DT	_	12	NMOD
12	manufacturer	manufacturer	NN	_	10	PMOD
13	(	(	-LRB-	_	14	P
14	Clontech	clontech	NNP	_	12	PRN
15	,	,	,	_	14	P
16	Mountain	mountain	NNP	_	17	NMOD
17	View	view	NNP	_	14	APPO
18	,	,	,	_	17	P
19	California	california	NNP	_	17	APPO
20	,	,	,	_	19	P
21	United	united	NNP	_	22	NMOD
22	States	state	NNP	_	19	APPO
23	)	)	-RRB-	_	14	P
24	.	.	.	_	3	P

1	PCR	pcr	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	subsequently	subsequently	RB	_	2	TMP
4	performed	perform	VBN	_	2	VC
5	using	use	VBG	_	4	MNR
6	oligonucleotides	oligonucleotides	NNS	_	5	OBJ
7	specific	specific	JJ	_	6	NMOD
8	to	to	IN	_	7	AMOD
9	exon	exon	NN	_	8	PMOD
10	7	0	CD	_	9	NMOD
11	and	and	CC	_	9	COORD
12	exon	exon	NN	_	11	CONJ
13	11	0	CD	_	12	NMOD
14	of	of	IN	_	9	NMOD
15	Acadm	acadm	NN	_	14	PMOD
16	.	.	.	_	2	P

1	PCR	pcr	NN	_	2	NMOD
2	amplifications	amplification	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	described	describe	VBN	_	5	SUB
7	above	above	RB	_	6	ADV
8	.	.	.	_	3	P

1	PCR	pcr	NN	_	2	NMOD
2	fragments	fragment	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	subsequently	subsequently	RB	_	3	TMP
5	sequenced	sequence	VBN	_	3	VC
6	after	after	IN	_	5	TMP
7	subcloning	subcloning	VBG	_	6	PMOD
8	into	into	IN	_	7	DIR
9	pGEM	pgem	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	T	t	NN	_	13	NMOD
12	Easy	easy	NNP	_	13	NMOD
13	vector	vector	NNP	_	8	PMOD
14	(	(	-LRB-	_	15	P
15	Promega	promega	NNP	_	13	PRN
16	,	,	,	_	15	P
17	Madison	madison	NNP	_	15	APPO
18	,	,	,	_	17	P
19	Wisconsin	wisconsin	NNP	_	17	APPO
20	,	,	,	_	19	P
21	United	united	NNP	_	22	NMOD
22	States	state	NNP	_	19	APPO
23	)	)	-RRB-	_	15	P
24	.	.	.	_	3	P

1	In	in	IN	_	22	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	determine	determine	VB	_	3	IM
5	the	the	DT	_	6	NMOD
6	extent	extent	NN	_	4	OBJ
7	of	of	IN	_	6	NMOD
8	Acadm	acadm	NN	_	9	NMOD
9	mRNA	mrna	NN	_	7	PMOD
10	expressed	express	VBN	_	9	NMOD
11	from	from	IN	_	10	ADV
12	the	the	DT	_	17	NMOD
13	MCAD	mcad	NN	_	17	NMOD
14	−	−	SYM	_	13	P
15	/	/	HYPH	_	13	P
16	−	−	SYM	_	13	P
17	mice	mouse	NNS	_	11	PMOD
18	,	,	,	_	22	P
19	northern	northern	NNP	_	20	NMOD
20	blot	blot	NN	_	21	NMOD
21	analysis	analysis	NN	_	22	SBJ
22	was	be	VBD	_	0	ROOT
23	performed	perform	VBN	_	22	VC
24	.	.	.	_	22	P

1	Total	total	JJ	_	2	NMOD
2	RNA	rna	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	isolated	isolate	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	heart	heart	NN	_	5	PMOD
7	,	,	,	_	6	P
8	liver	liver	NN	_	6	CONJ
9	,	,	,	_	8	P
10	brown	brown	JJ	_	11	NMOD
11	fat	fat	NN	_	8	CONJ
12	,	,	,	_	11	P
13	brain	brain	NN	_	11	CONJ
14	,	,	,	_	13	P
15	kidney	kidney	NN	_	13	CONJ
16	,	,	,	_	15	P
17	skeletal	skeletal	JJ	_	18	NMOD
18	muscle	muscle	NN	_	15	CONJ
19	,	,	,	_	18	P
20	white	white	JJ	_	21	NMOD
21	fat	fat	NN	_	18	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	testes	testis	NNS	_	23	CONJ
25	of	of	IN	_	6	NMOD
26	3	0	CD	_	28	NMOD
27	-	-	HYPH	_	26	P
28	mo	mo	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	old	old	JJ	_	40	NMOD
31	MCAD	mcad	NN	_	40	NMOD
32	+	+	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	+	+	SYM	_	31	P
35	and	and	CC	_	31	COORD
36	MCAD	mcad	NN	_	35	CONJ
37	−	−	SYM	_	36	P
38	/	/	HYPH	_	36	P
39	−	−	SYM	_	36	P
40	mice	mouse	NNS	_	25	PMOD
41	using	use	VBG	_	4	MNR
42	the	the	DT	_	46	NMOD
43	Ultraspec	ultraspec	NNP	_	46	NMOD
44	RNA	rna	NN	_	45	NMOD
45	Isolation	isolation	NN	_	46	NMOD
46	Kit	kit	NN	_	41	OBJ
47	(	(	-LRB-	_	49	P
48	BIOTEX	biotex	NNP	_	49	NMOD
49	Laboratories	laboratory	NNPS	_	46	PRN
50	,	,	,	_	49	P
51	Inc.	inc.	NNP	_	49	NMOD
52	,	,	,	_	49	P
53	Houston	houston	NNP	_	49	APPO
54	,	,	,	_	53	P
55	Texas	texas	NNP	_	53	APPO
56	,	,	,	_	55	P
57	United	united	NNP	_	58	NMOD
58	States	state	NNP	_	55	APPO
59	)	)	-RRB-	_	49	P
60	as	as	IN	_	41	ADV
61	per	per	IN	_	60	PMOD
62	manufacturer	manufacturer	NN	_	64	NMOD
63	's	's	POS	_	62	NMOD
64	protocol	protocol	NN	_	61	PMOD
65	.	.	.	_	3	P

1	Ten	ten	CD	_	2	NMOD
2	μg	μg	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	total	total	JJ	_	5	NMOD
5	RNA	rna	NN	_	3	PMOD
6	from	from	IN	_	2	NMOD
7	each	each	DT	_	8	NMOD
8	sample	sample	NN	_	6	PMOD
9	was	be	VBD	_	0	ROOT
10	loaded	load	VBN	_	9	VC
11	onto	onto	IN	_	10	ADV
12	a	a	DT	_	18	NMOD
13	0.8	0	CD	_	14	NMOD
14	%	%	NN	_	17	NMOD
15	agarose	agarose	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	formaldehyde	formaldehyde	NN	_	18	NMOD
18	gel	gel	NN	_	11	PMOD
19	,	,	,	_	10	P
20	transferred	transfer	VBN	_	10	CONJ
21	to	to	IN	_	20	DIR
22	nitrocellulose	nitrocellulose	NN	_	23	NMOD
23	filter	filter	NN	_	21	PMOD
24	(	(	-LRB-	_	32	P
25	Hybond	hybond	NNP	_	26	NMOD
26	N	n	NNP	_	32	DEP
27	;	;	:	_	32	P
28	GE	ge	NNP	_	32	NMOD
29	Healthcare	healthcare	NNP	_	32	NMOD
30	Amersham	amersham	NNP	_	32	NMOD
31	Biosciences	bioscience	NNP	_	32	NMOD
32	Corp.	corp.	NNP	_	23	PRN
33	,	,	,	_	32	P
34	Piscataway	piscataway	NNP	_	32	APPO
35	,	,	,	_	34	P
36	New	new	NNP	_	37	NMOD
37	Jersey	jersey	NNP	_	34	APPO
38	,	,	,	_	37	P
39	United	united	NNP	_	40	NMOD
40	States	state	NNP	_	37	APPO
41	)	)	-RRB-	_	32	P
42	,	,	,	_	20	P
43	and	and	CC	_	20	COORD
44	hybridized	hybridize	VBN	_	43	CONJ
45	with	with	IN	_	44	MNR
46	32P	0p	NN	_	48	AMOD
47	-	-	HYPH	_	46	P
48	radiolabeled	radiolabeled	VBN	_	55	NMOD
49	full	full	JJ	_	51	NMOD
50	-	-	HYPH	_	49	P
51	length	length	NN	_	55	NMOD
52	mouse	mouse	NN	_	55	NMOD
53	Acadm	acadm	NN	_	55	NMOD
54	cDNA	cdna	NN	_	55	NMOD
55	probe	probe	NN	_	45	PMOD
56	using	use	VBG	_	44	MNR
57	standard	standard	JJ	_	58	NMOD
58	procedures	procedure	NNS	_	56	OBJ
59	[	[	-LRB-	_	60	P
60	28	0	CD	_	10	PRN
61	]	]	-RRB-	_	60	P
62	.	.	.	_	9	P

1	Hybridizations	hybridization	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	performed	perform	VBN	_	2	VC
4	under	under	IN	_	3	MNR
5	highly	highly	RB	_	6	AMOD
6	stringent	stringent	JJ	_	7	NMOD
7	conditions	condition	NNS	_	4	PMOD
8	(	(	-LRB-	_	10	P
9	42	0	CD	_	10	NMOD
10	°C	°c	NN	_	4	PRN
11	in	in	IN	_	10	NMOD
12	2	0	CD	_	14	NMOD
13	×	×	SYM	_	12	P
14	SSC	ssc	NN	_	11	PMOD
15	,	,	,	_	10	P
16	50	0	CD	_	17	NMOD
17	%	%	NN	_	18	NMOD
18	formamide	formamide	NN	_	10	CONJ
19	,	,	,	_	18	P
20	10	0	CD	_	21	NMOD
21	%	%	NN	_	23	NMOD
22	dextran	dextran	NN	_	23	NMOD
23	sulfate	sulfate	NN	_	18	CONJ
24	,	,	,	_	23	P
25	5	0	CD	_	29	NMOD
26	×	×	SYM	_	25	P
27	Denhardt	denhardt	NNP	_	29	NMOD
28	's	's	POS	_	27	NMOD
29	reagent	reagent	NN	_	23	CONJ
30	,	,	,	_	29	P
31	1	0	CD	_	32	NMOD
32	%	%	NN	_	33	NMOD
33	SDS	sd	NN	_	29	CONJ
34	,	,	,	_	33	P
35	and	and	CC	_	33	COORD
36	salmon	salmon	NN	_	37	NMOD
37	sperm	sperm	NN	_	38	NMOD
38	DNA	dna	NN	_	35	CONJ
39	)	)	-RRB-	_	10	P
40	for	for	IN	_	3	TMP
41	18	0	CD	_	42	NMOD
42	h	h	NN	_	40	PMOD
43	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	hybridized	hybridized	JJ	_	3	NMOD
3	filter	filter	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	washed	wash	VBN	_	4	VC
6	two	two	CD	_	7	NMOD
7	times	time	NNS	_	5	TMP
8	in	in	IN	_	5	MNR
9	4	0	CD	_	11	NMOD
10	×	×	SYM	_	9	P
11	SSC	ssc	NN	_	8	PMOD
12	,	,	,	_	11	P
13	0.1	0	CD	_	14	NMOD
14	%	%	NN	_	15	NMOD
15	SDS	sd	NN	_	11	APPO
16	and	and	CC	_	5	COORD
17	two	two	CD	_	18	NMOD
18	times	time	NNS	_	16	GAP-TMP
19	in	in	IN	_	18	MNR
20	2	0	CD	_	22	NMOD
21	×	×	SYM	_	20	P
22	SSC	ssc	NN	_	26	NMOD
23	;	;	:	_	26	P
24	0.1	0	CD	_	25	NMOD
25	%	%	NN	_	26	NMOD
26	SDS	sd	NN	_	19	PMOD
27	at	at	IN	_	5	ADV
28	55	0	CD	_	30	NMOD
29	°	°	NNS	_	30	NMOD
30	C	c	NNP	_	27	PMOD
31	for	for	IN	_	5	TMP
32	1	0	CD	_	33	NMOD
33	h	h	NN	_	31	PMOD
34	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	filter	filter	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	exposed	expose	VBN	_	3	VC
5	to	to	IN	_	4	ADV
6	autoradiographic	autoradiographic	JJ	_	7	NMOD
7	film	film	NN	_	5	PMOD
8	(	(	-LRB-	_	15	P
9	Hyperfilm	hyperfilm	NNP	_	10	NMOD
10	MP	mp	NNP	_	15	DEP
11	;	;	:	_	15	P
12	GE	ge	NNP	_	15	NMOD
13	Healthcare	healthcare	NNP	_	15	NMOD
14	Amersham	amersham	NNP	_	15	NMOD
15	Biosciences	bioscience	NNP	_	7	PRN
16	,	,	,	_	15	P
17	Piscataway	piscataway	NNP	_	15	APPO
18	,	,	,	_	17	P
19	New	new	NNP	_	20	NMOD
20	Jersey	jersey	NNP	_	17	APPO
21	,	,	,	_	20	P
22	United	united	NNP	_	23	NMOD
23	States	state	NNP	_	20	APPO
24	)	)	-RRB-	_	15	P
25	.	.	.	_	3	P

1	Replicate	replicate	JJ	_	5	NMOD
2	agarose	agarose	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	formaldehyde	formaldehyde	NN	_	5	NMOD
5	gels	gel	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	stained	stain	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	ethidium	ethidium	NN	_	10	NMOD
10	bromide	bromide	NN	_	8	PMOD
11	to	to	TO	_	7	PRP
12	verify	verify	VB	_	11	IM
13	equal	equal	JJ	_	15	NMOD
14	RNA	rna	NN	_	15	NMOD
15	loading	loading	NN	_	12	OBJ
16	.	.	.	_	6	P

1	Immunoblot	immunoblot	NN	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	MCAD	mcad	NN	_	5	NMOD
5	protein	protein	NN	_	3	PMOD
6	.	.	.	_	2	P

1	To	to	TO	_	42	PRP
2	evaluate	evaluate	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	quantity	quantity	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	MCAD	mcad	NN	_	7	NMOD
7	protein	protein	NN	_	5	PMOD
8	in	in	IN	_	2	LOC
9	mouse	mouse	NN	_	10	NMOD
10	tissue	tissue	NN	_	8	PMOD
11	,	,	,	_	42	P
12	liver	liver	NN	_	13	NMOD
13	samples	sample	NNS	_	42	SBJ
14	from	from	IN	_	13	NMOD
15	6	0	CD	_	19	NMOD
16	–	–	SYM	_	15	P
17	8	0	CD	_	15	QMOD
18	-	-	HYPH	_	15	P
19	wk	wk	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	old	old	JJ	_	41	NMOD
22	MCAD	mcad	NN	_	41	NMOD
23	+	+	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	+	+	SYM	_	22	P
26	(	(	-LRB-	_	29	P
27	n	n	NN	_	29	SBJ
28	=	=	SYM	_	29	P
29	1	0	CD	_	22	PRN
30	)	)	-RRB-	_	29	P
31	and	and	CC	_	22	COORD
32	MCAD	mcad	NN	_	31	CONJ
33	−	−	SYM	_	32	P
34	/	/	HYPH	_	32	P
35	−	−	SYM	_	32	P
36	(	(	-LRB-	_	39	P
37	n	n	NN	_	39	SBJ
38	=	=	SYM	_	39	P
39	3	0	CD	_	32	PRN
40	)	)	-RRB-	_	39	P
41	mice	mouse	NNS	_	14	PMOD
42	were	be	VBD	_	0	ROOT
43	immediately	immediately	RB	_	42	TMP
44	frozen	freeze	VBN	_	42	VC
45	in	in	IN	_	44	LOC
46	liquid	liquid	JJ	_	47	NMOD
47	nitrogen	nitrogen	NN	_	45	PMOD
48	and	and	CC	_	44	COORD
49	stored	store	VBN	_	48	CONJ
50	at	at	IN	_	49	ADV
51	−	−	SYM	_	52	P
52	80	0	CD	_	53	NMOD
53	°C	°c	NN	_	50	PMOD
54	.	.	.	_	42	P

1	For	for	IN	_	5	PRP
2	analysis	analysis	NN	_	1	PMOD
3	,	,	,	_	5	P
4	tissue	tissue	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	homogenized	homogenize	VBN	_	5	VC
7	and	and	CC	_	6	COORD
8	lysed	lysed	VBN	_	7	CONJ
9	in	in	IN	_	8	LOC
10	RIPA	ripa	NN	_	11	NMOD
11	buffer	buffer	NN	_	9	PMOD
12	(	(	-LRB-	_	15	P
13	1	0	CD	_	15	NMOD
14	×	×	SYM	_	13	P
15	PBS	pb	NN	_	11	PRN
16	,	,	,	_	15	P
17	1	0	CD	_	18	NMOD
18	%	%	NN	_	20	NMOD
19	Nonidet	nonidet	NN	_	20	NMOD
20	P	p	NN	_	15	CONJ
21	-	-	HYPH	_	20	P
22	40	0	CD	_	20	NMOD
23	,	,	,	_	20	P
24	0.5	0	CD	_	25	NMOD
25	%	%	NN	_	27	NMOD
26	sodium	sodium	NN	_	27	NMOD
27	deoxycholate	deoxycholate	NN	_	20	CONJ
28	,	,	,	_	27	P
29	and	and	CC	_	27	COORD
30	1	0	CD	_	31	NMOD
31	%	%	NN	_	32	NMOD
32	SDS	sd	NN	_	29	CONJ
33	)	)	-RRB-	_	15	P
34	with	with	IN	_	8	MNR
35	10	0	CD	_	36	NMOD
36	%	%	NN	_	37	NMOD
37	glycerol	glycerol	NN	_	34	PMOD
38	and	and	CC	_	37	COORD
39	Complete	complete	JJ	_	41	NMOD
40	Protease	protease	NN	_	41	NMOD
41	Inhibitor	inhibitor	NN	_	38	CONJ
42	,	,	,	_	37	P
43	(	(	-LRB-	_	46	P
44	Roche	roche	NNP	_	46	NMOD
45	Diagnostics	diagnostics	NNP	_	46	NMOD
46	Corporation	corporation	NNP	_	37	PRN
47	,	,	,	_	46	P
48	Indianapolis	indianapolis	NNP	_	46	APPO
49	,	,	,	_	48	P
50	Indiana	indiana	NNP	_	48	APPO
51	,	,	,	_	50	P
52	United	united	NNP	_	53	NMOD
53	States	state	NNP	_	50	APPO
54	)	)	-RRB-	_	46	P
55	,	,	,	_	37	P
56	1	0	CD	_	57	NMOD
57	mM	mm	NN	_	37	CONJ
58	of	of	IN	_	57	NMOD
59	phenylmethylsulfonylfluoride	phenylmethylsulfonylfluoride	NN	_	58	PMOD
60	,	,	,	_	57	P
61	and	and	CC	_	57	COORD
62	1	0	CD	_	63	NMOD
63	mM	mm	NN	_	61	CONJ
64	of	of	IN	_	63	NMOD
65	sodium	sodium	NN	_	66	NMOD
66	orthovanadate	orthovanadate	NN	_	64	PMOD
67	.	.	.	_	5	P

1	Lysates	lysates	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	quantified	quantify	VBN	_	2	VC
4	by	by	IN	_	3	MNR
5	Bradford	bradford	NNP	_	8	NMOD
6	BCA	bca	NN	_	8	NMOD
7	protein	protein	NN	_	8	NMOD
8	assay	assay	NN	_	4	PMOD
9	(	(	-LRB-	_	12	P
10	Bio	bio	NNP	_	12	NMOD
11	-	-	HYPH	_	10	P
12	Rad	rad	NNP	_	8	PRN
13	,	,	,	_	12	P
14	Hercules	hercules	NNP	_	12	APPO
15	,	,	,	_	14	P
16	California	california	NNP	_	14	APPO
17	,	,	,	_	16	P
18	United	united	NNP	_	19	NMOD
19	States	state	NNP	_	16	APPO
20	)	)	-RRB-	_	12	P
21	.	.	.	_	2	P

1	Protein	protein	NN	_	2	NMOD
2	lysates	lysates	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	denatured	denature	VBN	_	3	VC
5	,	,	,	_	4	P
6	separated	separate	VBN	_	4	CONJ
7	in	in	IN	_	6	LOC
8	8	0	CD	_	9	NMOD
9	%	%	NN	_	12	NMOD
10	SDS	sd	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	PAGE	page	NN	_	7	PMOD
13	,	,	,	_	6	P
14	and	and	CC	_	6	COORD
15	transferred	transfer	VBN	_	14	CONJ
16	overnight	overnight	RB	_	15	TMP
17	onto	onto	IN	_	15	DIR
18	a	a	DT	_	22	NMOD
19	0.45	0	CD	_	20	NMOD
20	μm	μm	NN	_	22	NMOD
21	nitrocellulose	nitrocellulose	NN	_	22	NMOD
22	membrane	membrane	NN	_	17	PMOD
23	(	(	-LRB-	_	24	P
24	Schleicher	schleicher	NNP	_	22	PRN
25	and	and	CC	_	24	COORD
26	Schuell	schuell	NNP	_	25	CONJ
27	,	,	,	_	24	P
28	Keene	keene	NNP	_	24	APPO
29	,	,	,	_	28	P
30	New	new	NNP	_	31	NMOD
31	Hampshire	hampshire	NNP	_	28	APPO
32	,	,	,	_	31	P
33	United	united	NNP	_	34	NMOD
34	States	state	NNP	_	31	APPO
35	)	)	-RRB-	_	24	P
36	.	.	.	_	3	P

1	After	after	IN	_	22	TMP
2	blocking	block	VBG	_	1	PMOD
3	with	with	IN	_	2	MNR
4	5	0	CD	_	5	NMOD
5	%	%	NN	_	7	NMOD
6	nonfat	nonfat	JJ	_	7	NMOD
7	milk	milk	NN	_	3	PMOD
8	in	in	IN	_	2	LOC
9	phosphate	phosphate	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	buffered	buffer	VBN	_	12	NMOD
12	saline	saline	NN	_	8	PMOD
13	with	with	IN	_	12	NMOD
14	0.1	0	CD	_	15	NMOD
15	%	%	NN	_	16	NMOD
16	Tween	tween	NN	_	13	PMOD
17	-	-	HYPH	_	16	P
18	20	0	CD	_	16	NMOD
19	,	,	,	_	22	P
20	the	the	DT	_	21	NMOD
21	membrane	membrane	NN	_	22	SBJ
22	was	be	VBD	_	0	ROOT
23	immunoblotted	immunoblotted	VBN	_	22	VC
24	overnight	overnight	RB	_	23	TMP
25	at	at	IN	_	23	ADV
26	4	0	CD	_	27	NMOD
27	°C	°c	NN	_	25	PMOD
28	with	with	IN	_	23	MNR
29	1	0	CD	_	32	NMOD
30	:	:	SYM	_	29	P
31	500	0	CD	_	29	QMOD
32	dilution	dilution	NN	_	28	PMOD
33	of	of	IN	_	32	NMOD
34	an	an	DT	_	36	NMOD
35	anti-MCAD	anti-mcad	JJ	_	36	NMOD
36	antibody	antibody	NN	_	33	PMOD
37	.	.	.	_	22	P

1	Blots	blot	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	incubated	incubate	VBN	_	2	VC
4	in	in	IN	_	3	MNR
5	anti-mouse	anti-mouse	JJ	_	11	NMOD
6	IgG	igg	NN	_	11	NMOD
7	HRP	hrp	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	conjugated	conjugate	VBN	_	11	NMOD
10	secondary	secondary	JJ	_	11	NMOD
11	antibody	antibody	NN	_	4	PMOD
12	for	for	IN	_	3	TMP
13	2	0	CD	_	16	NMOD
14	–	–	SYM	_	13	P
15	4	0	CD	_	13	QMOD
16	h	h	NN	_	12	PMOD
17	at	at	IN	_	3	ADV
18	room	room	NN	_	19	NMOD
19	temperature	temperature	NN	_	17	PMOD
20	using	use	VBG	_	3	MNR
21	standard	standard	JJ	_	22	NMOD
22	procedures	procedure	NNS	_	20	OBJ
23	and	and	CC	_	3	COORD
24	developed	develop	VBN	_	23	CONJ
25	by	by	IN	_	24	MNR
26	chemiluminiscence	chemiluminiscence	NN	_	25	PMOD
27	(	(	-LRB-	_	28	P
28	Renaissance	renaissance	NNP	_	26	PRN
29	,	,	,	_	28	P
30	NEN	nen	NNP	_	32	NMOD
31	Lifesciences	lifesciences	NNP	_	32	NMOD
32	Products	product	NNPS	_	28	APPO
33	,	,	,	_	32	P
34	Boston	boston	NNP	_	32	APPO
35	,	,	,	_	34	P
36	Massachusetts	massachusetts	NNP	_	34	APPO
37	,	,	,	_	36	P
38	United	united	NNP	_	39	NMOD
39	States	state	NNP	_	36	APPO
40	)	)	-RRB-	_	28	P
41	.	.	.	_	2	P

1	Liver	liver	NN	_	2	NMOD
2	enzyme	enzyme	NN	_	3	NMOD
3	activity	activity	NN	_	0	ROOT
4	.	.	.	_	3	P

1	In	in	IN	_	12	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	evaluate	evaluate	VB	_	3	IM
5	MCAD	mcad	NN	_	6	NMOD
6	activity	activity	NN	_	4	OBJ
7	in	in	IN	_	4	LOC
8	mice	mouse	NNS	_	7	PMOD
9	,	,	,	_	12	P
10	liver	liver	NN	_	11	NMOD
11	homogenates	homogenate	NNS	_	12	SBJ
12	were	be	VBD	_	0	ROOT
13	prepared	prepare	VBN	_	12	VC
14	from	from	IN	_	13	ADV
15	MCAD	mcad	NN	_	29	NMOD
16	+	+	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	+	+	SYM	_	15	P
19	(	(	-LRB-	_	22	P
20	n	n	NN	_	22	SBJ
21	=	=	SYM	_	22	P
22	5	0	CD	_	15	PRN
23	)	)	-RRB-	_	22	P
24	and	and	CC	_	15	COORD
25	MCAD	mcad	NN	_	24	CONJ
26	−	−	SYM	_	25	P
27	/	/	HYPH	_	25	P
28	−	−	SYM	_	25	P
29	mice	mouse	NNS	_	14	PMOD
30	(	(	-LRB-	_	33	P
31	n	n	NN	_	33	SBJ
32	=	=	SYM	_	33	P
33	5	0	CD	_	29	PRN
34	)	)	-RRB-	_	33	P
35	.	.	.	_	12	P

1	The	the	DT	_	9	NMOD
2	sensitive	sensitive	JJ	_	9	NMOD
3	and	and	CC	_	2	COORD
4	highly	highly	RB	_	5	AMOD
5	specific	specific	JJ	_	3	CONJ
6	anaerobic	anaerobic	JJ	_	7	NMOD
7	ETF	etf	NN	_	9	NMOD
8	reduction	reduction	NN	_	9	NMOD
9	assay	assay	NN	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	used	use	VBN	_	10	VC
12	on	on	IN	_	11	ADV
13	tissue	tissue	NN	_	14	NMOD
14	extracts	extract	NNS	_	12	PMOD
15	with	with	IN	_	14	NMOD
16	octanoyl	octanoyl	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	CoA	coa	NN	_	15	PMOD
19	(	(	-LRB-	_	20	P
20	C8	c0	NN	_	18	PRN
21	)	)	-RRB-	_	20	P
22	and	and	CC	_	18	COORD
23	palmitoyl	palmitoyl	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	CoA	coa	NN	_	22	CONJ
26	(	(	-LRB-	_	27	P
27	C16	c0	NN	_	25	PRN
28	)	)	-RRB-	_	27	P
29	as	as	IN	_	18	NMOD
30	substrate	substrate	NN	_	29	PMOD
31	as	as	IN	_	11	ADV
32	previously	previously	RB	_	33	TMP
33	described	describe	VBN	_	31	SUB
34	[	[	-LRB-	_	35	P
35	29	0	CD	_	11	PRN
36	]	]	-RRB-	_	35	P
37	.	.	.	_	10	P

1	Fasting	fasting	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	cold	cold	NN	_	4	NMOD
4	challenge	challenge	NN	_	2	CONJ
5	.	.	.	_	1	P

1	Eight	eight	CD	_	3	NMOD
2	-	-	HYPH	_	1	P
3	wk	wk	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	old	old	JJ	_	15	NMOD
6	MCAD	mcad	NN	_	15	NMOD
7	+	+	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	+	+	SYM	_	6	P
10	and	and	CC	_	6	COORD
11	MCAD	mcad	NN	_	10	CONJ
12	−	−	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	−	−	SYM	_	11	P
15	mice	mouse	NNS	_	16	SBJ
16	were	be	VBD	_	0	ROOT
17	fasted	fast	VBN	_	16	VC
18	for	for	IN	_	17	TMP
19	18	0	CD	_	20	NMOD
20	h	h	NN	_	18	PMOD
21	(	(	-LRB-	_	24	P
22	cold	cold	NN	_	23	NMOD
23	tolerance	tolerance	NN	_	24	NMOD
24	experiments	experiment	NNS	_	20	PRN
25	)	)	-RRB-	_	24	P
26	or	or	CC	_	20	COORD
27	24	0	CD	_	28	NMOD
28	h	h	NN	_	26	CONJ
29	(	(	-LRB-	_	42	P
30	serum	serum	NN	_	31	NMOD
31	glucose	glucose	NN	_	42	NMOD
32	,	,	,	_	31	P
33	free	free	JJ	_	35	NMOD
34	fatty	fatty	JJ	_	35	NMOD
35	acid	acid	NN	_	31	CONJ
36	,	,	,	_	35	P
37	organic	organic	JJ	_	38	NMOD
38	acid	acid	NN	_	35	CONJ
39	,	,	,	_	38	P
40	and	and	CC	_	38	COORD
41	carnitine	carnitine	NN	_	40	CONJ
42	experiments	experiment	NNS	_	28	PRN
43	)	)	-RRB-	_	42	P
44	prior	prior	JJ	_	45	PMOD
45	to	to	IN	_	17	TMP
46	analysis	analysis	NN	_	45	PMOD
47	.	.	.	_	16	P

1	Glucose	glucose	NN	_	2	NMOD
2	concentration	concentration	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	measured	measure	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	10	0	CD	_	7	NMOD
7	μl	μl	NN	_	8	NMOD
8	sera	serum	NNS	_	5	PMOD
9	using	use	VBG	_	4	MNR
10	an	an	DT	_	14	NMOD
11	Ektachem	ektachem	NN	_	12	NMOD
12	DT	dt	NN	_	14	NMOD
13	II	ii	CD	_	12	NMOD
14	system	system	NN	_	9	OBJ
15	(	(	-LRB-	_	20	P
16	Johnson	johnson	NNP	_	20	NMOD
17	and	and	CC	_	16	COORD
18	Johnson	johnson	NNP	_	17	CONJ
19	Clinical	clinical	NNP	_	20	NMOD
20	Diagnostics	diagnostics	NNP	_	14	PRN
21	,	,	,	_	20	P
22	Rochester	rochester	NNP	_	20	APPO
23	,	,	,	_	22	P
24	New	new	NNP	_	25	NMOD
25	York	york	NNP	_	22	APPO
26	,	,	,	_	25	P
27	United	united	NNP	_	28	NMOD
28	States	state	NNP	_	25	APPO
29	)	)	-RRB-	_	20	P
30	.	.	.	_	3	P

1	Total	total	JJ	_	6	NMOD
2	non-esterified	non-esterified	JJ	_	4	NMOD
3	fatty	fatty	JJ	_	4	NMOD
4	acids	acid	NNS	_	6	NMOD
5	(	(	-LRB-	_	6	P
6	NEFA	nefa	NN	_	8	SBJ
7	)	)	-RRB-	_	8	P
8	were	be	VBD	_	0	ROOT
9	measured	measure	VBN	_	8	VC
10	by	by	IN	_	9	MNR
11	an	an	DT	_	15	NMOD
12	enzymatic	enzymatic	JJ	_	15	NMOD
13	,	,	,	_	15	P
14	colorimetric	colorimetric	JJ	_	15	NMOD
15	method	method	NN	_	10	PMOD
16	(	(	-LRB-	_	25	P
17	“	“	``	_	25	P
18	NEFA	nefa	NN	_	20	NMOD
19	-	-	HYPH	_	18	P
20	C	c	NN	_	22	NMOD
21	”	”	''	_	22	P
22	reagents	reagent	NNS	_	25	DEP
23	,	,	,	_	25	P
24	Wako	wako	NNP	_	25	NMOD
25	Diagnostics	diagnostics	NNP	_	9	PRN
26	,	,	,	_	25	P
27	Richmond	richmond	NNP	_	25	APPO
28	,	,	,	_	27	P
29	Virginia	virginia	NNP	_	27	APPO
30	,	,	,	_	29	P
31	United	united	NNP	_	32	NMOD
32	States	state	NNP	_	29	APPO
33	)	)	-RRB-	_	25	P
34	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	assay	assay	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	modified	modify	VBN	_	3	VC
5	to	to	TO	_	4	PRP
6	accommodate	accommodate	VB	_	5	IM
7	a	a	DT	_	10	NMOD
8	reduced	reduce	VBN	_	10	NMOD
9	sample	sample	NN	_	10	NMOD
10	size	size	NN	_	6	OBJ
11	(	(	-LRB-	_	13	P
12	10	0	CD	_	13	NMOD
13	μl	μl	NN	_	10	PRN
14	)	)	-RRB-	_	13	P
15	and	and	CC	_	10	COORD
16	use	use	NN	_	15	CONJ
17	of	of	IN	_	16	NMOD
18	a	a	DT	_	20	NMOD
19	microplate	microplate	NN	_	20	NMOD
20	reader	reader	NN	_	17	PMOD
21	for	for	IN	_	20	NMOD
22	measurement	measurement	NN	_	21	PMOD
23	of	of	IN	_	22	NMOD
24	optical	optical	JJ	_	25	NMOD
25	density	density	NN	_	23	PMOD
26	at	at	IN	_	25	NMOD
27	550	0	CD	_	28	NMOD
28	nm	nm	NN	_	26	PMOD
29	.	.	.	_	3	P

1	Urine	urine	NN	_	3	NMOD
2	organic	organic	JJ	_	3	NMOD
3	acid	acid	NN	_	4	NMOD
4	analyses	analysis	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	performed	perform	VBN	_	5	VC
7	using	use	VBG	_	6	MNR
8	gas	gas	NN	_	9	NMOD
9	chromatography	chromatography	NN	_	12	NMOD
10	-	-	HYPH	_	9	P
11	mass	mass	NN	_	12	NMOD
12	spectroscopy	spectroscopy	NN	_	7	OBJ
13	as	as	IN	_	7	ADV
14	previously	previously	RB	_	15	TMP
15	described	describe	VBN	_	13	SUB
16	[	[	-LRB-	_	19	P
17	22	0	CD	_	19	NMOD
18	,	,	,	_	19	P
19	30	0	CD	_	6	PRN
20	]	]	-RRB-	_	19	P
21	,	,	,	_	6	P
22	except	except	IN	_	6	ADV
23	tetracosane	tetracosane	NN	_	37	SBJ
24	(	(	-LRB-	_	27	P
25	C24	c0	NN	_	27	DEP
26	;	;	:	_	27	P
27	Sigma	sigma	NNP	_	23	PRN
28	,	,	,	_	27	P
29	St.	st.	NNP	_	30	NMOD
30	Louis	louis	NNP	_	27	APPO
31	,	,	,	_	30	P
32	Missouri	missouri	NNP	_	30	APPO
33	,	,	,	_	32	P
34	United	united	NNP	_	35	NMOD
35	States	state	NNP	_	32	APPO
36	)	)	-RRB-	_	27	P
37	was	be	VBD	_	22	PMOD
38	used	use	VBN	_	37	VC
39	as	as	IN	_	38	ADV
40	the	the	DT	_	42	NMOD
41	internal	internal	JJ	_	42	NMOD
42	standard	standard	NN	_	39	PMOD
43	,	,	,	_	5	P
44	and	and	CC	_	5	COORD
45	quantitative	quantitative	JJ	_	46	NMOD
46	determinations	determination	NNS	_	47	SBJ
47	were	be	VBD	_	44	CONJ
48	made	make	VBN	_	47	VC
49	based	base	VBN	_	48	ADV
50	on	on	IN	_	49	PMOD
51	comparison	comparison	NN	_	50	PMOD
52	with	with	IN	_	51	NMOD
53	synthetic	synthetic	JJ	_	55	NMOD
54	calibration	calibration	NN	_	55	NMOD
55	standards	standard	NNS	_	52	PMOD
56	.	.	.	_	5	P

1	Acylcarnitine	acylcarnitine	NN	_	2	NMOD
2	analyses	analysis	NNS	_	7	SBJ
3	in	in	IN	_	2	LOC
4	serum	serum	NN	_	3	PMOD
5	and	and	CC	_	4	COORD
6	bile	bile	NN	_	5	CONJ
7	were	be	VBD	_	0	ROOT
8	conducted	conduct	VBN	_	7	VC
9	using	use	VBG	_	8	MNR
10	electrospray	electrospray	NN	_	13	NMOD
11	tandem	tandem	JJ	_	13	NMOD
12	mass	mass	NN	_	13	NMOD
13	spectrometry	spectrometry	NN	_	9	OBJ
14	[	[	-LRB-	_	17	P
15	31	0	CD	_	17	NMOD
16	,	,	,	_	17	P
17	32	0	CD	_	8	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	7	P

1	Histopathology	histopathology	NN	_	0	ROOT
2	.	.	.	_	1	P

1	Twelve	twelve	CD	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	examined	examine	VBN	_	3	VC
5	for	for	IN	_	4	PRP
6	gross	gross	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	histologic	histologic	JJ	_	7	CONJ
9	abnormalities	abnormality	NNS	_	5	PMOD
10	,	,	,	_	4	P
11	including	include	VBG	_	2	NMOD
12	one	one	CD	_	11	PMOD
13	male	male	JJ	_	12	NMOD
14	and	and	CC	_	12	COORD
15	one	one	CD	_	14	CONJ
16	female	female	JJ	_	15	NMOD
17	MCAD	mcad	NN	_	21	NMOD
18	−	−	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	−	−	SYM	_	17	P
21	mouse	mouse	NN	_	15	NMOD
22	18	0	CD	_	24	NMOD
23	-	-	HYPH	_	22	P
24	mo	mo	NN	_	26	AMOD
25	-	-	HYPH	_	24	P
26	old	old	JJ	_	21	NMOD
27	,	,	,	_	21	P
28	one	one	CD	_	37	NMOD
29	male	male	JJ	_	28	NMOD
30	and	and	CC	_	28	COORD
31	one	one	CD	_	30	CONJ
32	female	female	JJ	_	31	NMOD
33	MCAD	mcad	NN	_	37	NMOD
34	+	+	SYM	_	33	P
35	/	/	HYPH	_	33	P
36	+	+	SYM	_	33	P
37	mouse	mouse	NN	_	21	CONJ
38	6	0	CD	_	40	NMOD
39	-	-	HYPH	_	38	P
40	mo	mo	NN	_	42	AMOD
41	-	-	HYPH	_	40	P
42	old	old	JJ	_	37	NMOD
43	,	,	,	_	37	P
44	two	two	CD	_	37	CONJ
45	male	male	JJ	_	44	NMOD
46	and	and	CC	_	44	COORD
47	two	two	CD	_	46	CONJ
48	female	female	JJ	_	47	NMOD
49	MCAD	mcad	NN	_	53	NMOD
50	−	−	SYM	_	49	P
51	/	/	HYPH	_	49	P
52	−	−	SYM	_	49	P
53	mice	mouse	NNS	_	47	NMOD
54	4	0	CD	_	56	NMOD
55	-	-	HYPH	_	54	P
56	wk	wk	NN	_	58	AMOD
57	-	-	HYPH	_	56	P
58	old	old	JJ	_	53	NMOD
59	,	,	,	_	53	P
60	and	and	CC	_	53	COORD
61	two	two	CD	_	60	CONJ
62	male	male	JJ	_	61	NMOD
63	and	and	CC	_	61	COORD
64	two	two	CD	_	63	CONJ
65	female	female	JJ	_	64	NMOD
66	MCAD	mcad	NN	_	70	NMOD
67	+	+	SYM	_	66	P
68	/	/	HYPH	_	66	P
69	+	+	SYM	_	66	P
70	mice	mouse	NNS	_	64	NMOD
71	4	0	CD	_	73	NMOD
72	-	-	HYPH	_	71	P
73	wk	wk	NN	_	75	AMOD
74	-	-	HYPH	_	73	P
75	old	old	JJ	_	70	NMOD
76	.	.	.	_	3	P

1	Kidney	kidney	NN	_	20	SBJ
2	,	,	,	_	1	P
3	spleen	spleen	NN	_	1	CONJ
4	,	,	,	_	3	P
5	pancreas	pancreas	NN	_	3	CONJ
6	,	,	,	_	5	P
7	liver	liver	NN	_	5	CONJ
8	,	,	,	_	7	P
9	brain	brain	NN	_	7	CONJ
10	,	,	,	_	9	P
11	heart	heart	NN	_	9	CONJ
12	,	,	,	_	11	P
13	testicles	testicle	NNS	_	11	CONJ
14	,	,	,	_	13	P
15	ovaries	ovary	NNS	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	skeletal	skeletal	JJ	_	19	NMOD
19	muscle	muscle	NN	_	17	CONJ
20	were	be	VBD	_	0	ROOT
21	fixed	fix	VBN	_	20	VC
22	by	by	IN	_	21	MNR
23	immersion	immersion	NN	_	22	PMOD
24	in	in	IN	_	23	LOC
25	buffered	buffer	VBN	_	28	NMOD
26	10	0	CD	_	27	NMOD
27	%	%	NN	_	28	NMOD
28	formalin	formalin	NN	_	24	PMOD
29	,	,	,	_	21	P
30	processed	process	VBN	_	21	CONJ
31	routinely	routinely	RB	_	30	ADV
32	for	for	IN	_	30	PRP
33	paraffin	paraffin	NN	_	34	NMOD
34	sectioning	sectioning	NN	_	32	PMOD
35	,	,	,	_	30	P
36	sectioned	section	VBN	_	30	CONJ
37	at	at	IN	_	36	ADV
38	5	0	CD	_	39	NMOD
39	μm	μm	NN	_	37	PMOD
40	,	,	,	_	36	P
41	and	and	CC	_	36	COORD
42	stained	stain	VBN	_	41	CONJ
43	with	with	IN	_	42	MNR
44	hematoxylin	hematoxylin	NN	_	43	PMOD
45	and	and	CC	_	44	COORD
46	eosin	eosin	NN	_	45	CONJ
47	.	.	.	_	20	P

1	Frozen	freeze	VBN	_	3	NMOD
2	liver	liver	NN	_	3	NMOD
3	sections	section	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	prepared	prepare	VBN	_	4	VC
6	using	use	VBG	_	5	MNR
7	standard	standard	JJ	_	8	NMOD
8	methods	method	NNS	_	6	OBJ
9	and	and	CC	_	4	COORD
10	sections	section	NNS	_	11	SBJ
11	were	be	VBD	_	9	CONJ
12	stained	stain	VBN	_	11	VC
13	with	with	IN	_	12	MNR
14	Oil	oil	NN	_	18	NMOD
15	-	-	HYPH	_	14	P
16	red	red	JJ	_	18	NMOD
17	-	-	HYPH	_	16	P
18	O	o	NN	_	13	PMOD
19	.	.	.	_	4	P

1	Slides	slide	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	examined	examine	VBN	_	2	VC
4	without	without	IN	_	3	ADV
5	knowledge	knowledge	NN	_	4	PMOD
6	of	of	IN	_	5	NMOD
7	genotype	genotype	NN	_	6	PMOD
8	or	or	CC	_	7	COORD
9	age	age	NN	_	8	CONJ
10	.	.	.	_	2	P

1	Other	other	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	examined	examine	VBN	_	3	VC
5	because	because	IN	_	4	PRP
6	of	of	IN	_	5	PMOD
7	sporadic	sporadic	JJ	_	9	NMOD
8	clinical	clinical	JJ	_	9	NMOD
9	disease	disease	NN	_	5	PMOD
10	.	.	.	_	3	P

1	Those	those	DT	_	6	SBJ
2	with	with	IN	_	1	NMOD
3	visible	visible	JJ	_	5	NMOD
4	cardiac	cardiac	JJ	_	5	NMOD
5	enlargement	enlargement	NN	_	2	PMOD
6	were	be	VBD	_	0	ROOT
7	evaluated	evaluate	VBN	_	6	VC
8	for	for	IN	_	7	PRP
9	cardiac	cardiac	JJ	_	10	NMOD
10	lesions	lesion	NNS	_	8	PMOD
11	.	.	.	_	6	P

1	Statistical	statistical	JJ	_	2	NMOD
2	analyses	analysis	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	Results	result	NNS	_	4	SBJ
2	between	between	IN	_	1	NMOD
3	groups	group	NNS	_	2	PMOD
4	were	be	VBD	_	0	ROOT
5	tested	test	VBN	_	4	VC
6	for	for	IN	_	5	PRP
7	statistical	statistical	JJ	_	8	NMOD
8	significance	significance	NN	_	6	PMOD
9	using	use	VBG	_	5	MNR
10	Student	student	NNP	_	14	NMOD
11	's	's	POS	_	10	NMOD
12	t	t	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	test	test	NN	_	9	OBJ
15	.	.	.	_	4	P

1	A	a	DT	_	2	NMOD
2	p	p	NN	_	5	SBJ
3	<	<	SYM	_	4	P
4	0.05	0	CD	_	2	NMOD
5	was	be	VBD	_	0	ROOT
6	set	set	VBN	_	5	VC
7	as	as	IN	_	6	ADV
8	significant	significant	JJ	_	7	PMOD
9	.	.	.	_	5	P

1	Supporting	support	VBG	_	2	NMOD
2	Information	information	NN	_	0	ROOT

1	Accession	accession	NN	_	2	NMOD
2	Number	number	NN	_	0	ROOT

1	The	the	DT	_	7	NMOD
2	GenBank	genbank	NNP	_	7	NMOD
3	(	(	-LRB-	_	4	P
4	http://www.ncbi.nlm.nih.gov/Genbank	http://www.ncbi.nlm.nih.gov/genbank	NN	_	2	PRN
5	)	)	-RRB-	_	4	P
6	accession	accession	NN	_	7	NMOD
7	number	number	NN	_	13	SBJ
8	for	for	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	mouse	mouse	NN	_	11	NMOD
11	gene	gene	NN	_	12	NMOD
12	Acadm	acadm	NN	_	8	PMOD
13	is	be	VBZ	_	0	ROOT
14	U07159	u0	NN	_	13	PRD
15	.	.	.	_	13	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	thank	thank	VBP	_	0	ROOT
3	Sushama	sushama	NNP	_	4	NMOD
4	Varma	varma	NNP	_	2	OBJ
5	for	for	IN	_	2	PRP
6	technical	technical	JJ	_	7	NMOD
7	assistance	assistance	NN	_	5	PMOD
8	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	research	research	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	ADV
6	the	the	DT	_	17	NMOD
7	University	university	NNP	_	13	NMOD
8	of	of	IN	_	7	NMOD
9	Alabama	alabama	NNP	_	8	PMOD
10	at	at	IN	_	7	LOC
11	Birmingham	birmingham	NNP	_	10	PMOD
12	(	(	-LRB-	_	13	P
13	UAB	uab	NNP	_	17	NMOD
14	)	)	-RRB-	_	17	P
15	Comprehensive	comprehensive	NNP	_	17	NMOD
16	Cancer	cancer	NNP	_	17	NMOD
17	Center	center	NNP	_	29	NMOD
18	(	(	-LRB-	_	24	P
19	Oligonucleotide	oligonucleotide	NNP	_	24	NMOD
20	and	and	CC	_	19	COORD
21	Transgenic	transgenic	NNP	_	22	NMOD
22	Animal	animal	NNP	_	20	CONJ
23	Shared	shared	NNP	_	24	NMOD
24	Facilities	facility	NNP	_	17	PRN
25	)	)	-RRB-	_	24	P
26	grant	grant	NN	_	29	NMOD
27	P30	p0	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	CA13148	ca0	NN	_	5	PMOD
30	,	,	,	_	29	P
31	UAB	uab	NNP	_	36	NMOD
32	Musculoskeletal	musculoskeletal	NNP	_	33	NMOD
33	Disease	disease	NNP	_	36	NMOD
34	and	and	CC	_	33	COORD
35	Arthritis	arthritis	NNP	_	34	CONJ
36	Center	center	NNP	_	46	NMOD
37	(	(	-LRB-	_	41	P
38	Gene	gene	NNP	_	39	NMOD
39	Targeting	targeting	NNP	_	41	NMOD
40	Core	core	NNP	_	41	NMOD
41	Facility	facility	NNP	_	36	PRN
42	)	)	-RRB-	_	41	P
43	grant	grant	NN	_	46	NMOD
44	P60	p0	NN	_	46	NMOD
45	-	-	HYPH	_	44	P
46	AR20614	ar0	NN	_	29	APPO
47	,	,	,	_	46	P
48	UAB	uab	NNP	_	52	NMOD
49	Clinical	clinical	NNP	_	50	NMOD
50	Nutrition	nutrition	NNP	_	52	NMOD
51	Research	research	NNP	_	52	NMOD
52	Center	center	NNP	_	56	NMOD
53	grant	grant	NN	_	56	NMOD
54	P30	p0	NN	_	56	NMOD
55	-	-	HYPH	_	54	P
56	DK	dk	NN	_	46	APPO
57	-	-	HYPH	_	56	P
58	56336	0	CD	_	56	NMOD
59	,	,	,	_	5	P
60	and	and	CC	_	5	COORD
61	by	by	IN	_	60	CONJ
62	National	national	NNP	_	63	NMOD
63	Institutes	institute	NNPS	_	69	NMOD
64	of	of	IN	_	63	NMOD
65	Health	health	NNP	_	64	PMOD
66	grants	grant	NNS	_	69	NMOD
67	R01	r0	NN	_	69	NMOD
68	-	-	HYPH	_	67	P
69	RR02599	rr0	NN	_	61	PMOD
70	(	(	-LRB-	_	71	P
71	PAW	paw	NNP	_	69	PRN
72	)	)	-RRB-	_	71	P
73	,	,	,	_	69	P
74	T32	t0	NN	_	76	NMOD
75	-	-	HYPH	_	74	P
76	RR	rr	NN	_	69	CONJ
77	-	-	HYPH	_	76	P
78	07003	0	CD	_	76	NMOD
79	(	(	-LRB-	_	80	P
80	RJT	rjt	NNP	_	76	PRN
81	)	)	-RRB-	_	80	P
82	,	,	,	_	76	P
83	K01	k0	NN	_	85	NMOD
84	-	-	HYPH	_	83	P
85	RR00129	rr0	NN	_	76	CONJ
86	(	(	-LRB-	_	87	P
87	RJT	rjt	NNP	_	85	PRN
88	)	)	-RRB-	_	87	P
89	,	,	,	_	85	P
90	RO1	ro0	NN	_	92	NMOD
91	-	-	HYPH	_	90	P
92	DK45482	dk0	NN	_	85	CONJ
93	(	(	-LRB-	_	94	P
94	JV	jv	NNP	_	92	PRN
95	)	)	-RRB-	_	94	P
96	,	,	,	_	92	P
97	and	and	CC	_	92	COORD
98	DK54936	dk0	NN	_	97	CONJ
99	(	(	-LRB-	_	100	P
100	JV	jv	NNP	_	98	PRN
101	)	)	-RRB-	_	100	P
102	.	.	.	_	3	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	bp	bp	NN	_	4	NMOD
2	-	-	:	_	4	P
3	base	base	NN	_	4	NMOD
4	pair	pair	NN	_	0	ROOT

1	ES	e	NN	_	4	NMOD
2	-	-	:	_	4	P
3	embryonic	embryonic	JJ	_	4	NMOD
4	stem	stem	NN	_	0	ROOT

1	ETF	etf	NN	_	5	NMOD
2	-	-	:	_	5	P
3	electron	electron	NN	_	4	NMOD
4	transport	transport	NN	_	5	NMOD
5	flavoprotein	flavoprotein	NN	_	0	ROOT

1	MCAD	mcad	NN	_	9	NMOD
2	-	-	:	_	9	P
3	medium	medium	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	chain	chain	NN	_	8	NMOD
6	acyl	acyl	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	CoA	coa	NN	_	9	NMOD
9	dehydrogenase	dehydrogenase	NN	_	0	ROOT

1	SCAD	scad	NN	_	9	NMOD
2	-	-	:	_	9	P
3	short	short	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	chain	chain	NN	_	8	NMOD
6	acyl	acyl	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	CoA	coa	NN	_	9	NMOD
9	dehydrogenase	dehydrogenase	NN	_	0	ROOT

1	SD	sd	NN	_	4	NMOD
2	-	-	:	_	4	P
3	standard	standard	JJ	_	4	NMOD
4	deviation	deviation	NN	_	0	ROOT

1	VLCAD	vlcad	NN	_	10	NMOD
2	-	-	:	_	10	P
3	very	very	RB	_	4	AMOD
4	long	long	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	chain	chain	NN	_	9	NMOD
7	acyl	acyl	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	CoA	coa	NN	_	10	NMOD
10	dehydrogenase	dehydrogenase	NN	_	0	ROOT

1	Footnotes	footnote	NNS	_	0	ROOT

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	declared	declare	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	no	no	DT	_	8	NMOD
7	competing	compete	VBG	_	8	NMOD
8	interests	interest	NNS	_	9	SBJ
9	exist	exist	VBP	_	5	SUB
10	.	.	.	_	3	P

1	Author	author	NN	_	2	NMOD
2	contributions	contribution	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	RJT	rjt	NNP	_	11	SBJ
2	,	,	,	_	1	P
3	JV	jv	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	PR	pr	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	DM	dm	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	PAW	paw	NNP	_	9	CONJ
11	conceived	conceive	VBD	_	0	ROOT
12	and	and	CC	_	11	COORD
13	designed	design	VBD	_	12	CONJ
14	the	the	DT	_	15	NMOD
15	experiments	experiment	NNS	_	11	OBJ
16	.	.	.	_	11	P

1	RJT	rjt	NNP	_	17	SBJ
2	,	,	,	_	1	P
3	DAH	dah	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	LT	lt	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	JV	jv	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	PR	pr	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	DM	dm	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	JDS	jds	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	and	and	CC	_	13	COORD
16	PAW	paw	NNP	_	15	CONJ
17	performed	perform	VBD	_	0	ROOT
18	the	the	DT	_	19	NMOD
19	experiments	experiment	NNS	_	17	OBJ
20	.	.	.	_	17	P

1	RJT	rjt	NNP	_	19	SBJ
2	,	,	,	_	1	P
3	DAH	dah	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	LT	lt	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	JV	jv	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	JDS	jds	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	PR	pr	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	DM	dm	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	TRS	trs	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	PAW	paw	NNP	_	17	CONJ
19	analyzed	analyze	VBD	_	0	ROOT
20	the	the	DT	_	21	NMOD
21	data	datum	NNS	_	19	OBJ
22	and	and	CC	_	19	COORD
23	contributed	contribute	VBD	_	22	CONJ
24	reagents	reagent	NNS	_	29	NMOD
25	/	/	HYPH	_	24	P
26	materials	material	NNS	_	29	NMOD
27	/	/	HYPH	_	26	P
28	analysis	analysis	NN	_	29	NMOD
29	tools	tool	NNS	_	23	OBJ
30	.	.	.	_	19	P

1	RJT	rjt	NNP	_	15	SBJ
2	,	,	,	_	1	P
3	JV	jv	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	PR	pr	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	DM	dm	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	TRS	trs	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	JDS	jds	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	PAW	paw	NNP	_	13	CONJ
15	wrote	write	VBD	_	0	ROOT
16	the	the	DT	_	17	NMOD
17	paper	paper	NN	_	15	OBJ
18	.	.	.	_	15	P

1	Citation	citation	NN	_	0	ROOT
2	:	:	:	_	1	P
3	Tolwani	tolwani	NNP	_	1	CIT
4	RJ	rj	NNP	_	3	DEP
5	,	,	,	_	3	P
6	Hamm	hamm	NNP	_	3	DEP
7	DA	da	NNP	_	3	DEP
8	,	,	,	_	3	P
9	Tian	tian	NNP	_	3	DEP
10	L	l	NNP	_	3	DEP
11	,	,	,	_	3	P
12	Sharer	sharer	NNP	_	3	DEP
13	JD	jd	NNP	_	3	DEP
14	,	,	,	_	3	P
15	Vockley	vockley	NNP	_	3	DEP
16	J	j	NNP	_	3	DEP
17	,	,	,	_	3	P
18	et	et	FW	_	3	DEP
19	al.	al.	FW	_	3	DEP
20	(	(	-LRB-	_	3	P
21	2005	0	CD	_	3	DEP
22	)	)	-RRB-	_	3	P
23	Medium	medium	JJ	_	25	NMOD
24	-	-	HYPH	_	23	P
25	chain	chain	NN	_	28	NMOD
26	acyl	acyl	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	CoA	coa	NN	_	29	NMOD
29	dehydrogenase	dehydrogenase	NN	_	30	NMOD
30	deficiency	deficiency	NN	_	1	DEP
31	in	in	IN	_	30	LOC
32	gene	gene	NN	_	34	AMOD
33	-	-	HYPH	_	32	P
34	targeted	target	VBN	_	35	NMOD
35	mice	mouse	NNS	_	31	PMOD
36	.	.	.	_	1	P

1	PLoS	plo	NN	_	0	ROOT
2	Genet	genet	NN	_	1	DEP
3	1	0	CD	_	1	DEP
4	(	(	-LRB-	_	1	P
5	2	0	CD	_	1	DEP
6	)	)	-RRB-	_	1	P
7	:	:	:	_	1	P
8	e23	e0	NN	_	1	DEP
9	.	.	.	_	1	P

